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ABSTRACT OF THE DISSERTATION 
Neuropsychological Correlates of Anosognosia in MCI and Dementia 
by 
Kyrstle Dina Barrera 
Doctor of Philosophy, Graduate Program in Psychology 
Loma Linda University, September 2013 
Drs. Travis G. Fogel and Susan A. Ropacki, Co-Chairpersons 
 
Anosognosia is a general term used to describe a lack of awareness of a disability 
and is well documented in various disorders associated with neurological compromise. 
While anosognosia is well documented as part and parcel to Alzheimer’s dementia, less 
research has focused on determining the presence of anosognosia in what has come to be 
viewed as the subclinical precursor to dementia, mild cognitive impairment. In addition, a 
number of different methodologies and instruments are employed in quantifying and 
assessing anosognosia in various populations, which make comparison across studies and 
diagnoses difficult. Research commonly employs a paradigm that uses the discrepancy 
between informant and patient reports as measures of anosognosia, using informant 
reports as the benchmark against which patient ratings are compared. Little research has 
been done, however, to investigate the accuracy of informant reports as they relate to 
actual patient performance.  
The current study sought to investigate the accuracy of patient and informant 
reports as they relate to actual neuropsychological function, identify the presence or 
absence of anosognosia within the MCI population, and explore the diagnostic utility of 
anosognosia assessment in MCI and dementia populations. A total of 49 patients were 
included in the sample (n=24 MCI patients and n=25 dementia patients). Patients 
 xx 
underwent routine neuropsychological evaluation across 6 domains of function. They 
were asked to predict their performance on each neuropsychological measure prior to 
administration, and then evaluate their actual performance subsequent to administration. 
Parallel prediction ratings were solicited from an informant.  
Results indicated that informant predictions were often less accurate with respect 
to actual neuropsychological performance than patient predictions. In addition, MCI 
patients often demonstrated greater levels of anosognosia than their dementia 
counterparts, with their ratings being less favorable than their actual performance. Lastly, 
results indicate that anosognosia measures are reliable in predicting group membership, 
with anosognosia for general cognitive ability and delayed contextual memory being the 
most predictive of all the measures administered. Thus, the current study provides 
evidence for the utility of routine assessment of anosognosia in MCI and dementia 
neuropsychological evaluation.
 
1 
CHAPTER ONE 
INTRODUCTION 
 
Anosognosia Defined 
Anosognosia is a general term used to describe a lack of awareness of a disability 
and was initially coined by Joseph Babinski in 1914 to describe patients who denied left-
sided hemiplegia.  The clinical syndrome that Babinski described was one in which 
patients professed that they were able to engage in activities that required full use of their 
left side, when in fact the left side of their body lay flaccid in their hospital bed.  
Although an unawareness of this magnitude could lead one to question the psychiatric 
underpinning of these beliefs, it was noted long before Babinski’s involvement that this 
behavioral anomaly was typically a result of acute focal cerebral lesions (Prigatano & 
Schacter, 1991).  
Unawareness of injury and its relation to denial of an injury are presumed to be 
two different phenomena, and careful steps are taken in the literature to distinguish 
between the two (Kortte & Wegener, 2004).  Denial of injury is often used to describe a 
characterological dynamic in which a patient is unwilling to accept the presence of a 
medical condition and the impact that is may have on his/her health.  For example, a 
patient diagnosed with diabetes may deny the presence of the disorder and refuse to 
account for the impact it may have on his/her overall well-being, continuing to eat foods 
repeatedly shown to exacerbate the medical condition.  Denial may also be viewed as a 
psychological defense employed by an individual to guard against the emotional pain 
associated with a significant loss (Heilman & Harciarek, 2010).  The clinical presentation 
2 
of denial lies in theoretical contrast to that of anosognosia, which is typically observed in 
conjunction with neurological dysfunction.   
 
Facets and Clinical Relevance of Anosognosia 
Flashman and McAllister (2002) discuss unawareness as a multifaceted construct, 
and identify three dimensions of unawareness that are important in conceptualizing the 
anosognostic picture across different neurologic populations.  The first dimension is 
whether an individual is aware of a specific deficit, and this dimension is commonly a 
dichotomous (yes or no) distinction that can vary across different areas of deficit.  For 
example, an individual may be aware of a deficit in memory but unaware of a deficit in 
social pragmatics.  The second dimension is a corresponding emotional response to each 
area of functioning, regardless of whether or not an individual is aware of a deficit.  This 
second dimension is best understood on a continuum related to emotional arousal, with 
complete indifference (anosodiasphoria) on one end of the spectrum and anger on the 
other.  Given these two dimensions, it is possible that an individual may be aware of a 
deficit but display indifference to it.  The third dimension relates to an individual’s ability 
to appreciate the functional impact that a deficit may have on day-to-day life and speaks 
to the real-world implications of anosognosia and the obstacle it creates in meaningful 
rehabilitation.  An individual may be aware of a deficit, have an emotional response to 
experiencing the deficit, but have little or no grasp of how such a deficit would impede 
his/her daily function, and may fail to appreciate the importance of procuring help from 
friends and family members.  Thus, this dimension is also best understood on a 
continuum, with a lack of appreciation for the functional impact of a deficit on one end 
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and complete appreciation for the functional impact on the other (Flashman & McAllister, 
2002). 
Unawareness puts patients in immediate physical danger, and the impact of 
anosognosia on rehabilitation efforts after an acute injury is immense (Hartman-Maeir, 
Soroker, & Katz, 2001).  For example, a patient without an awareness of his/her own 
hemiplegia may be inclined to get out of bed to use the restroom, which would ultimately 
result in a fall.  Patients with anosognosia have been found to have a higher incidence of 
safety issues as well as a higher incidence of being deemed unsafe at discharge from 
acute rehabilitation (Hartman-Maeir et al., 2001).  Patients lacking insight into their 
impairments will be unable to utilize compensatory strategies in real world situations and 
have the propensity to get into situations that they will subsequently have difficulty 
managing.  They are likely to be unable to assimilate and utilize feedback about their 
limitations to set realistic goals, and have poorer outcome after rehabilitation (see 
Prigatano (2005) for a review).  Due to the fact that they are unaware of their deficits, it is 
likely that patients exhibiting anosognosia will resist help and/or treatment offered by 
family and medical professionals who demonstrate concern for their overall well-being 
(Flashman & McAllister, 2002; McGlynn & Kaszniak, 1991).  In addition, a lack of 
insight into their areas of difficulty will make it more difficult to engage them in 
consistent rehabilitation efforts that are imperative to their overall improvement.  While 
these risks can be managed on an acute inpatient setting, once the patient is no longer in 
daily contact with treating medical providers or family members who may or may not be 
aware of their deficits, the responsibility for rehabilitation falls in the hands of the patient.  
Although the literature on functional outcome after acute rehabilitation for patients with 
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anosognosia is mixed, anosognosia has been implicated as having a negative impact on 
recovery in acute rehabilitation settings as well as in long term recovery (Gialanella, 
Monguzzi, Santoro, & Rocchi, 2005; Hartman-Maeir et al., 2001) 
While it can be difficult to discuss the presence and impact of anosognosia with 
patients who have just endured a life changing incident, having a specific event with 
which to tie functional and/or cognitive changes can make these issues more tangible for 
patients and their families. For patients who exhibit anosognostic traits in relation to 
general, typically longstanding neurological dysfunction, in the absence of acute focal 
neurological damage, clinical concerns become increasingly difficult to broach.  Often 
times cognitive degeneration associated with dementia, for example, is insidious and 
even family members who are actively involved in caregiving for the patient have 
difficulty pinpointing the onset of symptoms (for a review, see Levy (1994)).  In the 
elderly population, it is often difficult for family members to discern the nature of 
cognitive decline associated with normal aging and abnormal cognitive decline indicative 
of neurological dysfunction warranting medical attention (Levy, 1994). Thus, methods of 
compensating for cognitive deficits and promoting healthy cognition are likely to be 
ignored. 
 
Anosognosia in Various Disorders 
As previously discussed, the initial body of literature describing anosognosia 
focused primarily on unawareness of, or lack of appreciation for, the functional impact of 
encapsulated deficits of gross motor or perceptual ability that resulted from acute 
neurological injury (Prigatano & Schacter, 1991).  The nature of these deficits was such 
5 
that they were readily apparent by observers, primarily complete hemiplegia or 
hemianopia.  Over time, the term has broadened in its application and has come to be 
used to describe a lack of insight into any deficit resulting from atypical neurological 
functioning, including focal neurologic damage such as stroke (Kortte & Hillis, 2009; 
Pedersen, Jørgensen, Nakayama, Raaschou, & Olsen, 1996; Starkstein, Jorge, & 
Robinson, 2010), cortical blindness (Prigatano & Wolf, 2010), Wernicke’s aphasia 
(Kertesz, 2010), as well as more diffuse neurologic dysfunction, such as traumatic brain 
injury (Prigatano, 1991, 2005, 2010a), schizophrenia (Gilleen & David, 2010), and a 
variety of dementia (McGlynn & Kaszniak, 1991; O.C. Okonkwo, Spitznagel, Alosco, & 
Tremont, 2010). 
 
Anosognosia and Stroke 
Anosognosia for motor deficits as a consequence of right hemisphere stroke is 
well documented and thoroughly researched (Kortte & Hillis, 2009; Pedersen et al., 1996; 
Starkstein et al., 2010), although the cause of anosognosia and the neuroanatomical 
mechanism of action remains highly disputed.  In a recent literature review on 
anosognosia and stroke, the incidence of anosognosia was cited to range between 20% to 
40%, with the variability across studies ascribed to time since stroke, age, and operational 
definitions of anosognosia (Starkstein, Jorge & Robinson, 2010).  According to Starkstein 
et al.’s (2010) review of the literature, anosognosia often resolves relatively early on in 
the rehabilitation trajectory and is rarely seen three months post-stroke.  The occurrence 
of anosognosia increases with age, and its incidence varies depending on the 
methodology used to define anosognosia in the literature.  Clinically, it is relatively 
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simple to diagnose using discrepancies between interviews with patients reporting their 
functional ability and observation of patients’ actual functional ability, especially for 
impairments as blatant as hemiplegia.  The operational definition that is necessitated by 
systematic research, however, requires that true anosognosia be clearly distinguished 
from other syndromes that are commonly observed with in clinical settings (Starkstein et 
al., 2010).   
Anosognosia in stroke patients is typically seen as one piece of a multifaceted 
clinical presentation, and is often associated with a host of other peculiar symptoms, the 
two most common being a lack of recognition of ownership of a limb (asomatognosia) as 
well as attributing one’s limb to another person (somatoperephrenia).  Anosognosia is 
also observed with concomitant indifference to the affected limb (anosodiaphoria), as 
well as feeling automatic movement in the affected limb (kinaesthetic hallucinations) and 
negative feelings toward the affected limb (misoplegia) (see Starkstein et al., (2010) for 
review).  Interestingly, sensation in the affected limb in these patients is often intact, and 
thus cannot be accounted for by a lack of incoming sensory stimuli.  Although these 
symptoms are typically documented in right hemisphere damage, anosognosia for motor 
impairment has also been documented in left hemisphere damage, which complicates the 
explanation of the anosognostic syndrome as being “housed” in right hemisphere 
function (Cocchini, Beschin, Cameron, Fotopoulou, & Della Sala, 2009). 
 
Anosognosia and Focal Lesions: Cortical Blindness 
Anton’s syndrome, or cortical blindness, is a loss of vision characterized by 
dysfunction of the occipital lobe where visual sensory information is processed.  This is 
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in contrast to the more common forms of blindness associated with a dysfunction of 
sensory perception (Vighetto & Krolak-Salmon, 2007).  Anosognosia for cortical 
blindness is also highly documented in the literature, actually predating the time of 
Babinski.  In 1898, Anton reported cases of patients who demonstrated unawareness of 
visual loss incurred as a result of focal cerebral lesions (as cited in Prigatano, 2010b).  
Due to the fact that cortical blindness is not a focus of current anosognostic research, 
there has been little advancement in its understanding.  According to theoretical 
discussion by Prigatano and Wolf (2010), the clinical presentation of anosognosia for 
cortical blindness deserves special attention and the authors proposed a specific set of 
terminology to differentiate between its subtypes.  The authors argue that Anton’s 
syndrome is a term that should be reserved for patients who experience true cortical 
blindness, or experience complete loss of vision secondary to bilateral primary visual 
cortex damage in the occipital lobe, and demonstrate an unawareness of this blindness.  
The term Anton-like syndrome should be ascribed to patients who are completely blind 
secondary to damage to the orbit or to the optic nerve, and thus not cortical in nature.  
Lastly, Prigatano and Wolf (2010) posit that those patients unaware of a hemianopia 
(UHEM) secondary to damage to visual projection areas should be differentiated as well.  
These patients’ blindness is, by definition, limited to discernable portions of their visual 
field(s) as a direct result of brain lesions.  A majority of the literature on Anton’s and 
related syndromes consists of case studies, and little is known about the neuroanatomical 
underpinnings of how these conditions relate to unawareness and why the two often go 
hand in hand.  
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Anosognosia and Focal Lesions: Wernicke’s Aphasia 
 An arguably more frequent clinical syndrome that results from acute neurological 
insult, and a prime example of anosognostic behavior, is that of jargon aphasia, also 
referred to as “anosognosic aphasia” (Rubens & Garrett, 1991).  Jargon aphasia is 
traditionally associated with Wernicke’s aphasia, but is also seen in transcortical sensory 
and global aphasia.  It is colloquially referred to as “word salad”, such that meaningless 
combinations of words wrought with phonemic, semantic, and neologistic paraphasias 
characterize a patient’s speech (for a review of aphasia, see Abutalebi & Cappa, 2008).  
Of note, and the reason this behavioral pattern is associated with anosognosia, is that 
patients exhibiting this type of speech have no awareness that their speech is nonsensical 
and no insight into the fact that the listener is unable to comprehend what they are saying.  
The fact that these patients are so fluent in their speech, speaking without correction, 
pause, or hesitation, suggests that they are simply unaware that anything is in need of 
being corrected (Kertesz, 2010; Rubens & M. F. Garrett, 1991). 
 
Anosognosia and Traumatic Brain Injury 
 While many early accounts of anosognosia are related to focal cerebral injury, 
more recent inquiry into anosognosia focuses on more diffuse neurological involvement.  
Although detailed accounts date back to the time of Phineas Gage, anosognosia 
subsequent to traumatic brain injury has been the topic of scientific investigation in more 
recent anosognosia literature.  While significant strides have been made in quantifying 
and systematically studying the disorder, the wide range of abilities and disabilities for 
which a patient could be lacking awareness as well as the variation in the degree of 
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severity of unawareness makes generalizable conclusions difficult to achieve (Dirette & 
Plaisier, 2007; Hart, Sherer, Whyte, Polansky, & Novack, 2004; Hoofien, Gilboa, Vakil, 
& Barak, 2004; Newman, Garmoe, Beatty, & Ziccardi, 2000; G.P. Prigatano, 2010a; 
Trahan, Pepin, & Hopps, 2006).  While previously discussed anosognostic phenomena 
were related to specific deficits in awareness, traumatic brain injury can lead to impaired 
awareness across many areas of life.  Thus, the lack of awareness in traumatic brain 
injury is often multifaceted, including, but not limited to, overall cognitive ability, 
sensorimotor functioning, general mood state and emotional lability, behavioral 
impulsivity, and social pragmatics.   
 Flashman and McAllister (2002) reported that up to 45% of individuals who have 
sustained a moderate to severe traumatic brain injury exhibit deficits in awareness of 
disabilities that are readily observable by others, and that these deficits in awareness, 
unlike that of anosognosia of hemiplegia post-stroke, are often permanent.  Numerous 
questionnaires and interviews have been constructed to measure anosognosia in traumatic 
brain injury populations, but many of these studies are confounded by the presence of 
denial that is not quantifiably differentiated.  In the previously discussed neurological 
disorders, anosognosia is often seen in the absence of any severe cognitive impairment, 
thus the patients presumably have the capacity for awareness.  This is in contrast to 
traumatic brain injury, where impaired self-awareness is often seen as part of a 
constellation of cognitive difficulties that may, in and of themselves, render the patient 
cognitively incapable of grasping such an intangible construct.   
Not surprisingly, the severity of the traumatic brain injury, as assessed by length 
of post-traumatic amnesia and admitting Glasgow Come Scale score, has been shown to 
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be related to severity and duration of anosognosia, such that mild traumatic brain injury 
patients often become aware of deficits in balance, memory, concentration, and sensory 
sensitivity (to light and noise) rather quickly (Prigatano, 2010a).  This patient population 
typically experiences distress secondary to their improved awareness, which typically 
abates within the first 30 to 90 days post-injury with improved neuropsychological 
functioning (Prigatano, 2010a).  Their self-assessments of functioning are typically 
comparable to the assessments provided by informants, which facilitates post-injury 
rehabilitation efforts.  For patients with severe traumatic brain injury, the clinical picture 
is often more concerning.  These patients typically have no recollection of their injury 
and often fail to appreciate their need for medical care (Prigatano, 2010a).  Many of these 
individuals, even after undergoing acute inpatient neuropsychological rehabilitation, 
continue to exhibit anosognosia for multiple impairments even one to two years post 
injury.  It is estimated that approximately 30-40% of patients suffering from severe 
traumatic brain injury demonstrate anosognosia, but it is unknown what proportion of 
these patients display longstanding anosognostic behavior (Prigatano, 2010a).  For 
patients with moderate traumatic brain injury, awareness typically emerges once 
posttraumatic amnesia clears, but this rule of thumb is mitigated by frontal lobe 
involvement, such that increased frontal lobe damage is associated with more severe 
levels of anosognosia.  Unfortunately, this group of patients has yet to be well-studied in 
isolation and are typically combined with patients with severe traumatic brain injury in 
research studies (Prigatano, 1991, 2005, 2010a). 
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Anosognosia and Schizophrenia 
Given the complicated nature of assessing anosognosia subsequent to an acute 
neurological insult and the equivocal nature of conclusions from these studies, the study 
of anosognosia in neurological conditions characterized by generalized cognitive 
impairment can be expected to be increasingly complex.  Schizophrenia is traditionally 
viewed as a psychiatric disorder characterized by a general detachment from reality, 
which can be conceptually linked to the unawareness inherent in anosognostic 
phenomena.  Patients with schizophrenia are typically unaware of the presence of a 
mental disorder, which makes treatment and community integration notoriously difficult.  
Given the evidence correlating schizophrenia to frontal lobe dysfunction, and frontal lobe 
dysfunction to impaired self-awareness, viewing schizophrenic symptomology through 
the lens of anosognosia provides an opportunity to combine theoretically related clinical 
syndromes (Gilleen et al., 2010; McGlynn & Kaszniak, 1991; Stuss, 1991).   
According to Gilleen and collegues (2010), the nature of unawareness seen in 
schizophrenia is best conceptualized as a deficit in judgment and reasoning, such that 
they interpret and attribute abnormal perceptions related to hallucinations and delusions 
as true.  Anosognosia secondary to neurological insult, however, is argued to be a product 
of an inaccessibility of the information to monitoring systems responsible for modality 
specific perception.  In current literature, three main theories seek to conceptualize 
unawareness in schizophrenia in the following ways: as a symptom of psychiatric 
symptomology in general, as a result of neuropsychological impairment inherent in 
schizophrenia, or as a psychologically motivated defense against negative emotions.   
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Although the unawareness seen in schizophrenia can theoretically be 
differentiated from the unawareness seen in neurologic populations, there are also 
commonalities between the unawareness observed in the two populations.  Interestingly, 
patients with schizophrenia have been shown to lack awareness regarding their abnormal, 
involuntary motor movements (McGlynn & Kaszniak, 1991).  While it is parsimonious to 
attribute both the presence of the motor movement and the lack of awareness of their 
presence to the side effects of neuroleptic medications, the presence of these motoric 
abnormalities has been documented long before the invention of neuroleptic medication 
and are seen in patients who are unmedicated (McGlynn & Kaszniak, 1991).  Thus, there 
appears to be a connection between the neuroanatomical systems that mediate motor 
movement and that which mediate awareness of motor movement that would account for 
this dynamic, similar to that seen in right hemisphere stroke patients that demonstrate 
anosognosia for hemiplegia.  Analogous to patients with anosognosia secondary to 
diffuse traumatic brain injury, and thus general neurological dysfunction, patients with 
schizophrenia also often experience unawareness of deficit in various spheres of 
functioning, including overall cognitive functioning, mood and irritability, as well as 
social pragmatics.  This implies that awareness may be linked to intact gross systemic 
brain function as opposed to being localized in a specific brain area (Gilleen et al., 2010). 
 
Anosognosia and Dementia 
Similar to schizophrenia, dementia is also characterized by gross neurological 
involvement that is often accompanied by an impaired awareness of both cognitive and 
behavioral deficit.  While the prevalence of anosognosia is debatable in stroke and 
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traumatic brain injury literature, anosognosia is consistently part and parcel to the clinical 
picture of dementia.  It is most frequently reported in dementia of the Alzheimer’s type, 
which is definitively diagnosed post-mortem and is colloquially distinguished by poor 
memory ability (Wagner, Spangenberg, Bachman, & O’Connell, 1997).  Alzheimer’s 
dementia is a degenerative disorder that is characterized by amyloid plaque build up in 
cortical tissue, which impedes proper functioning of neural networks and results in 
dramatic functional decline.  The initial cause for concern in patients who are eventually 
diagnosed with Alzheimer’s dementia is marked forgetfulness, which progresses into 
confusion, and ultimately into disorientation as the disease unfolds (McGlynn & 
Kaszniak, 1991).   
Anosognosia is a common feature of dementia of the Alzheimer’s type, and of 
particular concern to family members and caregivers who cannot understand why their 
loved one is unaware of their decline in functioning or is unconcerned and offers benign 
explanations.  Barrett, Eslinger, Ballentine, and Heilman (2005) conducted a study asking 
patients diagnosed with probably Alzheimer’s dementia (pAD) to conduct pretest and 
posttest estimations of their performance within various cognitive domains.  The pretest 
ratings asked the patient to estimate how well they thought they would do on tasks 
assessing their ability within a certain cognitive domain, such as measures of memory or 
visuospatial skills.  The posttest ratings were conducted after the entire battery of 
measures had been completed, presumably with the patient having a better understanding 
of how they performed on the tasks and better insight into their own capabilities.  The 
authors created an anosognosia ratio, which allowed them to account for both 
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overestimations as well as underestimations, and their performance was compared to a 
control group.   
Barrett and colleagues (2005) found that, compared to their healthy control 
counterparts, patients with pAD overestimated their visuospatial skills on pretesting and 
overestimated their memory skills on post testing.  Thus, visuospatial skill estimations 
were amended by actual performance on tasks, whereas estimations of memory continued 
to be poorly estimated after testing took place.  Thus, patients demonstrated anosognosia 
for memory even after performing poorly on memory tasks.  While the authors noted that 
pAD patients performed significantly worse on memory measures, actual performance on 
neuropsychological testing was not analyzed in relation to their pretest or posttest 
estimations.  Interestingly, these results elucidate domain specific anosognosia and 
differential impact of poor performance on estimations of ability (Barrett et al., 2005).  
Of note, it is unclear if the discrepancy in scores can more readily be accounted for by the 
nature of the patient population’s poor memory, which would preclude participants from 
providing accurate estimates of their performance on measures simply due to a lack of 
memory for having completed them. 
In a review by Agnew and Morris (1998), a number of correlates have been 
proposed to coincide with anosognosia and Alzheimer’s dementia, and it is difficult to 
determine which of these facets are directly related to and/or responsible for the 
anosognostic phenomena seen in this population.  Moreover, failure to adequately 
measure these facets in controlled studies puts them in the position of being potential 
confounds, and could account for the discrepancy in results across studies.  According to 
the authors, anosognosia has been associated with the severity of dementia, with higher 
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levels of anosognosia related to more severe states of dementia, and relatively preserved 
awareness associated with early stages of dementia.    
Current literature on the topic, however, remains inconsistent, with argument that 
even early stages of dementia exhibit marked anosognosia, and that the presence of early 
anosognosia can be used as a predictor of dementia characterized by a more rapid 
deterioration of overall ability (Carr, Gray, Baty, & J. C. Morris, 2000; Derouesné et al., 
1999).  Agnew and Morris (1998) also discuss language impairment as a correlate of 
anosognosia in dementia, which may be related to the anosognosia seen in aphasia 
patients discussed earlier.  Not surprisingly, memory impairment is also correlated with 
anosognosia, as well as executive dysfunction and frontal lobe deficits (Agnew & Morris, 
1998). 
While initial anosognostic literature in Alzheimer’s dementia patients focused on 
the lack of awareness for memory dysfunction, relatively recent literature also highlights 
a lack of awareness for visuospatial skills as well (Agnew & Morris, 1998; Barrett, 
Eslinger, Ballentine, & Heilman, 2005).  Less is known about frontotemporal dementia 
and primary progressive aphasia in relation to anosognosia, primarily due to the fact that 
the literature on anosognosia and dementia is still in its infancy.  Briefly, frontotemporal 
dementia is characterized by marked behavioral changes associated with a decline in 
frontotemporal brain function.  A hallmark of this disorder is the lack of awareness of the 
behavioral changes, as well as a lack of concern when these changes are discussed with 
the patient (Miller & Cummings, 2006).  Thus, a lack of awareness for behavioral 
changes is a main criterion in its diagnosis.  Primary progressive aphasia is another type 
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of dementia associated with frontotemporal degeneration, marked by deficits in language 
ability (Banks & Weintraub, 2009).   
Patients with frontotemporal dementia also demonstrate impaired awareness for 
cognitive and behavioral deficits, which is consistent with the role of the frontal lobes as 
being involved in self-monitoring and inhibition (Agnew & Morris, 1998).  Patients with 
primary progressive aphasia typically do not initially demonstrate impaired awareness, 
but little is known about the awareness of this population because few studies have 
investigated primary progressive aphasia in relation to anosognosia (Agnew & Morris, 
1998).  A study conducted by Banks and Weintraub (2009) found that patients with 
frontotemporal dementia did not significantly differ from patients with Alzheimer’s 
dementia in their level of awareness, but that patients with primary progressive aphasia 
demonstrated relatively intact levels of awareness.  Due to the fact that the 
symptomatology between primary progressive aphasia and frontotemporal dementia 
begin to overlap as both diseases progress, assessment of awareness early on in treatment 
may be a beneficial tool in diagnosis and treatment planning (Banks & Weintraub, 2009) 
 
Anosognosia and Mild Cognitive Impairment 
Current conceptualization of dementia views the disorder as a continuum of 
impairment with mild cognitive impairment on one end of the spectrum and traditional 
dementia on the other, as opposed to a dichotomous diagnostic category.  Mild cognitive 
impairment (MCI) can be viewed as a sub-clinical precursor to dementia, and factors 
predicting conversion to dementia are not well known or understood.  The most 
promising area of research, and the most flourishing, is the investigation of 
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pathognomonic biomarkers beta-amyloid protein () and tau (, which are closely 
associated with the progression of Alzheimer’s dementia (Albert et al., 2011).   and  
are biological markers for the amyloid plaques and neurofibrillary tangles whose buildup 
are thought to be responsible for the neurodegeneration of cortical tissue.  The cognitive 
dysfunction seen in MCI, and ultimately Alzheimer’s dementia, are attributed to this 
neurodegeneration.  The following section provides a review of the current literature 
relating to MCI diagnosis and its clinical presentation.  MCI has received considerable 
attention in recent literature and the prognostic value of levels of insight into areas of 
impairment as a predictor of conversion to Alzheimer’s dementia is gaining popularity.  
Patients with mild cognitive impairment demonstrate impaired awareness for memory 
and visuospatial skills, similar to Alzheimer’s dementia patients (Galeone, Pappalardo, 
Chieffi, Iavarone, & Carlomagno, 2011; Vogel et al., 2004).  In fact, Vogel and 
colleagues (2004) found that there was no statistical difference between the level of 
unawareness demonstrated by patients with mild cognitive impairment and that of 
patients with probable Alzheimer’s dementia.  While Clément, Belleville, and Gauthier 
(2008) found that there was no difference in overall cognitive complaints in both groups, 
numerous studies have found that patients who eventually converted to Alzheimer’s 
dementia reported less deficits than their informants did, and that patients who did not 
convert had the opposite pattern (Okonkwo et al., 2008, 2009).  Patients with mild 
cognitive impairment have also been shown to have impaired insight into functional 
abilities such as driving, medication management, and financial abilities, which presents 
grave concerns for these patients since they are typically in the beginning stages of 
treatment and are, by definition, functionally independent (Okonkwo et al., 2008, 2009).   
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While anosognosia investigation typically focuses on memory and visuospatial 
domains in the MCI and dementia populations, comprehensive evaluation of levels of 
awareness and their relationship with actual neuropsychological performance is limited.  
Anosognosia is conceptualized as a discrepancy score between informant and patient 
predictions of performance, which is problematic in many respects and presents 
challenges to the validity of the conclusions produced by these studies (Derouesné et al., 
1999; Okonkwo et al., 2009; Vogel et al., 2004).  The current study seeks to explore the 
level of awareness in the mild cognitive impairment population using both informant 
ratings and actual neuropsychological performance as means of determining anosognosia 
in a comprehensive neuropsychological battery. 
 
Mild Cognitive Impairment and Dementia 
Diagnostic Criteria for Mild Cognitive Impairment and Dementia 
Mild cognitive impairment is a relatively new diagnosis, and was initially created 
to give attention to patients who did not meet criteria for dementia but displayed 
clinically significant impairment that deserved focused medical care.  While the MCI 
diagnosis has been discussed in prior literature, it was streamlined by Petersen (2004).  
His model proposed four subtypes of MCI that differentiate patients based on the 
domain(s) of impairment.  The most widely researched and arguably most common 
subtype of MCI is the amnestic type single domain, whose hallmark symptom is 
impairment in memory and is thought to convert to dementia of the Alzheimer’s type.  In 
contrast, the MCI non-amnestic type single domain is characterized by impairment in a 
non-memory cognitive domain such as language, visuospatial skills, attention and 
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concentration, or executive function.  This subtype of MCI is the least common and is 
thought to convert into Lewy Body dementia or fronto-temporal dementia.  The last two 
subtypes of MCI both involve multiple areas of impairment, one of which includes 
memory impairment and one that does not.  They are labeled multiple domain amnestic 
type and multiple domain non-amnestic type, and are thought to convert to Alzheimer’s 
dementia and Lewy Body dementia, respectively (Petersen, 2004).    
A majority of the current literature focuses on the type of MCI due to Alzheimer’s 
dementia.  These patients exhibit memory impairment but remain functionally 
independent, and are seen as the subclinical form of what will eventually progress into 
clinical Alzheimer’s dementia (Albert et al., 2011).  Dementia and related disorders can 
also be viewed along a continuum of functionality, with functionally independent MCI 
patients at one end of the spectrum and dementia patients on the other, such that patients 
that meet criteria for a diagnosis of dementia are no longer capable of functional 
independence (Albert et al., 2011). 
While Petersen made great strides in the conceptualization and categorization of 
MCI and its subtypes, further exploration of the topic deemed step-by-step diagnostic 
criteria that would guide overall MCI diagnosis necessary.  Recent efforts have been put 
forth to do just that in order to create a standard set of diagnostic criteria for MCI due to 
Alzheimer’s dementia.  In order to be diagnosed with MCI, a patient must meet the 
following four criteria: (1) Have a concern about a change in cognitive status, either from 
the patient, family members, caregivers, or a treating clinician, obtained through 
thorough clinical evaluation by a skilled clinician.  If serial assessments of patients’ 
cognitive status are available, objective measurement of the changes is helpful.  (2) 
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Objective cognitive impairment in one or more cognitive domains, one of which being 
episodic memory, as obtained by formal clinical neuropsychological evaluation.  Patients 
with MCI typically score between 1 and 1.5 standard deviations below their same age and 
educated peer group, with estimates of premorbid functioning taken into consideration. 
(3) Functional independence is the distinguishing criterion between MCI and dementia, 
such that MCI patients are still able to complete their activities of daily living and 
instrumental activities of daily living with minimal assistance.  Activities of daily living 
include activities such as dressing, bathing, caring for personal hygiene, and cooking, 
whereas instrumental activities of daily living refer to higher-level activities required for 
independent living.  Examples of instrumental activities of daily living are paying bills on 
time, writing checks, or shopping.  Patients may demonstrate decreased efficiency on 
these tasks, but in order to meet criteria for an MCI diagnosis, they must be able to 
complete them with minimal assistance. (4) A lack of a dementia diagnosis (Albert et al., 
2011; McKhann et al., 2011; Petersen, 2004).   
With advances in technology come efforts at obtaining biologically driven, 
objective markers that are useful in determining etiology and prognosis for various 
disorders.  As discussed briefly earlier, the area of dementia research is no exception.  A 
complementary research paradigm for studying MCI has set forth recommendations for 
research protocols studying MCI in an effort to guide the field of study into a more 
standardized assessment across research groups (Albert et al., 2011).  The authors 
propose that tracking beta-amyloid protein () and tau (), both of which are biological 
markers for Alzheimer’s dementia, can help definitively reflect the progression of 
Alzheimer’s dementia and provide support for the contention that MCI due to 
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Alzheimer’s dementia is a predementia stage along the continuum of Alzheimer’s disease 
(Albert et al., 2011). 
 
Neuropsychological Profiles for Mild Cognitive Impairment and 
Dementia 
 Due to the fact that mild cognitive impairment (MCI) can be viewed as a catch-all 
diagnostic entity encompassing multiple types of sub-clinical dementia, the 
neuropsychological profiles that accompany each variant of MCI correlate closely with 
their dementia counterparts. Petersen (2004) proposed a stepwise dichotomous model of 
categorizing the variants of MCI, with the first dichotomous distinction being the 
presence of a memory impairment.  If memory impairment is present, it follows the 
amnestic MCI trajectory with further classification accounting for single domain 
impairment or multiple domain impairment.  Thus, a patient performing in the impaired 
range on  verbal or non-verbal measures of memory and within normal limits on all other 
neuropsychological domains, using Petersen’s model, would be diagnosed with single 
domain amnestic MCI.  Amnestic patients demonstrating impairment in multiple domains 
can be seen as being closer to the dementia threshold than their single domain MCI 
counterparts, as more cognitive impairment is associated with lower functional 
independence.  Of the patients along this trajectory that demonstrate further cognitive 
decline and eventually meet criteria for a diagnosis of dementia, they typically convert to 
dementia of the Alzheimer’s type (Albert et al., 2011; Looi & Sachdev, 1999; Pachana, 
Boone, Miller, Cummings, & Berman, 1996; Petersen, 2004) 
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For diagnosis of patients with intact verbal and visual memory but impairment in 
a non-memory cognitive domain, the non-amnestic MCI trajectory is most appropriate.  
Non-amnestic MCI can also be further categorized into single domain or multiple domain, 
depending on how many impairments are seen on neuropsychological testing (Petersen, 
2004).  Similar to the amnestic MCI trajectory, the non-amnestic, multiple domain MCI 
diagnosis is best viewed as closer to the threshold for a diagnosis of dementia than its 
single domain counterpart, with impairments in multiple cognitive domains indicative of 
lower levels of functionality.  Of the patients that eventually decline to the point of 
functional dependence, these patients may convert to one of a number of different types 
of dementia (Looi & Sachdev, 1999; Petersen, 2004). 
 Vascular dementia is the second most commonly diagnosed type of dementia, but 
unlike Alzheimer’s dementia, it is less widely studied and lacking clear 
neuropsychological profiles consistently produced across studies.  Current diagnostic 
criteria for vascular dementia include the following: (1) Impaired memory, including 
difficulty learning and/or recalling learned information, or the presence of aphasia, 
apraxia, agnosia, or impaired executive function, (2) impairment in social or occupational 
function, (3) focal neurological signs related to cerebrovascular disease and (4) a lack of 
delirium.  Due to the diffuse nature of the vasculature in the brain, there is a lack of 
consensus regarding the typical neuropsychological profile seen in these patients, most 
likely due to the fact that different brain areas can be affected by cerebrovascular disease, 
which would lead to heterogeneity of symptoms (Garrett et al., 2004; Looi & Sachdev, 
1999; McPherson & Cummings, 1996; Sachdev et al., 2004). 
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Many of the non-amnestic dementia diagnoses are still under investigation, and 
research regarding the neuropsychological profiles of each is ongoing.  Many of the 
defining factors that contribute to a diagnosis of a non-amnestic dementia are clinical in 
nature, such that behavioral observation and interpretation become equally as important 
as neuropsychological test performance.   The behavioral variant of frontotemporal 
dementia is often associated with cognitive impairment in one or multiple non-memory 
domains accompanied by dramatic changes in personality, reduced social pragmatics, and 
often times language impairment in the face of intact visuospatial skills (Banks & 
Weintraub, 2009; Neary & Snowden, 1996; Pachana et al., 1996).  Lewy body dementia, 
which can also be seen in conjunction with Alzheimer’s dementia, is associated with 
relatively characteristic delusions and hallucinations, with evidence for executive 
dysfunction and reduced visuospatial skills (Galasko, Katzman, Salmon, & Hansen, 
1996; Salmon et al., 1996) 
  
Neuroanatomical Bases of Anosognosia 
While early research on anosognosia for left sided hemiplegia lent itself to a 
simplistic neuroanatomical explanation for the localization of anosognosia in right 
hemisphere function, the broadening of the anosognostic picture to include different 
diagnoses with diverse neuroanatomical involvement has made neuroanatomical 
correlations for anosognosia exceedingly complex.  Indeed, the accumulation of 
anatomical theories used to make sense of the different neurological and neuropsychiatric 
populations discussed in the current study would implicate almost every gross brain area 
possible in a bilateral fashion.  Anosognosia for hemiplegia and hemianopia would 
24 
implicate right temporal and right occipital involvement, while anosognosia for aphasia 
would implicate left temporal involvement.  Anosognosia for deficits incurred from 
traumatic brain injury typically discuss right frontal or bifrontal involvement.  Similarly, 
anosognosia in schizophrenia is usually associated with bilateral frontal functioning in 
the literature (Banks & Weintraub, 2009).   
Given that research on anosognosia as a result of focal injury has been 
unsuccessful at localizing awareness, it is not surprising that research on disorders 
characterized by general cognitive decline such as MCI and dementia have also been 
unsuccessful at accounting for anosognostic symptoms in a parsimonious 
neuroanatomically based theory.  In general, researchers have resigned to the fact that 
anosognosia is a complex, multifaceted neurological syndrome that is not well 
understood and is still in the beginning stages of research (Gilleen et al., 2010; Kertesz, 
2010; McGlynn & Kaszniak, 1991; Prigatano, 1991; Prigatano & Wolf, 2010; Stuss, 
1991).  Several studies have, however, begun to form the foundation for scientific inquiry 
regarding neuroanatomical correlates of dementia.  Functional imaging studies in 
Alzheimer’s dementia patients revealed hypoperfusion in the prefrontal pathway, which 
includes the right prefrontal cortex, inferior parietal lobe, anterior cingulate gyrus, and 
limbic system.  Further investigation implicated the right post-central gyrus, the right 
parietotemporal-occipital association cortex, and the rostral prefrontal cortex (Cutting, 
1978; Prigatano & Schacter, 1991).  Voxel-based morphometry imaging revealed right 
ventromedial prefrontal cortex involvement in patients with a mixed group of individuals 
with neurodegenerative disease (Rosen et al., 2010).   
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Neuropsychological studies have also attempted to make predictions regarding 
anatomical correlates of anosognosia, which not surprisingly point to frontal dysfunction 
(Rosen et al., 2010).  In general, these studies point to the involvement of prefrontal, 
temporal, and limbic structures in anosognosia and Alzheimer’s dementia, but the 
variability in protocols used across studies make generalizable conclusions difficult to 
obtain (Michon, Deweer, Pillon, Agid, & Dubois, 1994).  It is clear that more research 
needs to be done on this topic in order to fully understand the neuroanatomical 
underpinnings of awareness.  To date, a single study has attempted to use imaging to 
investigate the neurological correlates of awareness in the MCI population.  The authors 
utilized functional imaging technology to quantify brain activity while the patient 
engaged in a self-appraisal task where they were asked to make yes or no determinations 
as to whether a given characteristic (e.g. calm, obnoxious) was self-descriptive.  The 
researchers found reduced activation in cortical midline structures during tasks of self-
appraisal, which they argued attested to the role of cortical midline structures in 
awareness of the self, and thus related to anosognosia.  More research is necessary in 
order to come to meaningful conclusions about the relation of MCI and awareness as it 
relates to cortical and subcortical function (Ries et al., 2007). 
 
Methodological Issues Related to Measuring Awareness 
An integral first step towards systematic, thorough investigation of anosognosia is 
the development of is a robust measure of awareness.  Unfortunately, no such measure 
currently exists in anosognosia literature.  Instead, multiple measures have been 
implemented and none are used consistently across studies.  The following is a discussion 
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of the current methodologies used to quantify awareness, the difficulties associated with 
them, and the proposed methodology used in the current study that seeks to address these 
issues (Fleming, Strong, & Ashton, 1996). 
 
Clinician Diagnosis 
Clinical diagnosis of the presence or absence of anosognosia is relatively simple 
and relies solely upon the clinician’s observation of patient behavior.  The more objective 
the facet of behavior the patient is lacking awareness of, the more straightforward the 
diagnosis.  Thus, for diagnosis of easily observable deficits or deficits that can readily be 
tested bedside, such as hemiplegia and cortical blindness, this method of diagnosis is 
reliable and effective.  As assessment moves from more concrete to more abstract 
domains of cognitive skills or functional activities, however, clinician diagnosis becomes 
less helpful simply because clinicians do not have the luxury of spending extended 
periods of time with patients.  As the deficits for which an individual could potentially be 
unaware become less tangible in nature, reliable measurement becomes increasingly 
difficult.  While it is possible that the presence or absence of a lack of awareness is more 
readily detectable, the level of awareness becomes more difficult to quantify (Orfei, 
Caltagirone, & Spalletta, 2010).   
Structured interviews have been created to address the variability in information 
collected during clinician interviews, but still lead to inconsistent results (Cocchini et al., 
2009; Simmond & J. Fleming, 2003; Trudel, Tryon, & Purdum, 1998).  Clinicians, 
inevitably, will require the input of an informant regarding the patient’s everyday level of 
functioning, which can be assessed in relation to the patient’s perception of his/her 
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abilities, as a measure of overall awareness.  This implies that the informant is the most 
accurate rater of the patient’s true ability, which has not been thoroughly investigated or 
validated in the literature.  An additional problem in this methodology is that the patient 
may acknowledge having difficulty in a certain area of functioning, but have no insight 
into when the deficit is actually occurring, thus making compensation for the area of 
deficit difficult.  Thus, when a clinician is questioning the patient and using this as a 
measure of awareness, the clinician is assuming that awareness of a deficit will lead to 
appropriate compensation for the deficit, which is not always the case.  To address this 
issue, Crosson and collegues (1989) proposed a theoretical framework that accounted for 
various facets of awareness, including intellectual awareness, or the verbal 
acknowledgment of a disorder, emergent awareness that becomes evident when the 
patient has difficulty completing a task in real time, and anticipatory awareness, in which 
the patient is able to appreciate and compensate for the functional impact of a deficit.  
These facets of awareness are difficult to account for by clinician interview alone, which 
may account for the discrepancy in results across studies employing various measures of 
awareness. 
 
Discrepancy between Self and Informant-Reported Ability 
To account for the difficulties inherent in clinician diagnosis of anosognosia, a 
number of rating scales have been created to assess patient levels of awareness, and 
parallel versions have been created to allow for corresponding ratings by an informant.  
The patient him/herself, an informant/caregiver, and/or a treating clinician typically 
complete these rating scales, and awareness on the part of the patient can be assessed in 
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two ways.  Discrepancy between patient and informant ratings can be used, as well as 
discrepancy between patient and clinician ratings (Crosson et al., 1989).  A discrepancy 
score is typically created by subtracting the patient’s ratings from that of the informant, 
the absolute value of which is used to quantify the patient’s level of awareness (Evans, 
Sherer, Nick, Nakase-Richardson, & Yablon, 2005; Flashman & McAllister, 2002; Hart, 
Seignourel, & Sherer, 2009; Sherer et al., 1998).   
Using this type of comparison as a measure of anosognosia implies that the rating 
of the informant or the clinician is unbiased and accurate, because their ratings serve as 
the basis of comparison for the patient ratings.  Depending on the amount of interaction 
the informant has with the patient and how involved he or she is in the patient’s care, 
using this method of quantifying levels of awareness is problematic.  Levels of concern in 
relation to caregiver response bias and has not been addressed in any of the literature to 
date, so there is no method of accounting for how this may impact caregiver ratings.  In 
addition, response bias and recent experience with the patient have the tendency to color 
the manner in which both the patient and the informant answer these measures, which 
pose a threat to their validity and may unjustly impact the quantity of the discrepancy 
seen between informant and patient scores.  Also, taking absolute values of the 
discrepancy between patient and informant ratings does not account for both over and 
under estimation of ability, which artificially restricts the range of scores and can, in turn, 
impact the robustness of the statistical results. 
Another set of issues that must be addressed when using any type of questionnaire 
is the measure’s validity.  Measures of validity in neurologic populations are difficult 
given their inherent cognitive compromise, and relying on informant measures of 
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reliability imposes the same issues of bias previously discussed in using these measures 
for quantifying awareness.  Thus, these measures are poorly validated in general and are 
difficult to validate in the patient populations for which they are intended to measure.  
Due to the fact that patients with neurological impairments are completing these 
measures, it is assumed that they have the cognitive ability to understand what is being 
asked of them and answer the questions accurately.  Given their overall cognitive deficits, 
this is not always the case.  In addition, this is not taken into account in the literature, 
which can artificially impact the results derived from studies employing these 
methodologies. 
 
Discrepancy between Self-Reported Ability and Actual Performance 
Another way of quantifying anosognosia is by comparing patient ratings to actual 
neuropsychological performance, which removes the bias associated with using non-
participant ratings (Fleming, Strong, & Ashton, 1996).  Unfortunately, this method of 
quantification is less often used in the literature. The variability in rating scales employed 
across studies utilizing the discrepancy method, and the reliance upon potentially 
inaccurate informant ratings may account for the varied results and lack of consensus 
regarding mechanisms of action in the literature.   
Barrett and collegues (2005), as discussed earlier, conducted a studying asking 
MCI patients to provide estimations of ability before and after a battery of tests were 
completed.  They found that visuospatial skills were overestimated prior to testing, and 
memory skills were overestimated after testing.  Thus, the patient’s pretest and posttest 
ratings were used in relation to their actual performance on neuropsychological testing to 
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determine awareness levels.  Although this methodology removes the bias associated 
with informant ratings, it does pose a rather pragmatic problem.  Patients who have 
memory difficulties, as those with MCI due to Alzheimer’s dementia do, may not 
remember the battery administered, and thus may not be able to accurately estimate their 
performance after the battery is completed.  This is particularly problematic for measures 
that are earlier in the battery, due to the fact that more time has elapsed when posttest 
ratings were collected.  Thus, the overestimation of memory complaints may be, in part, 
accounted for by memory ability in and of itself.  In addition, memory measures are often 
multistep in nature, differentiating between types of memory function, such as immediate 
and delayed recall, as well as free recall and cued recall or recognition. Without clearly 
differentiating between which type of memory the evaluation is referring to, it is difficult 
to gain a more fine grained understanding of the specific areas of memory the patient 
views him/herself as having difficulty. Lastly, the ratings solicited from the patients were 
not tied explicitly to any given measure in the assessment battery, and were instead broad 
questions regarding general cognitive domains, such as memory, attention, etc.  If 
patients are unaware of how these constructs were tested, as well as which tasks 
measured each cognitive domain, it may be difficult for the patient to provide accurate 
pretest and posttest estimations of ability.  For example, the Wisconsin Card Sorting Test 
may not be viewed by the patient as a measure of executive function, and may be 
misinterpreted as a visuospatial task.  Thus, they may rate themselves poorly on posttest 
ratings of visuospatial functioning but rate themselves better on executive function tasks.  
Thus, while this methodology is moving the body of research in the right direction, it still 
leaves room for improvement (Barrett et al., 2005). 
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Discrepancy between Self-Predicted, Self-Evaluated, Informant-
Predicted, and Actual Performance 
The current study employs a novel paradigm to assess anosognosia that 
incorporates aspects of the previously discussed methodologies and allows for assessment 
of the accuracy of each.  The current study utilizes a prediction and evaluation model of 
assessing anosognosia in a standard neuropsychological evaluation, by obtaining 
participant predictions of performance a priori and evaluations of performance a 
posteriori before and after each test is administered.  Thus, before administering each 
measure, the participant is read a brief explanation of the task and asked to predict how 
well he/she will do on each measure.  Then the given task is completed.  After the task is 
completed, the patient is asked to evaluate his/her performance on the measure on the 
same scale that the prediction was provided on, as a way to remind the patient how he/she 
thought he/she would perform prior to engaging in the task.  Informant ratings for each 
neuropsychological measure are also obtained, using the same description of each 
measure given to the patient during the assessment.  This will allow for investigation as 
to the accuracy of informant ratings in comparison to actual neuropsychological 
performance, as well as provide an unbiased measure of anosognosia by comparing 
patient prediction of performance to actual performance on neuropsychological measures.  
By obtaining these prediction and evaluation ratings immediately before and after each 
neuropsychological measure, the impact of memory of the battery is removed, as well as 
the ambiguity associated with trying to understand what each measure is measuring.  In 
addition, it allows for the exploration of the possibility of emergent awareness as a result 
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of poor performance by obtaining evaluations of performance immediately after the 
measure is completed. 
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CHAPTER TWO 
HYPOTHESES 
 
 Given the current state of the literature on anosognosia in mild cognitive 
impairment, the following hypotheses are proposed: 
 
Hypothesis 1 – Patient Versus Informant Ratings 
Given that anosognosia has been documented in the literature in both the MCI and 
dementia populations, it is hypothesized that patient and informant predictions of patient 
performance will be significantly different (Dekkers, Joosten-Weyn Bannignh, & Eling, 
2009; Vogel et al., 2004), regardless of their diagnostic group.   The magnitude of 
discrepancy and direction of discrepancy will serve as indicators of the degree to which 
anosognosia is present. 
 
Hypothesis 2 – Accuracy of Ratings 
Research has yet to compare the accuracy of patient’s prediction of their own 
performance to that of informant predictions as they relate to true neuropsychological 
performance.  As it stands, informant predictions are presumed to accurately reflect the 
patient’s actual level of ability.  It is hypothesized that informant predictions will be more 
accurate predictors of the patient’s actual performance than patient predictions. In 
addition, informant predictions of patient ability will be more accurate for MCI patients 
than dementia patients. Given that dementia patients are less functional, it is likely that 
informants will underestimate their actual ability across domains of function that may, in 
fact, be less impacted by the severity of their diagnosis. Given that MCI patients are at 
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what could be considered a “turning point” in their cognitive function, it is likely that 
they will underestimate their actual ability, which can be seen as a reflection of their 
concern regarding their changes in cognitive status. 
As discussed earlier, domain specific anosognosia has been found for memory ability 
(Cosentino, Metcalfe, Butterfield, & Stern, 2009).  The current study also hypothesized 
that both patient and informant predictions will demonstrate poorer visuospatial 
awareness in relation to memory awareness. 
 
Hypothesis 3 – Emergent Awareness by Cognitive Domain 
Emergent awareness has not been systematically studied in formal 
neuropsychological assessment paradigms.  The current study hypothesized that emergent 
awareness will vary across cognitive domains, with more emergent awareness seen for 
tasks allowing for physical manipulation of objects and/or verbal feedback from the 
examiner (i.e. Block Design, Wisconsin Card Sorting Test). It is additionally 
hypothesized that this emergent awareness will be greater for MCI patients than dementia 
patients. 
 
Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment 
As previously stated, the diagnostic utility of anosognosia evaluation has yet to be 
researched in the field. As such, the current study hypothesizes that ratios of predicted 
performance relative to actual performance (anosognosia prediction ratios) will 
demonstrate diagnostic utility, such that diagnostic group membership can be predicted 
based on the anosognosia ratios generated throughout the course of the evaluation. In 
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addition, it is hypothesized that measures of memory will be most predictive of 
diagnostic group than other cognitive measures collected. 
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CHAPTER THREE 
METHOD 
 
Study Information 
Research activity took take place in Loma Linda University Medical Center’s 
East Campus Rehabilitation Center’s Department of Neuropsychology and Rehabilitation 
Psychology.  The data that was used for the current analysis was archived in nature, as 
the data is routinely collected as a part of the standard neuropsychological evaluation that 
Travis Fogel, Ph.D. conducts for persons with suspected dementia. 
 
Inclusion/Exclusion Criteria 
Males and females ages 18-100 who were referred to Loma Linda University 
Medical Center’s Rehabilitation Center Department of Neuropsychology and 
Rehabilitation Psychology for neuropsychological evaluation were included in the sample. 
 Exclusion criteria were as follows: (1) Individuals younger than 18 years of age or 
older than 100 years of age, as normative data for the neuropsychological tests 
administered in the standard evaluation range from ages 18 to 100, thus precluding the 
evaluators from attaining standardized scores for patients falling outside that age range.  
(2) Patients who were not fluent in the English language were excluded due to the impact 
that unfamiliarity with the language may have on patient performance.  (3) Patients who 
were hearing impaired or vision impaired were excluded due to the auditory and visual 
demands needed to engage in the neuropsychological evaluation in a meaningful way.  
(4) Lastly, patients with motor impairment in their dominant hand were also excluded due 
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to the manual dexterity needed for stimulus manipulation and writing demands needed 
for a portion of the neuropsychological measures administered. 
 
Subject Recruitment and Screening 
Medical charts of patients who were referred for neuropsychological evaluation 
and meet inclusion/exclusion criteria were examined from Loma Linda University 
Medical Center’s East Campus Department of Neuropsychology and Rehabilitation 
Psychology. The data collected were a part of the standard care practices for the 
Department of Neuropsychology and Rehabilitation Psychology; thus an informed 
consent waiver and HIPAA privacy waiver was requested. 
 
Participant Characteristics 
 A total of 49 participants were included in the study, with relevant demographic 
characteristics presented in Table 1. As displayed in Table 2, a total of 24 participants 
were diagnosed with MCI and 25 participants were diagnosed with dementia using 
criteria outlined previously (Albert et al., 2011; McKhann et al., 2011; Petersen, 2004). 
Diagnoses were provided by Dr. Travis Fogel, Ph.D. and corroborated by Kyrstle Barrera, 
M.A. A total of 23 male and 26 female participants were included in the sample. A total 
of 24 patients were excluded from the sample, twenty due to unclear or complicated 
clinical presentations or diagnostic rulings, one from reduced effort, two due to diagnosis 
not warranted (i.e. “worried-well”), and one due to prominent psychiatric overlay 
superimposed on compromised neuropsychological function. 
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Table 1 
 
Participant demographic characteristics 
    MCI   Dementia   Total 
Characteristic   n %   n %   n % 
Age (m, SD) 
 
(71, 9.63) 
 
(77, 7.85) 
 
(74, 9.33) 
     40-49 
 
1 4.2 
 
0 0.0 
 
1 2.0 
     50-59 
 
1 4.2 
 
1 4.0 
 
2 4.1 
     60-69 
 
5 20.8 
 
3 12.0 
 
8 16.3 
     70-79 
 
14 58.3 
 
11 44.0 
 
25 51.0 
     80-89 
 
3 12.5 
 
9 36.0 
 
12 24.5 
     90+ 
 
0 0.0 
 
1 4.0 
 
1 2.0 
     Total 
 
24 
  
25 
  
49 
 Gender 
              Male 
 
13 54.2 
 
10 40.0 
 
23 46.9 
     Female 
 
11 45.8 
 
15 60.0 
 
26 53.1 
Education 
              < 12 years 
 
0 0.0 
 
3 12.0 
 
3 6.1 
     12 years 
 
6 25.0 
 
5 20.0 
 
11 22.4 
     13-15 years 
 
7 29.2 
 
7 28.0 
 
14 28.6 
     16+ years 
 
11 45.8 
 
10 40.0 
 
21 42.9 
Race 
              White/Caucasian 
 
15 62.5 
 
20 80.0 
 
35 71.4 
     Black/African 
 
2 8.3 
 
2 8.0 
 
4 8.2 
     Other 
 
7 29.2 
 
3 12.0 
 
10 20.4 
Current Occupation 
              Not in Labor Force 
 
20 83.3 
 
23 92.0 
 
43 87.8 
     Unskilled Labor 
 
0 0.0 
 
0 0.0 
 
0 0.0 
     Semiskilled Labor 
 
1 4.2 
 
0 0.0 
 
1 2.0 
     Skilled Labor 
 
0 0.0 
 
0 0.0 
 
0 0.0 
     Managerial/Clerical/Sales 
 
2 8.3 
 
2 8.0 
 
4 8.2 
     Professional/Technical 
 
1 4.2 
 
0 0.0 
 
1 2.0 
Previous Occupation 
              Not in Labor Force 
 
0 0.0 
 
4 16.0 
 
4 8.2 
     Unskilled Labor 
 
0 0.0 
 
2 8.0 
 
2 4.1 
     Semiskilled Labor 
 
3 12.5 
 
1 4.0 
 
4 8.2 
     Skilled Labor 
 
2 8.3 
 
1 4.0 
 
3 6.1 
     Managerial/Clerical/Sales 
 
7 29.2 
 
7 28.0 
 
14 28.6 
     Professional/Technical   12 50.0   9 36.0   21 42.9 
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Table 2 
 
Participant diagnostic characteristics 
Diagnoses n 
% of 
Subgroup 
% of 
Diagnosis 
Group 
% of 
Sample 
Mild Cognitive Impairment (MCI)       
 
Amnestic  
    
  
Single Domain 1 6.3 4.2 2.1 
  
Multiple Domain 15 93.8 62.5 30.6 
  
Total 16 100.0 66.7 32.7 
 
Non-Amnestic 
    
  
Single Domain 3 37.5 12.5 6.1 
  
Multiple Domain 5 62.5 20.8 10.2 
  
Total 8 100.0 33.3 16.3 
 
MCI Total 24 
 
100.0 49.0 
Dementia 
    
 
Alzheimer's Dementia 
    
  
Mild 12 85.7 48.0 24.5 
  
Moderate 2 14.3 8.0 4.1 
  
AD Total 14 100.0 56.0 28.6 
 
Vascular Dementia 
    
  
Mild 2 66.7 8.0 4.1 
  
Moderate 1 33.3 4.0 2.0 
  
VD Total 3 100.0 12.0 6.1 
 
Mixed AD/VD 6 
 
24.0 12.2 
 
Frontotemporal Dementia 
    
  
Nonbehavioral Variant 1 50.0 4.0 2.0 
  
Behavioral Variant 1 50.0 4.0 2.0 
  
FTD Total 2 100 8.0 4.1 
 
Dementia Total 25 
 
100.0 51.0 
Total   49 100.0 100.0 100.0 
 
 
 
Study Design 
The following procedures are part of the standard of care for the Department of 
Neuropsychology and Rehabilitation Psychology neuropsychological evaluation 
procedure for patients referred to Dr. Travis Fogel, Ph.D.    
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Background 
The patients were initially seen by their primary care physician and were referred 
to Dr. Travis Fogel, Ph.D. for a comprehensive neuropsychological evaluation. At the 
initial point of contact, a Frequently Asked Question sheet was sent to the patient (see 
Appendix A), which included a recommendation to bring a family member or friend to 
the evaluation (informant). In instances when an informant was not present, informant 
paperwork was given to the patient, who was instructed to have a family member or 
friend complete. Each evaluation took approximately 2 – 2.5 hours in its entirety, which  
 
 
Table 3 
 
Informant characteristics 
  
  MCI   Dementia   Total 
Characteristic   n %   n %   n % 
Relationship to patient   
 
  
 
  
 
Spouse 14 58.30 
 
13 52.00 
 
27 55.10 
 
Child 8 33.30 
 
9 36.00 
 
17 35.40 
 
Caregiver 0 0.00 
 
0 0.00 
 
0 0.00 
 
Other Relative 2 8.30 
 
2 8.00 
 
4 8.30 
 
Friend 0 0.00 
 
0 0.00 
 
0 0.00 
 
Declined to respond 0 0.00 
 
1 4.00 
 
1 2.00 
 
Total 24 100.00 
 
25 100.00 
 
49 100.00 
Years of acquaintance (m, SD) (39, 15.07) 
 
(46, 15.62) 
 
(46, 42.97) 
Reported familiarity w/patient 
        
 
Very familiar (provides daily care) 23 95.80 
 
18 72.00 
 
41 83.70 
 
Somewhat familiar (often cares for) 0 0.00 
 
4 16.00 
 
4 8.20 
 
Not very familiar (has minimal contact) 1 4.20 
 
0 0.00 
 
1 2.00 
 
Declined to respond 0 0.00 
 
3 12.00 
 
3 6.10 
  Total 24 100.00   25 100.00   49 100.00 
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included a 30-minute clinical interview with the patient and family member/caregiver, 
and a 90 to 120-minute assessment session conducted with the patient individually. Table 
3 presents relevant informant characteristics. 
 
Clinical Interview 
The clinical interview typically lasted approximately 30 minutes, and Dr. Travis 
Fogel, Ph.D., the patient, and the informant(s) were present.  Dr. Fogel interviewed the 
patient and informant, and gathered clinically relevant information (see Appendix B for 
details regarding information collected).  The information collected fell within four 
domains: (1) demographic information (i.e. age, ethnicity, handedness, years of education, 
occupation, etc.), (2) history of cognitive complaints and current cognitive status, (3) 
personal medical/psychiatric history, and (4) family medical history. Upon completion of 
the clinical interview, the patient began the neuropsychological evaluation. The informant 
was asked to wait in the waiting room and was given two forms to complete; the patient 
history form and the Neuropsychiatric Inventory (see Appendix C and D, respectively). 
These forms were collected from the informant at the conclusion of the evaluation. 
 
Neuropsychological Evaluation 
The standard neuropsychological evaluation was approximately 90-120 minutes 
long.  Either Dr. Fogel, Ph.D. or Kyrstle Barrera, M.A., administered the 
neuropsychological measures individually with the patient in a quiet, distraction-free 
testing office.  The evaluation included administration of the following 
neuropsychological measures (see Appendix E): 
42 
1. Modified Mini Mental Status Exam (3MS): A 100 point, global screening of 
cognitive function assessing temporal and spatial orientation, attention and working 
memory, language, immediate and delayed recall, abstract reasoning, and verbal 
fluency (Teng & Chui, 1987). 
2. Trail Making Test Form A (Trails A): A speeded measure of attention, scanning, 
sequencing and psychomotor speed requiring the connection of numbered circles in 
consecutive order (Reitan & Wolfson, 1985). 
3. Trail Making Test Form B (Trails B): A speeded measure of attention, scanning, 
sequencing, psychomotor speed, mental flexibility, and set shifting requiring the 
connection of numbered and lettered circles in order, alternating between consecutive 
numbers and letters (i.e. 1-A-2-B-3-C etc.) (Reitan & Wolfson, 1985). 
4. Controlled Oral Word Association Test (FAS and Animals): A timed measure of 
phonemic and category verbal fluency requiring the generation of as many words as 
possible beginning with a given letter of the alphabet (F, A, and S) and as many items 
belonging to a given category (animals) in 60 seconds (Benton, Hasmsher, & Sivian, 
1994). 
5. California Verbal Learning Test – 2nd edition, Short Form (CVLT): List learning 
verbal memory test comprised of a 9-item word list containing words from three 
categories (fruit, clothing, and tools) tested in free recall, cued recall, recognition 
(CVLT Rec), and forced choice (CVLT FC) paradigms at short (CVLT IR) and long 
delays (CVLT DR) (Delis, Kramer, Kaplan, & Ober, 2000). 
6. Wechsler Adult Intelligence Scale – 3rd edition subtests (Wechsler, 1997) 
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a. Block Design (BD): A timed measure of visuospatial and visuoconstructive skill 
requiring the use of bicolored blocks (red and white) to reconstruct a given picture. 
b. Digit Span (DSF, DSB): A measure of attention, concentration, and working 
memory requiring the repetition of verbally presented stings of numbers of 
increasing length in both forward and backward sequences. 
7. Symbol Digit Modalities Test (SDMT; written version): a timed measure of complex 
visual scanning, tracking, perceptual speed, divided attention, and psychomotor 
processing requiring the transcription of symbols into numbers given a key (Smith, 
1991) 
8. Geriatric Depression Scale (GDS): A 30-item self-report inventory assessing feelings 
of depression over the past week (Yesavage et al., 1983). 
9. Wechsler Memory Scale – 3rd edition subtests (Wechsler, 1997b) 
a. Logical Memory I (LMI): A contextual verbal memory measure requiring the 
immediate memory of two short stories, the second of which is repeated twice 
b. Logical Memory II (LMII): A contextual verbal memory measure requiring the 
memory of two short stories after a delay. 
10. Judgment of Line Orientation (JLO): A spatial perception and orientation measure 
requiring the estimation of the orientation of two lines presented concurrently using a 
set of reference lines, similar to a protractor (Benton, Varney, & Hamsher, 1978).   
11. Boston Naming Test (BNT): A measure of confrontational naming requiring the 
naming of simple, line drawn pictures of common objects and animals (Kaplan, 
Goodglass, & S Weintraub, 1983). 
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12. Wechsler Test of Adult Reading (WTAR): A measure of premorbid intelligence 
requiring the reading and pronouncing of 50 words that have irregular grapheme-to-
phoneme translations (Wechsler, 1997a). 
13. Wisconsin Card Sorting Test-64 Card Version, Live administration (WCST): A test 
of abstract concept formation, mental set maintenance and shifting, and the ability to 
utilize feedback by properly sorting a deck of 64 cards differing in the color, shape, 
and number of symbols (Heaton, 1993) 
14. Dot Counting Test (DC): A timed measure of effort requiring the accurate and timely 
counting of randomly placed dots on cards (Boone, 2002) 
Each neuropsychological assessment measure was administered according to the 
standard administration procedures outlined by its respective publisher.  Routinely before 
the administration of each measure, the examiner verbally presented a brief overview of 
the upcoming measure and asked the patient to predict how well he/she would do on the 
measure (see Appendix F for script).  The patient was given a blue pen and a scale with 
“Extremely Well” at the top with a smiling face and “Extremely Poorly” at the bottom 
with a frowning face (see Appendix G for sample scales).  The patient was asked to base 
his/her prediction in comparison to his/her same aged and educated peers, and draw a line 
on the scale where he/she expected his/her performance to fall.  Once the measure was 
administered, the same scale was presented to the patient, which now contained his/her 
performance prediction.  The patient was given a green pen and asked to draw a line 
indicating an evaluation of how well he/she actually performed.  Different colored pens 
were used to differentiate between the two (prediction and evaluation) values.  In addition, 
the patient was asked how concerned he/she was about his/her cognitive ability, as well 
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as how concerned his/her family was about his/her cognitive ability.  The patient 
provided this assessment on a similar scale, with “Very Concerned” at the top and “Not 
Concerned” at the bottom.  The patient provided this assessment both before the 
assessment process began and after the entire assessment process was concluded.  At the 
conclusion of the session, the patient was also asked to provide a rating of how well 
he/she thinks he/she performed on the measures administered as a whole using the same 
scale used for the individual assessment measures. 
At the conclusion of the evaluation, the patient was informed that the information 
gleaned from the interview, neuropsychological evaluation, and forms completed by the 
informant would be used to compile a chart note, which would be included into the 
patient’s medical record.  They were informed that the information was available for 
review by their referring physician and would be discussed with the patient at their next 
follow up appointment, or should the patient desire, via a feedback session with Travis 
Fogel, PhD.  
 
Informant Data Collected 
 Within the patient history form (see Appendix C), informant predictions of patient 
performance were collected. Ratings were provided along a 10-point Likert scale such 
that lower values indicated less favorable predictions (i.e. 1 = “Relatively Poorly) and 
higher values indicated more favorable predictions (i.e. 10 = “Relatively Well”). Items 
corresponded exactly to the predictions collected from the patients for each 
neuropsychological measure and relevant subsections of measures. 
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Variables Captured 
Basic demographic information was obtained, as well as relevant historical 
information and psychiatric symptomatology, as provided by the informant.  Ratings of 
concern regarding patient’s cognitive ability on behalf of the family and the patient, from 
the perspective of the patient, was obtained before and after the assessment battery was 
administered.  Patient predictions of performance and evaluations of performance were 
obtained before and after each neuropsychological assessment measure, as well as at 
different steps on multistep measures when appropriate (see Appendix F for a complete 
list of neuropsychological prediction and evaluation measures collected and the script 
used to solicit ratings). Actual neuropsychological performance scores were obtained on 
each neuropsychological measure administered. 
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CHAPTER FOUR 
STATISTICAL ANALYSIS 
 
Data Preparation 
Prediction and Evaluation Percentages 
Prediction and evaluation scores provided by the patient were quantified by 
measuring the distance from the bottom of the scale to the response point, rounded down 
to the nearest quarter of an inch. Each value was then divided by the total length of the 
scale, and then multiplied by 100 to produce a percentage value of each response, such 
that: 
Prediction or Evaluation 
Percentage 
=  
Response Value 
 
X 100 
 
Total Possible Value 
  
For example, a prediction response for the Judgment of Line Orientation placed in the 
center of the scale, or a response 6 cm from the bottom of a 12 cm scale, would result in 
the following percentage: 
Prediction Percentage =  
6 
 
X 100 = 50.00 
 
12 
  
Of note, prediction values were also calculated for informant predictions, using the same 
mathematical calculation, save for the fact that the scales used for informant predictions 
were based on a 10 point Likert scale, with larger values indicated more favorable 
predictions. Since informants were not actually present for the neuropsychological 
evaluation, evaluation of performance responses were not collected. 
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Actual Performance Percentages 
 Actual performance percentages were calculated using the observed raw score 
value for each measure. These scores were then divided by the total possible raw score 
and multiplied by 100 to produce a percentage value for each measure, such that: 
Actual Performance 
Percentage 
=  
Observed Raw Score 
 
X 100 
 
Total Possible Raw Score 
  
For example, a raw score of 25 on the Judgment of Line Orientation, which has a total of 
30 items, would result in the following percentage: 
Actual Performance 
Percentage 
=  
25 
 
X 100 = 83.33 
 
30 
  
 
Anosognosia Prediction and Evaluation Ratios 
Anosognosia ratios were calculated by subtracting the predication or evaluation 
percentage from the actual performance percentage, and dividing by the sum of the two 
values (as seen in Barrett et al., 2005), such that: 
Anosognosia 
Prediction Ratio 
= 
 
Prediction Percentage - Actual Performance Percentage 
 
Prediction Percentage + Actual Performance Percentage 
 
or 
Anosognosia 
Evaluation Ratio 
=  
Evaluation Percentage - Actual Performance Percentage 
 
Evaluation Percentage + Actual Performance Percentage 
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Given the prediction percentage and actual performance percentage for the two examples 
above, the anosognosia prediction ratio would be calculated as follows: 
Anosognosia 
Prediction Ratio 
=  
50.00 – 83.33 
 
= -0.25 
 
50 + 83.33 
  
This analysis allows for a range between -1 and +1, thus accounting for both 
overestimations and underestimations of performance.  As such, values closer to 0 
indicate perfect awareness of actual performance, such that prediction or evaluation 
values are commensurate with actual performance. Negative values indicate under 
prediction or evaluation of performance relative to actual performance, with increased 
discrepancy as values near -1. Positive values indicate over prediction or evaluation of 
performance relative to actual performance, with increased discrepancy as values near +1. 
As such, this also takes into account the actual cognitive ability of the patient. 
 
Power Analysis 
Given the number of data points being collected on each patient, the required 
sample size in order to obtain the appropriate power to detect a meaningful difference in 
ratings with a medium effect size (Cohen’s d = 0.05, =0.05, =0.8), is a total of 30 
participants. 
 
Missing Data 
The neuropsychological assessments were clinical in nature, conducted by Kyrstle 
Barrera, M.A., or Travis Fogel, Ph.D., and were typically unrestrained by time.  Thus, the 
only reason a patient would be missing neuropsychological test data would be due to their 
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inability to perform the measure.  This was most commonly seen with the Judgment of 
Line Orientation test, which requires the patient to estimate the orientation of lines based 
on a reference set, similar to estimating angle orientation given a protractor as a reference.  
In order to keep these patients in the analysis, the lowest possible raw score was inputted 
(i.e. a score of zero).   
 
Data Cleaning 
Data was cleaned to ensure that the data meet the assumptions required to 
complete multivariate analysis of covariance (MANCOVA) and logistic regression 
analyses. A wide range of abilities was expected given the nature of mild cognitive 
impairment and mild dementia.  As such, data that could represent the wide range of 
ability seen in these diagnoses was not removed from the sample.  Normality was 
assessed using boxplots and histograms.  Scatterplots and Pearson’s R were used to assess 
linearity of the dependent variables.  Lastly, homogeneity of variance and covariance 
were assessed using Box’s M. Literature regarding significant Box’s M results indicate 
that MANCOVA analyses are robust to violations of the assumption of homogeneity of 
variance when sample sizes are equal between comparison groups (Field, 2005). As such, 
in instances when Box’s M values were significant, data interpretation continued, given 
that data was deemed normally distributed via the ancillary measures employed. 
 
Data Analyses 
Data was compiled using SPSS version 19 for the Macintosh operating system 
(Mac OSX) and analyzed using SPSS version 20. 
51 
Hypothesis 1 – Patient Versus Informant Ratings 
 In order to investigate the effect of information source on predictions of patient 
performance, a one way multivariate analysis of covariance was performed using 
information source as the independent variable with two levels, patient and informant 
prediction percentages across all 20 neuropsychological measures as the dependent 
variable. Pillai’s trace results were analyzed and the effect of age was removed by using 
age as a covariate in the analyses. It is important to note that this analysis is unadjusted 
for actual performance. 
 
Hypothesis 2 – Accuracy of Ratings 
In order to investigate the accuracy of information source and diagnosis on 
predictions of patient performance, a two-way multivariate analysis of covariance was 
performed using two independent variables: information source with three levels (patient 
prediction percentage, informant prediction percentage, and actual performance 
percentage) and diagnosis with two levels (MCI and dementia). Dependent variables 
included prediction percentages for all 20 neuropsychological measures. Pillai’s trace 
results were analyzed and the effect of age was removed by using age as a covariate in 
the analyses. It is important to note that this analysis is unadjusted for actual performance. 
 
Hypothesis 3 – Emergent Awareness by Cognitive Domain 
In order to investigate the presence of emergent awareness by diagnosis, a doubly 
multivariate analysis of covariance was performed using diagnosis group as the between-
subjects independent variable with two levels (MCI and dementia) and time as the 
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within-subjects independent variable with two time points (prediction and evaluation).  
Dependent variables included prediction and evaluation anosognosia ratios all 20 
neuropsychological measures. Pillai’s trace results were analyzed and the effect of age 
was removed by using age as a covariate in the analyses. It is important to note that this 
analysis is adjusted for actual performance by incorporating actual performance in the 
anosognosia ratios for each measure. 
 
Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment 
 In order to assess the diagnostic utility of anosognosia assessment, a logistic 
regression was used on patient prediction anosognosia ratios across all 20 
neuropsychological measures to predict diagnostic group membership (MCI versus 
dementia). Anosognosia ratios were multiplied by 100 to adjust the data range, changing 
the range from -1 to +1 to -100 to +100 to account for the impact of restricted range on 
the odds ratio results and interpretability. Initially an exploratory logistic regression was 
run by using the Enter method in SPSS, to see if predictive anosognosia ratios, as a group, 
reliably predicted diagnostic group membership. Then, a forward logistic regression was 
run to elucidate which combination of anosognosia ratios were reliably predictive of 
diagnostic group membership.  
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CHAPTER FIVE 
RESULTS 
 
Hypothesis 1 – Patient Versus Informant Ratings 
General Cognitive Ability, Premorbid Function, and Effort 
A one-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant) on predictions of patient performance in the domain of 
general cognitive ability, premorbid function, and effort, including the 3MS, WTAR, and 
DC, while controlling for age (see Table 4 and Figures 1-3). The main effect of 
information source indicated a significant effect on the combined DV (Pillai’s 
Trace=.441, F(3,79)=20.799, p=.000, multivariate η2=.441). The covariate did not 
significantly influence the combined DV (Pillai’s Trace=.033, F(3,79)=.910, p=.440, 
multivariate η2=.033). Multivariate results indicated that both 3MS predictions and DC 
predictions were significantly effected by information source (F(1,81)=29.022, p=.000, 
multivariate η2=.264; F(1,81)=8.090, p=.006, multivariate η2=.091, respectively), while 
the WTAR predictions were not (F(1,81)=.560, p=.456, multivariate η2=.007). 
Comparison of prediction means indicated that patients provided more favorable 
predictions than informants on the 3MS, while patients provided less favorable 
predictions than informants on the DC. 
 
Attention, Concentration, and Processing Speed 
A one-way MANCOVA was conducted to determine the effect of information source 
(patient vs. informant) on predictions of patient performance in the domain of attention, 
concentration, and processing speed, including Trails A, DSF, DSB, and the SDMT, 
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while controlling for age (see Table 5 and Figures 4-7). The main effect of information 
source indicated a significant effect on the combined DV (Pillai’s Trace=.216, 
F(4,85)=5.843, p=.000, multivariate η2=.216). The covariate did not significantly 
influence the combined DV (Pillai’s Trace=.079, F(4,85)=1.811, p=.134, multivariate 
η2=.079). Multivariate results indicated that Trails A predictions were significantly 
effected by information source (F(1,88)=13.560, p=.000, multivariate η2=.134), while 
DSF, DSB, and SDMT predictions were not (F(1,88)=2.876, p=.093, multivariate 
η2=.032; F(1,88)=.064, p=.801, multivariate η2=.001; F(1,88)=.089, p=.767, η2=.001). 
Comparison of prediction means indicated that patients provided more favorable 
predictions than informants on Trails A. 
 
 
 
Table 4  
 
Mean scores and standard deviations for the domain of general 
cognitive ability, premorbid function, and effort for patient and 
informant predictions of performance percentages, and 
multivariate analysis of covariance  
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,81) p η2 
3MS         29.02 0.000 0.26 
 Patient 45 63.03 22.46     
 Informant 39 39.74 16.46  
     Total 84 52.22 22.98  
   WTAR         0.56 0.456 0.01 
 Patient 45 43.04 27.89     
 Informant 39 38.97 20.36  
     Total 84 41.15 24.62  
   DC         8.09 0.006 0.09 
 Patient 45 38.27 22.78     
 Informant 39 52.56 22.91  
    Total 84 44.90 23.81  
   Note: F(3,79)=20.799, p=.000, η2=.441 
 
 
55 
 
 
Figure 1. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Modified Mini 
Mental Status Examination (3MS) 
 
 
 
 
 
Figure 2. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Wechsler Test of 
Adult Reading (WTAR) 
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Figure 3. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Dot Counting Test 
(DC) 
 
 
 
Table 5 
 
Mean scores and standard deviations for the domain of attention, concentration, 
and processing speed for patient and informant predictions of performance 
percentages, and associated multivariate analysis of covariance  
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,88) p η2 
Trails A         13.56 0.000 0.13 
 Patient 49 57.47 21.89     
 Informant 42 41.19 20.02  
    Total 91 49.96 22.47  
   DSF         2.88 0.093 0.03 
 Patient 49 39.89 22.62     
 Informant 42 32.62 17.95  
    Total 91 36.54 20.81  
   DSB         0.06 0.801 0.00 
 Patient 49 26.44 22.26     
 Informant 42 27.62 19.10  
    Total 91 26.98 20.76  
   SDMT         0.09 0.767 0.00 
 Patient 49 37.15 23.14     
 Informant 42 35.71 21.43  
    Total 91 36.49 22.26  
   Note: F(4,85)=5.843, p=.000, η2=.216 
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Figure 4. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Trail Making Test 
Part A (Trails A) 
 
 
 
 
Figure 5. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Digit Span Forward 
(DSF) 
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Figure 6. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Digit Span Backward 
(DSB) 
 
 
 
 
Figure 7. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Symbol Digit 
Modalities Test (SDMT) 
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Language 
A one-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant) on predictions of patient performance in the domain of 
language, including FAS, Animals, and the BNT, while controlling for age (see Table 6 
and Figures 8-10). The main effect of information source did not indicated a significant 
effect on the combined DV (Pillai’s Trace=.041, F(3,87)=1.241, p=.300, multivariate 
η2=.041). 
 
 
 
Table 6 
 
Mean scores and standard deviations for the domain of language 
for patient and informant predictions of performance 
percentages, and associated multivariate analysis of covariance  
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,92) p η2 
FAS         0.06 0.808 0.00 
 Patient 48 48.05 21.75     
 Informant 44 47.05 18.25  
    Total 92 47.57 20.05  
   Animals         0.81 0.370 0.01 
 Patient 48 48.00 22.19     
 Informant 44 52.27 23.61  
    Total 92 50.04 22.86  
   BNT         2.42 0.123 0.03 
 Patient 48 54.42 23.17     
 Informant 44 62.05 23.78  
    Total 92 58.07 23.65  
   Note: F(3,87)=1.241, p=.300, η2=.041 
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Figure 8. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for FAS 
 
 
 
 
Figure 9. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Animals 
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Figure 10. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Boston Naming 
Test (BNT) 
 
 
 
Visuoperception and Visuoconstruction 
A one-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant) on predictions of patient performance in the domain of 
visuoperception and visuoconstruction, including the JLO and BD, while controlling for 
age (see Table 7 and Figures 11-12). The main effect of information source did not 
indicate a significant effect on the combined DV (Pillai’s Trace=.08, F(2,88)=2.692, 
p=.073, multivariate η2=.058). 
 
Memory 
A one-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant) on predictions of patient performance in the domain of 
memory, including the CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI and LMII, 
while controlling for age (see Table 8 and Figures 13-18). The main effect of information 
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Table 7 
 
Mean scores and standard deviations for the domain of 
visuoperception and visuoconstruction for patient and informant 
predictions of performance percentages, and associated 
multivariate analysis of covariance  
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,89) p η2 
JLO         1.50 0.224 0.02 
 Patient 49 49.81 24.76     
 Informant 43 43.49 24.48  
    Total 92 46.85 24.70  
   BD         1.32 0.254 0.01 
 Patient 49 44.89 23.93     
 Informant 43 50.47 22.25  
    Total 92 47.50 23.20  
   Note: F(2,88)=2.692, p=.073, η2=.058 
 
 
 
Figure 11. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Judgment of Line 
Orientation (JLO) 
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Figure 12. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Block Design 
 
 
 
 
source indicated a significant effect on the combined DV (Pillai’s Trace=.252, 
F(6,77)=4.321, p=.001, multivariate η2=.252). The covariate did not significantly 
influence the combined DV (Pillai’s Trace=.110, F(6,77)=1.590, p=.162, multivariate 
η2=.110). Multivariate results indicated that the CVLT FC and LMII predictions were 
significantly effected by information source (F(1,82)=6.039, p=.016, multivariate 
η2=.069; F(1,82)=3.999, p=.049, multivariate η2=.047, respectively), while CVLT IR, 
CVLT DR, CVLT Rec, and LMII predictions were not (F(1,82)=.764, p=.385, 
multivariate η2=.009; F(1,82)=.047, p=.829, multivariate η2=.001; F(1,82)=.026, p=.872, 
multivariate η2=.000; F(1,82)=3.218, p=.077, multivariate η2=.038, respectively). 
Comparison of prediction means indicated that patients provided more favorable 
predictions than informants on CVLT FC, but less favorable predictions than informants 
on LMII. 
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Table 8  
 
Mean scores and standard deviations for the domain of memory 
for patient and informant predictions of performance 
percentages, and associated multivariate analysis of covariance  
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,82) p η2 
CVLT-IR         0.76 0.385 0.01 
 Patient 48 29.29 20.01  
    Informant 37 33.24 19.30  
    Total 85 31.01 19.68  
   CVLT-DR         0.05 0.829 0.00 
 Patient 48 24.75 22.10     
 Informant 37 23.78 16.39  
    Total 85 24.33 19.71  
   CVLT-Rec         0.03 0.872 0.00 
 Patient 48 33.60 24.67     
 Informant 37 32.70 20.09  
    Total 85 33.21 22.67  
   CVLT-FC         6.04 0.016 0.07 
 Patient 48 46.96 23.82     
 Informant 37 35.68 17.72  
    Total 85 42.05 21.99  
   LMI         3.22 0.077 0.04 
 Patient 48 44.46 23.37     
 Informant 37 36.22 17.22  
    Total 85 40.87 21.20  
   LMII         4.00 0.049 0.05 
 Patient 48 21.13 20.24     
 Informant 37 29.46 16.99  
    Total 85 24.75 19.24  
   Note: F(6,77)=4.321, p=.001, η2=.252 
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Figure 13. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the California Verbal 
Learning Test Immediate Recall (CVLT IR) 
 
 
 
 
Figure 14. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the California Verbal 
Learning Test Delayed Recall (CVLT DR) 
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Figure 15. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the California Verbal 
Learning Test Recognition (CVLT Rec) 
 
 
 
 
Figure 16. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the California Verbal 
Learning Test Forced Choice Recognition (CVLT FC) 
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Figure 17. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Logical Memory I 
(LMI) 
 
 
 
 
Figure 18. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for Logical Memory II 
(LMII) 
 
 
 
Executive Function 
A one-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant) on predictions of patient performance in the domain of 
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executive function, including the WCST and Trails B, while controlling for age (see 
Table 9 and Figures 19-20). The main effect of information source indicated a significant 
effect on the combined DV (Pillai’s Trace=.156, F(2,88)=8.147, p=.001, multivariate 
η2=.156). The covariate did not significantly influence the combined DV (Pillai’s 
Trace=.004, F(2,88)=.182, p=.834, multivariate η2=.004). Multivariate results indicated 
that both the WCST and Trails B predictions were significantly effected by information 
source (F(1,92)=616.384, p=.000, multivariate η2=.155; F(1,92)=4.845, p=.030, 
multivariate η2=.052, respectively). Comparison of prediction means indicated that 
patients provided more favorable predictions than informants on both the WCST and 
Trails B. 
 
 
 
Table 9 
 
Mean scores and standard deviations for the domain of 
executive function for patient and informant predictions of 
performance percentages, and associated multivariate analysis 
of covariance 
  Information Prediction   MANCOVA 
  Source n Mean SD 
 
F(1,92) p η2 
WCST         16.38 0.000 0.16 
 Patient 49 50.37 24.92     
 Informant 43 30.93 20.21  
    Total 92 41.28 24.72  
   Trails B         4.85 0.030 0.05 
 Patient 49 45.80 26.42     
 Informant 43 34.88 19.93  
     Total 92 40.70 24.11         
Note: F=(2,88)=8.147, p=.001, η2=.156 
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Figure 19. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Wisconsin Card 
Sorting Test (WCST) 
 
 
 
 
Figure 20. Patient and informant prediction of performance percentages and actual 
performance percentage (±SD) for MCI and dementia patients for the Trail Making Test 
Part B (Trails B) 
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Hypothesis 2 – Accuracy of Ratings 
General Cognitive Ability, Premorbid Function, and Effort 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
applicable) in the domain of general cognitive ability, premorbid function, and effort, 
including the 3MS, WTAR, and DC, while controlling for age (see Table 10 and Figures 
1-3). As presented in Table 11, the main effect of information source indicated a 
significant effect on the combined DV (Pillai’s Trace=.74, F(6,238)=23.39, p=.000, 
η2=.37). The main effect of diagnosis group indicated a significant effect on the 
combined DV (Pillai’s Trace=.09, F(3,118)=3.69, p=.014, η2=.09). The interaction effect 
between information source and diagnosis group also indicated a significant effect on the 
combined DV (Pillai’s Trace=.18, F(6,238)=3.93, p=.001, η2=.09). The covariate did not 
significantly influence the combined DV (Pillai’s Trace=.03, F(3,118)=1.15, p=.333, 
multivariate η2=.03).  
Univariate ANOVA results are presented in Table 12. Results indicated that all 
three DVs (3MS, WTAR, and DC) predictions/performances were significantly effected 
by information source (F(2,120)=52.18, p=.000, partial η2=.47; F(2,120)=6.86, p=.002, 
partial η2=.010; F(2,120)=21.33, p=.000, partial η2=.026, respectively). Results indicated 
that the 3MS and DC were also significantly effected by diagnosis group (F(1,120)=5.06, 
p=.026, partial η2=.04; F(1,120)=10.05, p=.002, partial η2=.08, respectively), but the 
WTAR was not (F(1,120)=1.47, p=.227, partial η2=.01). In addition, the interaction effect 
between information source and diagnosis group was significant for the 3MS  
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Table 10 
 
Mean scores and standard deviations for the domain of 
general cognitive ability, premorbid function, and effort 
for patient and informant predictions of performance 
percentages and actual performance percentages for MCI 
and dementia patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
3MS               
 MCI 22 55.58 19.87  19 45.79 17.74 
 Dementia 23 70.16 22.88  20 34.00 13.14 
  Total 45 63.03 22.46  39 39.74 16.46 
WTAR               
 MCI 22 39.96 28.30  19 43.68 23.62 
 Dementia 23 45.99 27.79  20 34.50 16.05 
  Total 45 43.04 27.89  39 38.97 20.36 
DC               
 MCI 22 39.27 22.17  19 62.11 21.49 
 Dementia 23 37.31 23.80  20 43.50 20.84 
 Total 45 38.27 22.78  39 52.56 22.91 
    Performance   Total 
  n Mean SD 
 
n Mean SD 
3MS               
 MCI 21 86.33 6.94  62 63.00 23.33 
 Dementia 22 68.14 14.26  65 58.35 23.80 
  Total 43 77.02 14.47  127 60.62 23.59 
WTAR               
 MCI 21 62.86 16.45  62 48.86 25.17 
 Dementia 22 50.82 21.32  65 44.09 23.17 
  Total 43 56.70 19.83  127 46.42 24.19 
DC               
 MCI 21 73.37 7.09  62 57.82 23.13 
 Dementia 22 59.80 20.99  65 46.83 23.71 
  Total 43 66.43 17.07   127 52.19 23.98 
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Table 11 
 
Multivariate analysis of covariance for the domain of cognitive ability, 
premorbid function, and effort for patient and informant prediction 
percentages and actual performance percentages for MCI and dementia 
patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.03 1.15 3 118 0.333 0.03 
Source 0.74 23.39 6 238 0.000 0.37 
Diagnosis 0.09 3.69 3 118 0.014 0.09 
Source * Diagnosis 0.18 3.93 6 238 0.001 0.09 
 
 
 
 
Table 12 
 
Univariate analysis of covariance for the domain of general cognitive ability, premorbid 
function, and effort for patient and informant prediction percentages and actual 
performance percentages for MCI and dementia patients 
  Main Effect of      
Source 
  Main Effect of 
Diagnosis 
  Source x Diagnosis 
Interaction 
   Measure F(2,120) p η2 
 
F(1,120) p η2 
 
F(2,120) p η2 
3MS 52.18 .000 0.47 
  
5.06 .026 0.04 
  
12.08 .00
0 
0.17 
WTAR 6.86 .002 0.10 
 
1.47 .227 0.01  1.95 .14
7 
0.03 
DC 21.33 .000 0.26 
  
10.05 .002 0.08   1.88 .15
7 
0.03 
Note: ABC= Significant Multivariate Analyses 
 
 
 
(F(2,120)=6.86, p=.000, partial η2=.017) but not the WTAR or DC (F(2,120)=1.95, 
p=.147, partial η2=.010; F(2,120)=1.88, p=.157, partial η2=.03, respectively).  
Pairwise comparison data are presented in Table 13. Comparison of 
prediction/performance means for the 3MS indicated that both patients and informants 
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predicted lower performance than the patients actually performed, informants predicted 
lower performance for dementia patients than MCI patients, and dementia patients 
performed worse than MCI patients. In general, predictions/performances were lower 
across all sources of information for the dementia group than the MCI group. Comparison 
of prediction/performance means for the WTAR indicated that informants and patients 
provided similar predictions of performance, and both predicted lower performance than 
patients actually performed. In addition, informants predicted that dementia patients 
would perform worse than MCI patients. Comparison of prediction/performance means 
for the DC indicated that informants and patients predicted that patients would perform 
worse than they actually did, with patients predicting lower performance than informants 
 
 
Table 13 
 
Pairwise comparisons for the domain of general cognitive ability, premorbid function, 
and effort for patient and informant prediction percentages and actual performance 
percentages for MCI and dementia patients 
  Source   Diagnosis   Source x Diagnosis 
    p 
 
  p 
 
  p 
3MS               
 Pt x Inf 0.000  MCI x Dem 0.026  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag 0.004 
 Inf x AP 0.000    
 
AP x Diag 0.000 
WTAR               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP 0.017    
 
Inf x Diag 0.047 
 Inf x AP 0.002    
 
AP x Diag ns 
DC               
 Pt x Inf 0.004  MCI x Dem 0.002  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag 0.014 
  Inf X AP 0.008         AP x Diag 0.010 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
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did. Informants predicted than dementia patients would perform worse than MCI patients, 
and dementia patients did, in fact, perform worse than MCI patients. 
 
Attention, Concentration, and Processing Speed 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
applicable) in the domain of attention, concentration, and processing speed, including 
Trails A, DSF, DSB, and the SDMT, while controlling for age (see Table 14 and Figures 
4-7). As presented in Table 15, the main effect of information source indicated a 
significant effect on the combined DV (Pillai’s Trace=.38, F(8,262)=7.71, p=.000, 
η2=.19). The main effect of diagnosis group indicated a significant effect on the 
combined DV (Pillai’s Trace=.13, F(4,130)=4.79, p=.00001, η2=.13). The interaction 
effect between information source and diagnosis group also indicated a significant effect 
on the combined DV (Pillai’s Trace=.11, F(8,262)=1.98, p=.049, η2=.06). The covariate 
did not significantly influence the combined DV (Pillai’s Trace=.05, F(4,130)=1.74, 
p=.146, multivariate η2=.05).  
Univariate ANOVA results are presented in Table 16. They indicated that Trails 
A and DSF predictions/performances were significantly effected by information source 
(F(2,133)=16.77, p=.000, partial η2=.20; F(2,133)=11.47, p=.000, partial η2=.15, 
respectively) while DSB and SDMT were not (F(2,133)=.36, p=.696, partial η2=.01;  
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Table 14 
Mean scores and standard deviations for the domain of attention, 
concentration, and processing speed for patient and informant 
predictions of performance percentages and actual performance 
percentages for MCI and dementia patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
Trails A               
 MCI 24 56.80 23.84  22 47.27 19.56 
 Dementia 25 58.12 20.32  20 34.50 18.77 
  Total 49 57.47 21.89  42 41.19 20.02 
DSF               
 MCI 24 37.46 24.63  22 38.18 20.85 
 Dementia 25 42.23 20.73  20 26.50 11.82 
  Total 49 39.89 22.62  42 32.62 17.95 
DSB               
 MCI 24 23.30 19.42  22 30.91 18.49 
 Dementia 25 29.45 24.71  20 24.00 19.57 
  Total 49 26.44 22.26  42 27.62 19.10 
SDMT               
 MCI 24 37.28 24.88  22 40.91 23.08 
 Dementia 25 37.02 21.87  20 30.00 18.35 
  Total 49 37.15 23.14   42 35.71 21.43 
  Performance 
 
Total 
  n Mean SD 
 
n Mean SD 
Trails A               
 MCI 24 81.23 7.03  70 62.18 23.01 
 Dementia 25 54.45 34.46  70 50.06 27.47 
  Total 49 67.56 28.29  140 56.12 25.97 
DSF               
 MCI 24 54.69 16.51  70 43.59 22.15 
 Dementia 25 47.00 12.38  70 39.44 17.70 
  Total 49 50.77 14.91  140 41.52 20.09 
DSB               
 MCI 24 35.42 14.82  70 29.84 18.14 
 Dementia 25 23.71 13.63  70 25.84 19.74 
  Total 49 29.45 15.27  140 27.84 19.00 
SDMT               
 MCI 24 51.88 18.42  70 43.42 22.83 
 Dementia 25 24.60 18.38  70 30.58 20.12 
  Total 49 37.96 22.83   140 37.00 22.39 
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Table 15 
 
Multivariate analysis of covariance for the domain of attention, concentration, 
and processing speed for patient and informant prediction percentages and 
actual performance percentages for MCI and dementia patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.05 1.74 4 130 0.146 0.05 
Source 0.38 7.71 8 262 0.000 0.19 
Diagnosis 0.13 4.79 4 130 0.001 0.13 
Source * Diagnosis 0.11 1.98 8 262 0.049 0.06 
 
 
 
F(2,133)=.20, p=.821, partial η2=.00, respectively). Results indicated that the Trails A 
and SDMT were significantly effected by diagnosis group (F(1,133)=15.05, p=.000, 
partial η2=.10, F(1,133)=11.97, p=.001, partial η2=.08, respectively), while DSF and DSB 
were not (F(1,133)=1.73, p=.191, partial η2=.01; F(1,133)=.92, p=.340, partial η2=.01, 
respectively). In addition, the interaction effect between information source and diagnosis 
group was significant for Trails A and SDMT (F(2,133)=4.92, p=.009, partial η2=.07; 
F(2,133)=5.09, p=007, η2=.07) but not DSF or DSB (F(2,133)=2.50, p=.86, partial η2=.04, 
F(2,133)=2.94, p=.056, partial η2=.04, respectively).  
Pairwise comparison data are presented in Table 17. Comparison of 
prediction/performance means for Trails A indicated that patients provided less favorable 
predictions than informants, and that informants predicted that patients would perform 
worse than they actually did. In general, predictions/performances were lower across all 
sources of information for the dementia group than the MCI group. In addition, 
informants predicted that dementia patients would perform worse than MCI patients, and 
dementia patients actually did perform worse than MCI patients. Comparison of 
prediction/performance means for DSF indicated that patients and informants provided  
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Table 16 
 
Univariate analysis of covariance for the domain of attention, concentration, and 
processing speed for patient and informant prediction percentages and actual 
performance percentages for MCI and dementia patients 
  Main Effect of      
Source 
  Main Effect of 
Diagnosis 
  Source x Diagnosis 
Interaction 
   
Measure 
F(2,133
) p η2 
 
F(1,133
) p η2 
 
F(2,133
) p η2 
Trails A 16.77 .000 0.20   15.05 .000 0.10   4.92 .009 0.07 
DSF 11.47 .000 0.15 
 
1.73 .191 0.01  2.50 .086 0.04 
DSB 0.36 .696 0.01 
 
0.92 .340 0.01  2.94 .056 0.04 
SDMT 0.20 .821 0.00   11.97 .001 0.08   5.09 .007 0.07 
Note: ABC= Significant Multivariate Analyses 
 
 
 
Table 17 
 
Pairwise comparisons for the domain of attention, concentration, and processing speed 
for patient and informant prediction percentages and actual performance percentages for 
MCI and dementia patients 
  Source   Diagnosis   Source x Diagnosis  
    p 
 
  p 
 
  p 
Trails A               
 Pt x Inf 0.002  MCI x Dem 0.000  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag 0.018 
 Inf x AP 0.000    
 
AP x Diag 0.001 
DSF               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP 0.012    
 
Inf x Diag 0.033 
 Inf x AP 0.000    
 
AP x Diag 0.046 
DSB               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag ns 
 Inf x AP ns    
 
AP x Diag 0.006 
SDMT               
 Pt x Inf ns  MCI x Dem 0.001 
 
Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag ns 
  Inf x AP ns         AP x Diag 0.000 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
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similar predictions, and both predicted that patients would perform worse than they 
actually did. Comparison of prediction/performance means for SDMT indicated that, in 
general, predictions/performances were lower for the dementia group than the MCI group. 
In addition, dementia patients actually did perform worse than MCI patients. 
 
Language 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
applicable) in the domain of language, including FAS, Animals, and the BNT, while 
controlling for age (see Table 18 and Figures 8-10). As presented in Table 19, the main 
effect of information source indicated a significant effect on the combined DV (Pillai’s 
Trace=.26, F(6,266)=6.51, p=.000, η2=.13). The main effect of diagnosis group indicated 
a significant effect on the combined DV (Pillai’s Trace=.07, F(3,132)=3.29, p=.023,  
η2=.07). The interaction effect between information source and diagnosis group did not 
indicate a significant effect on the combined DV (Pillai’s Trace=.08, F(6,266)=1.89, 
p=.083, η2=.04). The covariate did not significantly influence the combined DV (Pillai’s 
Trace=.01, F(4,130)=1.74, p=.146, multivariate η2=.05). 
Univariate ANOVA results are presented in Table 20. The results indicated that 
Animals and BNT predictions/performances were significantly effected by information 
source (F(2,134)=4.80, p=.010, partial η2=.07; F(2,134)=6.93, p=.001, partial η2=.09, 
respectively) while FAS was not (F(2,132)=.46, p=.632, partial η2=.01). Results indicated 
that Animals and BNT predictions/performances were significantly effected by diagnosis  
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Table 18 
 
Mean scores and standard deviations for the domain of 
language for patient and informant predictions of 
performance percentages and actual performance 
percentages for MCI and dementia patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
FAS               
 MCI 23 45.56 24.42  22 54.55 17.11 
 Dementia 25 50.35 19.19  22 39.55 16.47 
  Total 48 48.05 21.75  44 47.05 18.25 
Animals               
 MCI 23 45.07 23.55  22 62.27 23.69 
 Dementia 25 50.69 20.99  22 42.27 19.26 
  Total 48 48.00 22.19  44 52.27 23.61 
BNT               
 MCI 23 54.26 25.40  22 68.18 22.18 
 Dementia 25 54.57 21.45  22 55.91 24.23 
  Total 48 54.42 23.17   44 62.05 23.78 
  Performance 
 
Total 
  n Mean SD 
 
n Mean SD 
FAS               
 MCI 24 47.25 16.55  69 49.01 19.77 
 Dementia 25 41.12 24.76  72 43.84 20.86 
  Total 49 44.12 21.15  141 46.37 20.43 
Animals               
 MCI 24 46.67 20.04  69 51.11 23.41 
 Dementia 25 32.00 15.87  72 41.63 20.14 
  Total 49 39.18 19.32  141 46.27 22.24 
BNT               
 MCI 24 78.06 18.99  69 66.98 24.10 
 Dementia 25 63.33 16.18  72 58.02 20.81 
  Total 49 70.54 18.95   141 62.40 22.85 
 
group (F(1,134)=8.57, p=.004, partial η2=.06, F(1,134)=6.36, p=.013, partial η2=.05, 
respectively), while FAS was not (F(1,134)=3.12, p=.080, partial η2=.02). In addition, the 
interaction effect between information source and diagnosis group was significant for 
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Animals (F(2,134)=5.04, p=.008, partial η2=.07) but not FAS or BNT (F(2,134)=2.80, 
p=.064, partial η2=.04, F(2,134)=1.69, p=.189, partial η2=.02, respectively). Pairwise 
comparisons are presented in Table 21. Comparison of prediction/performance means for 
FAS indicated that informants predicted worse performance for MCI patients than 
dementia patients. Comparison of prediction/performance means for Animals indicated 
that dementia patients, in general, received less favorable predictions than MCI patients,  
 
 
 
Table 19 
 
Multivariate analysis of covariance for the domain of language for patient 
and informant prediction percentages and actual performance percentages for 
MCI and dementia patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.01 0.33 3 132 0.800 0.01 
Source 0.26 6.51 6 266 0.000 0.13 
Diagnosis 0.07 3.29 3 132 0.023 0.07 
Source * Diagnosis 0.08 1.89 6 266 0.083 0.04 
 
 
 
Table 20 
 
Univariate analysis of covariance for the domain of language for patient and informant 
prediction percentages and actual performance percentages for MCI and dementia 
patients 
  Main Effect of      
Source 
  Main Effect of 
Diagnosis 
  Source x Diagnosis 
Interaction 
   Measure F(2,134) p η2   F(1,134) p η2   F(2,134) p η2 
FAS 0.46 .632 0.01   3.12 .080 0.02   2.80 .064 0.04 
Animals 4.80 .010 0.07 
 
8.57 .004 0.06  5.04 .008 0.07 
BNT 6.93 .001 0.09   6.36 .013 0.05   1.69 .189 0.02 
Note: ABC= Significant Multivariate Analyses 
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regardless of source. In addition, informants rated dementia patients less favorably than 
MCI patients, and dementia patients did, indeed, perform worse than MCI patients. 
Comparison of prediction/performance means for the BNT indicated that informants 
predicted lower performance for patients than patients as a whole actually performed. 
Dementia patients, overall, received lower predictions than MCI patients, regardless of 
source. Lastly, dementia patients predicted less favorable performance than their MCI 
counterparts, and dementia patients did, in fact, perform worse than MCI patients. 
 
 
 
Table 21 
 
Pairwise comparisons for the domain of language for patient and informant prediction 
percentages and actual performance percentages for MCI and dementia patients 
  Source   Diagnosis   Source x Diagnosis 
    p 
 
  p 
 
  p 
FAS               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag 0.001 
  Inf x AP ns    
 
AP x Diag ns 
Animals               
 Pt x Inf ns  MCI x Dem 0.004  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag 0.001 
  Inf x AP 0.009    
 
AP x Diag 0.010 
BNT               
 Pt x Inf ns  MCI x Dem 0.013  Pt x Diag 0.010 
 Pt x AP 0.001    
 
Inf x Diag ns 
  Inf x AP ns         AP x Diag 0.010 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
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Visuoperception and Visuoconstruction 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
applicable) in the domain of visuoperception and visuoconstruction, including the JLO 
and BD, while controlling for age (see Table 22 and Figures 11-12). As presented in 
Table 23, the main effect of information source indicated a significant effect on the 
combined DV (Pillai’s Trace=.37, F(4,268)=15.34, p=.000, η2=.19). The main effect of 
diagnosis group indicated a significant effect on the combined DV (Pillai’s Trace=.13, 
F(2,133)=9.47, p=.000, η2=.13). The interaction effect between information source and 
diagnosis group also indicated a significant effect on the combined DV (Pillai’s 
Trace=.13, F(4,268)=4.53, p=.001, η2=.06). The covariate did not significantly influence 
the combined DV (Pillai’s Trace=.02, F(2,133)=1.16, p=.316, multivariate η2=.02). 
Univariate ANOVA results are presented in Table 24. They indicated that BD 
predictions/performances were significantly effected by information source 
(F(2,134)=22.89, p=.000, partial η2=.25) while the JLO was not (F(2,134)=2.12, p=.124, 
partial η2=.03). Results indicated that both the JLO and BD predictions/performances 
were significantly effected by diagnosis group (F(1,134)=13.31, p=.000, partial η2=.09, 
F(1,134)=14.66, p=.000, partial η2=.10, respectively). In addition, the interaction effect 
between information source and diagnosis group was significant for the JLO and BD as 
well (F(2,134)=7.20, p=.001, partial η2=.10; F(2,134)=4.81, p=.010, η2=.07).  
Pairwise comparisons are presented in Table 25. Comparison of 
prediction/performance means for the JLO indicated that dementia patients, overall,  
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Table 22 
 
Mean scores and standard deviations for the domain of 
visuoperception and visuoconstruction for patient and 
informant predictions of performance percentages and 
actual performance percentages for MCI and dementia 
patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
JLO               
 MCI 24 46.22 24.27  22 52.73 25.67 
 Dementia 25 53.24 25.23  21 33.81 19.36 
  Total 49 49.81 24.76  43 43.49 24.48 
BD               
 MCI 24 44.50 25.70  22 61.82 18.93 
 Dementia 25 45.26 22.63  21 38.57 19.31 
  Total 49 44.89 23.93   43 50.47 22.25 
  Performance 
 
Total 
  n Mean SD 
 
n Mean SD 
JLO               
 MCI 24 66.94 16.65  70 55.37 23.81 
 Dementia 25 39.33 27.55  71 42.60 25.56 
  Total 49 52.86 26.59  141 48.94 25.44 
BD               
 MCI 24 32.78 9.71  70 45.93 22.41 
 Dementia 25 17.00 13.72  71 33.33 22.38 
  Total 49 24.73 14.24   141 39.58 23.19 
 
 
 
Table 23 
Multivariate analysis of covariance for the domain of visuoperception and 
visuoconstruction for patient and informant prediction percentages and actual 
performance percentages for MCI and dementia patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.02 1.16 2 133 0.316 0.02 
Source 0.37 15.34 4 268 0.000 0.19 
Diagnosis 0.13 9.47 2 133 0.000 0.13 
Source * Diagnosis 0.13 4.53 4 268 0.001 0.06 
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Table 24 
 
Univariate analysis of covariance for the domain of visuoperception and 
visuoconstruction for patient and informant prediction percentages and actual 
performance percentages for MCI and dementia patients 
  Main Effect of      
Source 
Main Effect of 
Diagnosis 
Source x Diagnosis 
Interaction 
 Measure F(2,134) p η2 F(1,134) p η2 F(2,134) p η2 
JLO 2.12 .124 0.0
3 
13.31 .000 0.09 7.20 .001 0.10 
BD 22.88 .000 0.2
5 
14.66 .000 0.10 4.81 .010 0.07 
 
 
 
Table 25 
 
Pairwise comparisons for the domain of visuoperception and visuoconstruction for 
patient and informant prediction percentages and actual performance percentages for 
MCI and dementia patients 
  Source   Diagnosis   Source x Diagnosis 
    p 
 
  p 
 
  p 
JLO               
 Pt x Inf ns  MCI x Dem 0.000  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag 0.013 
  Inf x AP ns    
 
AP x Diag 0.000 
BD               
 Pt x Inf ns  MCI x Dem 0.000  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag 0.000 
  Inf x AP 0.000         AP x Diag 0.000 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
 
 
 
received less favorable predictions than MCI patients regardless of information source. In 
addition, informants rated dementia patients less favorably than MCI patients, and 
dementia patients did, in fact, demonstrate lower performance than MCI patients. 
Comparison of predication/performance means for BD indicated that, although patient 
and informant predictions were similar, patients predicted more favorable performance 
85 
than they were actually able to perform. Dementia patients, as a whole, received less 
favorable predictions than their MCI counterparts, regardless of source of information. 
Lastly, informants predicted lower performance for dementia patients than MCI patients, 
and dementia patients did, in fact, performed lower than MCI patients did. 
 
Memory 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
applicable) in the domain of memory, including the CVLT IR, CVLT DR, CVLT Rec, 
CVLT FC, LMI and LMII, while controlling for age (see Table 26 and Figures 13-18). 
As presented in Table 27, the main effect of information source indicated a significant 
effect on the combined DV (Pillai’s Trace=1.02, F(12,246)=21.38, p=.000, η2=.51). The 
main effect of diagnosis group did not indicate a significant effect on the combined DV 
(Pillai’s Trace=.06, F(6,122)=1.31, p=.259, η2=.06). The interaction effect between 
information source and diagnosis group indicated a significant effect on the combined 
DV (Pillai’s Trace=.25, F(12,246)=2.96, p=.001, η2=.13). The covariate did not 
significantly influence the combined DV (Pillai’s Trace=.02, F(6,122)=1.05, p=.396, 
multivariate η2=.05). 
Univariate ANOVA results are presented in Table 28. They indicated that all 
predictions/performance values (CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI, and 
LMII) were significantly effected by information source (F(2,134)=22.89, p=.000, partial 
η2=.25). Results indicated that both the CVLT IR and CVLT FC  
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Table 26 
Mean scores and standard deviations for the domain of 
memory for patient and informant predictions of 
performance percentages and actual performance 
percentages for MCI and dementia patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
CVLT-IR               
 MCI 23 27.04 18.83  19 36.84 21.10 
 Dementia 25 31.36 21.20  18 29.44 16.97 
  Total 48 29.29 20.01  37 33.24 19.30 
CVLT-DR               
 MCI 23 21.93 20.06  19 27.37 19.68 
 Dementia 25 27.35 23.93  18 20.00 11.38 
  Total 48 24.75 22.10  37 23.78 16.39 
CVLT-Rec               
 MCI 23 34.40 25.06  19 33.68 19.21 
 Dementia 25 32.87 24.81  18 31.67 21.49 
  Total 48 33.60 24.67  37 32.70 20.09 
CVLT-FC               
 MCI 23 50.54 24.61  19 38.95 16.96 
 Dementia 25 43.67 23.07  18 32.22 18.33 
  Total 48 46.96 23.82  37 35.68 17.72 
LMI               
 MCI 23 42.51 27.17  19 39.47 15.45 
 Dementia 25 46.26 19.64  18 32.78 18.73 
  Total 48 44.46 23.37  37 36.22 17.22 
LMII               
 MCI 23 16.91 14.09  19 35.79 18.65 
 Dementia 25 25.01 24.24  18 22.78 12.27 
  Total 48 21.13 20.24   37 29.46 16.99 
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Table 26 continued 
 
Mean scores and standard deviations for the domain of 
memory for patient and informant predictions of 
performance percentages and actual performance 
percentages for MCI and dementia patients continued 
    Information Source 
 Diagnosis Performance 
 
Total 
 Group n Mean SD 
 
n Mean SD 
CVLT-IR               
 MCI 24 54.63 21.21  66 39.89 23.32 
 Dementia 25 24.00 20.71  68 28.15 19.96 
  Total 49 39.00 25.87  134 33.93 22.39 
CVLT-DR               
 MCI 24 51.85 20.64  66 34.37 24.00 
 Dementia 25 31.56 23.06  68 26.95 21.20 
  Total 49 41.50 23.98  134 30.61 22.84 
CVLT-Rec               
 MCI 24 85.49 10.06  66 52.77 31.18 
 Dementia 25 72.00 12.70  68 46.94 27.68 
  Total 49 78.61 13.25  134 49.81 29.49 
CVLT-FC               
 MCI 24 98.15 5.35  66 64.52 31.19 
 Dementia 25 91.11 14.70  68 58.08 31.90 
  Total 49 94.56 11.59  134 61.25 31.60 
LMI               
 MCI 24 36.11 15.07  66 39.31 20.09 
 Dementia 25 19.68 9.61  68 32.92 19.80 
  Total 49 27.73 14.96  134 36.07 20.13 
LMII               
 MCI 24 25.08 18.72  66 25.32 18.57 
 Dementia 25 9.20 9.92  68 18.61 18.35 
  Total 49 16.98 16.78   134 21.91 18.69 
 
 
 
predictions/performances were significantly effected by diagnosis group (F(1,127)=6.53, 
p=.012, partial η2=.05, F(1,127)=4.01, p=.047, partial η2=.03, respectively) while the 
CVLT DR, CVLT Rec, LMI and LMII were not (F(1,127)=2.49, p=.117, partial η2=.02, 
F(1,127)=2.97, p=.087, partial η2=.02, F(1,127)=2.59, p=.110, partial η2=.02, 
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F(1,127)=3.43, p=.06, partial η2=.03, respectively). In addition, the interaction effect 
between information source and diagnosis group was significant for the CVLT IR, CVLT 
DR, LMI and LMII (F(2,127)=9.40, p=.000, partial η2=.13; F(2,127)=4.72, p=.011, 
η2=.07, F(2,127)=3.64, p=.029, partial η2=.05; F(2,127)=6.83, p=.002, η2=.10, 
respectively), but not for the CVLT Rec or CVLT FC (F(2,127)=1.39, p=.253, partial 
η2=.02; F(2,127)=0.00, p=.999, η2=.00, respectively).  
Pairwise comparison data are presented in Table 29. Comparison of 
prediction/performance means for the CVLT IR indicated that patients provided less 
favorable predictions than they were actually able to perform, and dementia patients 
received less favorable ratings regardless of the source of information. In addition, 
dementia patients did, in fact, perform more poorly than MCI patients. Comparison of 
prediction/performance means for the CVLT DR indicated that patients provided lower 
predictions than they were actually able to perform, and that dementia patients displayed 
lower performance than their MCI counterparts. Comparison of prediction/performance 
means for the CVLT Rec indicated that patients provided less favorable predictions than 
they were actually able to perform, and that dementia patients performed worse than MCI 
patients. Comparison of prediction/performance means for the CVLT FC indicated that 
both patients and informants provided less favorable predictions than patients were 
actually able to perform, and that dementia patients received less favorable ratings 
regardless of information source. In addition, dementia patients demonstrated a lower 
level of performance than their MCI counterparts. Comparison of prediction/performance  
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Table 27 
 
Multivariate analysis of covariance for the domain of memory for patient and 
informant prediction percentages and actual performance percentages for 
MCI and dementia patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.05 1.05 6 122 0.396 0.05 
Source 1.02 21.38 12 246 0.000 0.51 
Diagnosis 0.06 1.31 6 122 0.259 0.06 
Source * Diagnosis 0.25 2.96 12 246 0.001 0.13 
 
 
 
Table 28 
 
Univariate analysis of covariance for the domain of memory for patient and informant 
prediction percentages and actual performance percentages for MCI and dementia 
patients 
  Main Effect of      
Source 
Main Effect of 
Diagnosis 
Source x Diagnosis 
Interaction 
 Measure F(2,127) p η2 F(1,127) p η2 F(2,127) p η2 
CVLT-IR 3.11 .048 0.05 6.53 .012 0.05 9.40 .000 0.13 
CVLT-DR 11.26 .000 0.15 2.49 .117 0.02 4.72 .011 0.07 
CVLT-Rec 83.06 .000 0.57 2.97 .087 0.02 1.39 .253 0.02 
CVLT-FC 131.20 .000 0.67 4.01 .047 0.03 0.00 .999 0.00 
LMI 9.71 .000 0.13 2.59 .110 0.02 3.64 .029 0.05 
LMII 5.29 .006 0.08 3.43 .066 0.03 6.83 .002 0.10 
 
 
 
for LMI indicated that, although patients and informants provided similar ratings, they 
both underestimated patient’s actual performance. In addition, dementia patients 
performed worse than MCI patients. Lastly, comparison of prediction/performance means 
for LMII indicated that informants provided more favorable predictions than patients 
were actually able to perform. In addition, informants rated dementia patients less 
favorably than MCI patients, and dementia patients did, indeed, perform worse than MCI 
patients. 
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Table 29 
 
Pairwise comparisons for the domain of memory for patient and informant prediction 
percentages and actual performance percentages for MCI and dementia patients 
  Source   Diagnosis   Source x Diagnosis 
    p 
 
  p 
 
  p 
CVLT-IR               
 Pt x Inf ns  MCI x Dem 0.012  Pt x Diag ns 
 Pt x AP 0.044    
 
Inf x Diag ns 
  Inf x AP ns    
 
AP x Diag 0.000 
CVLT-DR               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag ns 
  Inf x AP 0.000    
 
AP x Diag 0.018 
CVLT-Rec               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag ns 
  Inf x AP 0.000    
 
AP x Diag 0.010 
CVLT-FC               
 Pt x Inf 0.015  MCI x Dem 0.047  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag ns 
  Inf x AP 0.000    
 
AP x Diag 0.010 
LMI               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag ns 
  Inf x AP ns    
 
AP x Diag 0.001 
LMII               
 Pt x Inf ns  MCI x Dem ns  Pt x Diag ns 
 Pt x AP ns    
 
Inf x Diag 0.002 
  Inf x AP 0.005         AP x Diag 0.005 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
 
 
 
Executive Function 
A two-way MANCOVA was conducted to determine the effect of information 
source (patient vs. informant vs. actual performance) and diagnosis group (MCI vs. 
dementia) on predictions of patient performance (or actual performance, when 
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applicable) in the domain of executive function, including the WCST and Trails B, while 
controlling for age (see Table 30 and Figures 19-20). As presented in Table 31, the main 
effect of information source indicated a significant effect on the combined DV (Pillai’s 
Trace=.29, F(4,268)=11.31, p=.000, η2=.14). The main effect of diagnosis group also 
indicated a significant effect on the combined DV (Pillai’s Trace=.08, F(2,133)=6.08, 
p=.003, η2=.08). Lastly, the interaction effect between information source 
 
 
Table 30 
 
Mean scores and standard deviations for the domain of 
executive function for patient and informant predictions of 
performance percentages and actual performance 
percentages for MCI and dementia patients 
    Information Source 
 
Diagnosis Patient 
 
Informant 
  Group n Mean SD 
 
n Mean SD 
WCST               
 MCI 24 41.61 24.08  22 37.27 24.53 
 Dementia 25 58.78 23.15  21 24.29 11.65 
  Total 49 50.37 24.92  43 30.93 20.21 
Trails B               
 MCI 24 46.50 27.18  22 41.36 22.53 
 Dementia 25 45.13 26.21  21 28.10 14.36 
  Total 49 45.80 26.42   43 34.88 19.93 
 
 
Performance 
 
Total 
  
n Mean SD 
 
n Mean SD 
WCST               
 MCI 24 48.24 19.30  70 42.52 22.83 
 Dementia 25 45.06 16.83  71 43.75 22.69 
  Total 49 46.62 17.96  141 43.14 22.68 
Trails B               
 MCI 24 37.38 26.88  70 41.76 25.62 
 Dementia 25 13.15 20.17  71 28.83 24.84 
  Total 49 25.02 26.45   141 35.25 25.96 
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and diagnosis group indicated a significant effect on the combined DV (Pillai’s 
Trace=.12, F(4,268)=4.09, p=.003, η2=.06). The covariate did not significantly influence 
the combined DV (Pillai’s Trace=.00, F(2,133)=.05, p=.952 multivariate η2=.00). 
Univariate ANOVA results are presented in Table 32. They indicated that both 
the WCST and Trails B predictions/performances were significantly effected by 
information source (F(2,134)=11.31, p=.000, partial η2=.14; F(2,134)=9.30, p=.000, 
partial η2=.12). Results indicated that Trails B predictions/performance was significantly 
effected by diagnosis group (F(1,134)=9.61, p=.002, partial η2=.07) while WCST was not 
(F(1,134)=.02, p=.879, partial η2=.00). Lastly, the interaction effect between information 
source and diagnosis group was significant for the WCST (F(2,134)=6.51, p=.002, partial 
η2=.09), but not Trails B (F(2,134)=2.88, p=.060, η2=.04).  
Pairwise comparison data are presented in Table 33. Comparison of 
prediction/performance means for the WCST indicate that informants provided lower 
predictions of performance than patients provided and than patients were actually able to 
perform. In addition, MCI patients predicted that they would perform worse than  
 
 
Table 31 
 
Multivariate analysis of covariance for the domain of executive function for 
patient and informant prediction percentages and actual performance 
percentages for MCI and dementia patients 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Age 0.00 0.05 2 133 0.952 0.00 
Source 0.29 11.31 4 268 0.000 0.14 
Diagnosis 0.08 6.08 2 133 0.003 0.08 
Source * Diagnosis 0.12 4.09 4 268 0.003 0.06 
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Table 32 
 
Univariate analysis of covariance for the domain of executive function for patient and 
informant prediction percentages and actual performance percentages for MCI and 
dementia patients 
  Main Effect of      
Source 
  Main Effect of 
Diagnosis 
  Source x Diagnosis 
Interaction 
   Measure F p η2   F p η2   F p η2 
WCST 11.31 .000 0.14 
 
0.02 .879 0.00  6.51 .002 0.09 
Trails B 9.30 .000 0.12   9.61 .002 0.07   2.88 .060 0.04 
Note: ABC= Significant Multivariate Analyses 
 
 
 
Table 33 
 
Pairwise comparisons for the domain of executive function for patient and informant 
prediction percentages and actual performance percentages for MCI and dementia 
patients 
  Source   Diagnosis   Source x Diagnosis 
    p 
 
  p 
 
  p 
WCST               
 Pt x Inf 0.000  MCI x Dem ns  Pt x Diag 0.037 
 Pt x AP ns    
 
Inf x Diag 0.027 
  Inf x AP 0.001    
 
AP x Diag ns 
Trails B               
 Pt x Inf ns  MCI x Dem 0.002  Pt x Diag ns 
 Pt x AP 0.000    
 
Inf x Diag 0.042 
  Inf x AP ns         AP x Diag 0.003 
Note: Pt= Patient, Inf = Informant, AP = Actual Performance, Dem = Dementia, Diag = 
Diagnosis, ABC= Significant Multivariate Analyses, ABC= Interpretable Pairwise 
Comparisons 
 
 
 
dementia patients, while informants predicted that dementia patients would perform 
worse than MCI patients. Lastly, dementia and MCI patients performed similarly. 
Comparison of prediction/performance means for Trails B indicated that, although 
patients and informants provided similar ratings, patients provided more favorable 
predictions than they were actually able to perform. In addition, dementia patients 
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received less favorable ratings than MCI patients, regardless of the information source. 
Lastly, informants predicted that dementia patients would perform less favorably than 
MCI patients, and dementia patients did, in fact, perform worse than their MCI 
counterparts. 
 
Hypothesis 3 – Emergent Awareness by Cognitive Domain 
General Cognitive Ability, Premorbid Function, and Effort 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to 
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time 
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of 
general cognitive ability, premorbid function, and effort, including the 3MS, WTAR, and 
DC, while controlling for age (see Table 34 and Figures 21-23). As presented in Table 35, 
the between subjects main effect of diagnosis group indicated a significant effect on the 
combined DV (Pillai’s Trace=.22, F(3,38)=3.60, p=.022, multivariate η2=.22). The 
within-subjects main effect of time did not indicate a significant effect on the combined 
DV (Pillai’s Trace=.05, F(3,38)=.64, p=.596, multivariate η2=.05). The interaction effect 
between diagnosis group and time did not indicate a significant effect on the combined 
DV (Pillai’s Trace=.16, F(3,38)=2.32, p=.091, multivariate η2=.16). The covariate did not 
significantly influence the combined DV (Pillai’s Trace=.03, F(3,38)=.03, p=.805, 
multivariate η2=.03).  
Univariate ANOVA results are presented in Table 36, and indicated that 3MS 
anosognosia ratios were significantly effected by diagnosis group (F(1,40)=10.90, p=.002, 
partial η2=.21), while the WTAR and DC anosognosia ratios were not (F(1,40)=1.16, 
95 
p=.288, partial η2=.03; F(1,40)=.093, p=.340, partial η2=.01, respectively). Comparison 
of 3MS anosognosia ratio means indicated that anosognosia ratios for MCI patients were 
lower than those of dementia patients, indicating that MCI patients had the tendency to 
provide less favorable predictions of their performance relative to their actual 
performance in comparison to the dementia group. 
 
Attention, Concentration, and Processing Speed 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to 
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time  
 
 
Table 34 
 
Mean scores and standard deviations for the domain of general cognitive ability, 
premorbid function, and effort for patient prediction anosognosia ratios for MCI 
and dementia patients 
    Time 
 
Diagnosis Prediction 
 
Evaluation 
 
Total 
  Group n Mean SD 
 
n Mean SD 
 
n Mean SD 
3MS                       
 MCI 21 -0.24 0.19  21 -0.30 0.28  42 -0.27 0.19 
 Dementia 22 0.02 0.19  22 -0.12 0.23  44 -0.05 0.19 
  Total 43 -0.11 0.23  43 -0.21 0.27  86 -0.16 0.03 
WTAR                       
 MCI 21 -0.30 0.35  21 -0.16 0.32  42 -0.23 0.08 
 Dementia 22 -0.10 0.38  22 -0.11 0.42  44 -0.10 0.08 
  Total 43 -0.20 0.37  43 -0.13 0.37  86 -0.17 0.05 
DC                       
 MCI 21 -0.35 0.31  21 -0.14 0.29  42 0.22 0.08 
 Dementia 22 -0.21 0.46  22 0.00 0.34  44 0.03 0.08 
  Total 43 -0.28 0.39   43 -0.07 0.32   86 0.13 0.05 
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Figure 21. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Modified Mini Mental Status Examination (3MS) 
 
 
 
 
Figure 22. Prediction and evaluation ratios (±SD) for the Wechsler Test of Adult Reading 
(WTAR) 
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Figure 23. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Dot Counting Test (DC) 
 
 
 
Table 35 
 
Multivariate analysis of covariance analysis for the domain of general cognitive 
ability, premorbid function, and effort for patient prediction and evaluation 
anosognosia ratios for MCI and dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between  Intercept 0.04 0.53 3 38 0.665 0.04 
 
Age 0.03 0.33 3 38 0.805 0.03 
 
Diagnosis 0.22 3.60 3 38 0.022 0.22 
Within  Time 0.05 0.64 3 38 0.596 0.05 
 
Time*Age 0.06 0.87 3 38 0.465 0.06 
  Time*Diagnosis 0.16 2.32 3 38 0.091 0.16 
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Table 36 
 
Univariate analysis of covariance analysis for the domain of general cognitive 
ability, premorbid function, and effort for patient prediction and evaluation 
anosognosia ratios for MCI and dementia patients 
    Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
  Measure 
 
F(1,40) p η2 F(1,40) p η2 F(1,40) p η2 
3MS 0.07 .791 0.00 10.90 .002 0.21 1.05 .313 0.03 
WTAR 1.04 .314 0.03 1.16 .288 0.03 7.18 .011 0.15 
DC 0.41 .526 0.01 0.93 .340 0.02 0.00 .979 0.00 
 
 
 
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of 
attention, concentration, and processing speed, including Trails A, DSF, DSB, and the 
SDMT, while controlling for age (see Table 37 and Figures 24-27). As presented in Table 
38, the between subjects main effect of diagnosis group indicated a significant effect on 
the combined DV (Pillai’s Trace=.29, F(4,42)=4.23, p=.006, multivariate η2=.29). The 
within-subjects main effect of time did not indicate a significant effect on the combined 
DV (Pillai’s Trace=.05, F(4,42)=.56, p=.692, multivariate η2=.05). The interaction effect 
between diagnosis group and time did not indicate a significant effect on the combined 
DV (Pillai’s Trace=.06, F(4,42)=.062, p=.654, multivariate η2=.06). The covariate did not 
significantly influence the combined DV (Pillai’s Trace=.05, F(7,42)=.056, p=.693, 
multivariate η2=.05).  
Univariate ANOVA results are presented in Table 39, and indicated that Trails A, 
DSB, and SDMT anosognosia ratios were significantly effected by diagnosis group 
(F(1,45)=9.58, p=.003, partial η2=.18; F(1,45)=5.84, p=.020, partial η2=.11; 
F(1,45)=12.04, p=.001, partial η2=.21, respectively), while DSF anosognosia ratios were  
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Table 37 
 
Mean scores and standard deviations for the domain of attention, concentration, 
and processing speed for patient prediction anosognosia ratios for MCI and 
dementia patients 
    Time 
 
Diagnosis Prediction 
 
Evaluation 
 
Total 
  Group n Mean SD 
 
n Mean SD 
 
n Mean SD 
Trails A                       
 MCI 24 -0.21 0.24  24 -0.17 0.19  48 -0.18 0.08 
 Dementia 24 0.15 0.48  24 0.20 0.45  48 0.16 0.08 
  Total 48 -0.03 0.42  48 0.02 0.39  96 -0.01 0.05 
DSF                      
 MCI 24 -0.25 0.44  24 -0.15 0.34  48 -0.22 0.07 
 Dementia 24 -0.11 0.30  24 -0.11 0.36  48 -0.09 0.07 
  Total 48 -0.18 0.38  48 -0.13 0.35  96 -0.16 0.05 
DSB                      
 MCI 24 -0.29 0.44  24 -0.16 0.46  48 -0.25 0.10 
 Dementia 24 0.00 0.60  24 0.15 0.50  48 0.11 0.10 
  Total 48 -0.14 0.54  48 -0.01 0.50  96 -0.07 0.07 
SDMT                      
 MCI 24 -0.25 0.41  24 -0.07 0.32  48 -0.16 0.08 
 Dementia 24 0.20 0.50  24 0.30 0.39  48 0.25 0.08 
  Total 48 -0.02 0.51   48 0.12 0.40   96 0.05 0.05 
 
 
 
 
Figure 24. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Trail Making Test Part A (Trails A) 
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Figure 25. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Digit Span Forward (DSF) 
 
 
 
 
Figure 26. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Digit Span Backward (DSB) 
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Figure 27. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Symbol Digit Modalities Test (SDMT) 
 
 
 
Table 38 
 
Multivariate analysis of covariance analysis for the domain of attention, concentration, 
and processing speed for patient prediction and evaluation anosognosia ratios for MCI 
and dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between  Intercept 0.03 0.36 4 42 0.838 0.03 
 
Age 0.05 0.56 4 42 0.693 0.05 
 
Diagnosis 0.29 4.23 4 42 0.006 0.29 
Within  Time 0.05 0.56 4 42 0.692 0.05 
 
Time*Age 0.08 0.86 4 42 0.495 0.08 
  Time*Diagnosis 0.06 0.62 4 42 0.654 0.06 
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Table 39 
 
Univariate analysis of covariance analysis for the domain of attention, 
concentration, and processing speed for patient prediction and evaluation 
anosognosia ratios for MCI and dementia patients 
   Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
 Measure F(1,45) p η2 F(1,45) p η2 F(1,45) p η2 
Trails A 0.04 .844 0.00 9.58 .003 0.18 0.03 .872 0.00 
DSF 0.01 .915 0.00 1.74 .194 0.04 1.32 .257 0.03 
DSB 1.69 .200 0.04 5.84 .020 0.11 0.19 .667 0.00 
SDMT 0.47 .497 0.01 12.04 .001 0.21 1.06 .308 0.02 
 
 
 
not (F(1,45)=1.74, p=.194, partial η2=.04). Comparison of anosognosia ratio means for 
all three significant subtests (Trails A, DSB, and SDMT) indicated that anosognosia 
ratios for MCI patients were lower than those of dementia patients, indicating that MCI 
patients had the tendency to provide less favorable predictions of their performance 
relative to their actual performance in comparison to their dementia patient counterparts. 
 
Language 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to 
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time 
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of 
language, including FAS, Animals, and the BNT, while controlling for age (see Table 40 
and Figures 28-30). As presented in Table 41, the between subjects main effect of 
diagnosis group did not indicate a significant effect on the combined DV (Pillai’s 
Trace=.14, F(3,43)=2.33, p=.088, multivariate η2=.14). The within-subjects main effect 
of time did not indicate a significant effect on the combined DV (Pillai’s Trace=.06, 
F(3,43)=.86, p=.471, multivariate η2=.06). The interaction effect between diagnosis  
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Table 40 
 
Mean scores and standard deviations for the domain of language for patient 
prediction anosognosia ratios for MCI and dementia patients 
 
Diagnosis Prediction Evaluation Total 
  Group n Mean SD n Mean SD n Mean SD 
FAS                   
 MCI 23 -0.05 0.36 23 -0.21 0.36 46 -0.15 0.06 
 Dementia 25 0.14 0.30 25 -0.05 0.29 50 0.06 0.06 
  Total 48 0.05 0.34 48 -0.13 0.33 96 -0.04 0.04 
Animals                   
 MCI 23 -0.04 0.34 23 -0.18 0.39 46 -0.11 0.07 
 Dementia 25 0.20 0.32 25 0.01 0.41 50 0.10 0.07 
  Total 48 0.09 0.35 48 -0.08 0.41 96 0.00 0.05 
BNT                   
 MCI 23 -0.21 0.25 23 -0.19 0.23 46 -0.20 0.05 
 Dementia 25 -0.09 0.22 25 -0.07 0.26 50 -0.08 0.05 
  Total 48 -0.15 0.24 48 -0.13 0.25 96 -0.14 0.03 
 
 
 
 
Figure 28. Prediction and evaluation ratios (±SD) for MCI and dementia patients for FAS 
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Figure 29. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Animals 
 
 
 
 
Figure 30. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Boston Naming Test (BNT) 
 
group and time did not indicate a significant effect on the combined DV (Pillai’s 
Trace=.02, F(3,43)=0.29, p=.833, multivariate η2=.02). The covariate did not 
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significantly influence the combined DV (Pillai’s Trace=.04, F(3,43)=.64, p=.592, 
multivariate η2=.04). Univariate ANOVA results are presented in Table 42, though they 
are uninterpretable. 
 
Visuoperception and Visuoconstruction 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to determine the 
effect of diagnosis group (between subjects, MCI vs. dementia) and time (within-subjects, 
prediction vs. evaluation) on anosognosia ratios in the domain of visuoperception and 
 
 
Table 41 
 
Multivariate analysis of covariance analysis for the domain of language for patient 
prediction and evaluation anosognosia ratios for MCI and dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between  Intercept 0.04 0.54 3 43 0.659 0.04 
 
Age 0.04 0.64 3 43 0.592 0.04 
 
Diagnosis 0.14 2.33 3 43 0.088 0.14 
Within  Time 0.06 0.86 3 43 0.471 0.06 
 
Time*Age 0.03 0.39 3 43 0.760 0.03 
  Time*Diagnosis 0.02 0.29 3 43 0.833 0.02 
 
 
 
Table 42 
 
Univariate analysis of covariance analysis for the domain of language for patient 
prediction and evaluation anosognosia ratios for MCI and dementia patients 
  Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
 Measure F(1,45) p η2 F(1,45) p η2 F(1,45) p η2 
FAS 2.37 .131 0.05 5.46 .024 0.11 0.53 .471 0.01 
Animals 1.03 .315 0.02 4.08 .049 0.08 0.63 .433 0.01 
BNT 0.04 .841 0.00 3.30 .076 0.07 0.06 .801 0.00 
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visuoconstruction, including the JLO and BD, while controlling for age (see Table 43 and 
Figures 31-32). As presented in Table 44, the between subjects main effect of diagnosis 
group indicated a significant effect on the combined DV (Pillai’s Trace=.21, 
F(2,43)=5.71, p=.006, multivariate η2=.21). The within-subjects main effect of time did 
not indicate a significant effect on the combined DV (Pillai’s Trace=.07, F(2,43)=.1.50, 
p=.235, multivariate η2=.07). The interaction effect between diagnosis group and time did 
not indicate a significant effect on the combined DV (Pillai’s Trace=.06, F(2,43)=1.31, 
p=.281, multivariate η2=.06). The covariate did not significantly influence 
 
 
 
Table 43 
 
Mean scores and standard deviations for the domain of visuoperception and 
visuoconstruction for patient prediction anosognosia ratios for MCI and dementia 
patients 
    Time 
 
Diagnosis Prediction Evaluation Total 
  Group n Mean SD n Mean SD n Mean SD 
JLO                   
 MCI 24 -0.22 0.33 24 -0.10 0.22 48 -0.18 0.08 
 Dementia 23 0.21 0.50 23 0.18 0.50 46 0.21 0.08 
  Total 47 -0.01 0.47 47 0.03 0.41 94 0.02 0.06 
BD                   
 MCI 24 0.06 0.31 24 -0.20 0.38 48 -0.08 0.08 
 Dementia 23 0.43 0.37 23 0.12 0.60 46 0.28 0.09 
  Total 47 0.24 0.39 47 -0.04 0.52 94 0.10 0.06 
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Figure 31. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Judgment of Line Orientation (JLO) 
 
 
 
 
Figure 32. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Block Design 
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Table 44 
 
Multivariate analysis of covariance analysis for the domain of visuoperception and 
visuoconstruction for patient prediction and evaluation anosognosia ratios for MCI and 
dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between Intercept 0.02 0.37 2 43 0.694 0.02 
 
Age 0.02 0.35 2 43 0.709 0.02 
 
Diagnosis 0.21 5.71 2 43 0.006 0.21 
Within Time 0.07 1.50 2 43 0.235 0.07 
 
Time*Age 0.04 0.93 2 43 0.401 0.04 
  Time*Diagnosis 0.06 1.31 2 43 0.281 0.06 
 
 
 
Table 45 
 
Univariate analysis of covariance analysis for the domain of visuoperception and 
visuoconstruction for patient prediction and evaluation anosognosia ratios for MCI 
and dementia patients 
  Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
 Measure F(1,44) p η2 F(1,44) p η2 F(1,44) p η2 
JLO 2.21 .144 0.05 10.37 .002 0.19 2.01 .163 0.04 
BD 1.17 .284 0.03 8.71 .005 0.17 0.43 .516 0.01 
  
 
    
the combined DV (Pillai’s Trace=.02, F(2,43)=.35, p=.709, multivariate η2=.02).  
Univariate ANOVA results are presented in Table 45, and indicated that both JLO 
and BD anosognosia ratios were significantly effected by diagnosis group (F(1,44)=10.37, 
p=.002, partial η2=.19; F(1,44)=8.71, p=.005, partial η2=.17, respectively). Comparison 
of prediction means for both measures indicated that anosognosia ratios for MCI patients 
were lower than those of dementia patients, indicating that MCI patients had the tendency 
to provide less favorable predictions of their performance relative to their actual 
performance than their dementia group counterparts. 
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Memory 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to 
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time 
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of 
memory, including the CVLT IR, CVLT DR, CVLT Rec, CVLT FC, LMI and LMII, 
while controlling for age (see Table 46 and Figures 33-38). As presented in Table 47, the 
between subjects main effect of diagnosis group indicated a significant effect on the 
combined DV (Pillai’s Trace=.33, F(6,39)=3.23, p=.011, multivariate η2=.33). The 
within-subjects main effect of time did not indicate a significant effect on the combined 
DV (Pillai’s Trace=.17, F(6,39)=1.33, p=.596, multivariate η2=.17). The interaction 
effect between diagnosis group and time did not indicate a significant effect on the 
combined DV (Pillai’s Trace=.16, F(6,39)=1.19, p=.033, multivariate η2=.16). The 
covariate did not significantly influence the combined DV (Pillai’s Trace=.12, 
F(6,39)=.92, p=.494, multivariate η2=.12).  
Univariate ANOVA results are presented in Table 48, and indicated that CVLT 
IR, LMI and LMII anosognosia ratios were significantly effected by diagnosis group 
(F(1,44)=10.16, p=.003, partial η2=.19; F(1,44)=12.20, p=.001, partial η2=.22; 
F(1,44)=6.96, p=.011, partial η2=.14, respectively), while CVLT DR, CVLT Rec, and 
CVLT FC anosognosia ratios were not (F(1,44)=3.61, p=.064, partial η2=.08; 
(F(1,44)=.03, p=.874, partial η2=.00; F(1,44)=0.00, p=.961, partial η2=.00, respectively). 
Comparison of prediction means indicated that anosognosia ratios for MCI patients were 
lower than those of dementia patients for all three significant measures (CVLT IR, LMI 
and LMII), indicating that MCI patients had the tendency to provide less favorable  
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Table 46 
 
Mean scores and standard deviations for the domain of memory for patient prediction 
anosognosia ratios for MCI and dementia patients 
 
Diagnosis Prediction Evaluation Total 
  Group n Mean SD n Mean SD n Mean SD 
CVLT-IR                   
 MCI 23 -0.35 0.42 23 -0.30 0.39 46 -0.33 0.12 
 Dementia 24 0.23 0.64 24 0.16 0.65 48 0.20 0.11 
  Total 47 -0.05 0.61 47 -0.06 0.58 94 -0.06 0.08 
CVLT-DR                   
 MCI 23 -0.42 0.47 23 -0.47 0.47 46 -0.42 0.11 
 Dementia 24 -0.03 0.58 24 -0.19 0.51 48 -0.13 0.10 
  Total 47 -0.23 0.56 47 -0.33 0.50 94 -0.28 0.07 
CVLT-Rec                   
 MCI 23 -0.50 0.31 23 -0.39 0.30 46 -0.44 0.06 
 Dementia 24 -0.47 0.30 24 -0.38 0.32 48 -0.43 0.06 
  Total 47 -0.48 0.30 47 -0.39 0.31 94 -0.44 0.04 
CVLT-FC                   
 MCI 23 -0.36 0.25 23 -0.21 0.26 46 -0.31 0.05 
 Dementia 24 -0.40 0.26 24 -0.26 0.18 48 -0.31 0.05 
  Total 47 -0.38 0.25 47 -0.23 0.22 94 -0.31 0.03 
LMI                   
 MCI 23 0.00 0.40 23 -0.26 0.39 46 -0.15 0.08 
 Dementia 24 0.36 0.35 24 0.12 0.48 48 0.25 0.08 
  Total 47 0.18 0.42 47 -0.06 0.47 94 0.05 0.05 
LMII                   
 MCI 23 -0.06 0.63 23 -0.02 0.62 46 -0.02 0.12 
 Dementia 24 0.49 0.48 24 0.40 0.51 48 0.42 0.11 
  Total 47 0.22 0.62 47 0.19 0.60 94 0.20 0.08 
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Figure 33. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
California Verbal Learning Test Immediate Recall (CVLT IR) 
 
 
 
 
Figure 34. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
California Verbal Learning Test Delayed Recall (CVLT DR) 
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Figure 35. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
California Verbal Learning Test Recognition (CVLT Rec) 
 
 
 
 
Figure 36. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
California Verbal Learning Test Forced Choice Recognition (CVLT FC) 
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Figure 37. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Logical Memory I (LMI) 
 
 
 
 
Figure 38. Prediction and evaluation ratios (±SD) for MCI and dementia patients for 
Logical Memory II (LMII) 
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Table 47 
 
Multivariate analysis of covariance analysis for the domain of memory for patient 
prediction and evaluation anosognosia ratios for MCI and dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between Intercept 0.17 1.36 6 39 0.254 0.17 
 
Age 0.12 0.92 6 39 0.494 0.12 
 
Diagnosis 0.33 3.23 6 39 0.011 0.33 
Within  Time 0.17 1.33 6 39 0.269 0.17 
 
Time*Age 0.19 1.56 6 39 0.185 0.19 
  Time*Diagnosis 0.16 1.19 6 39 0.33 0.16 
 
 
 
Table 48 
 
Univariate analysis of covariance analysis for the domain of memory for patient 
prediction and evaluation anosognosia ratios for MCI and dementia patients 
  Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
 Measure F(1,44) p η2 F(1,44) p η2 F(1,44) p η2 
CVLT-IR 3.93 .054 0.08 10.16 .003 0.19 5.06 .029 0.10 
CVLT-DR 0.92 .342 0.02 3.61 .064 0.08 0.63 .432 0.01 
CVLT-Rec 2.93 .094 0.06 0.03 .874 0.00 0.06 .803 0.00 
CVLT-FC 0.00 .989 0.00 0.00 .961 0.00 0.06 .803 0.00 
LMI 0.74 .393 0.02 12.20 .001 0.22 0.45 .505 0.01 
LMII 0.00 .965 0.00 6.96 .011 0.14 1.22 .276 0.03 
 
 
 
predictions of their performance relative to their actual performed in comparison to their 
dementia group counterparts. 
 
Executive Function 
A two-way, mixed (doubly-multivariate) MANCOVA was conducted to 
determine the effect of diagnosis group (between subjects, MCI vs. dementia) and time 
(within-subjects, prediction vs. evaluation) on anosognosia ratios in the domain of 
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executive function, including the WCST and Trails B, while controlling for age (see 
Table 49 and Figures 39-40). As presented in Table 50, the between subjects main effect 
of diagnosis group indicated a significant effect on the combined DV (Pillai’s Trace=.21, 
F(2,45)=6.04, p=.005, multivariate η2=.21). The within-subjects main effect of time did 
not indicate a significant effect on the combined DV (Pillai’s Trace=.00, F(2,45)=.09, 
p=.916, multivariate η2=.00). The interaction effect between diagnosis group and time did 
not indicate a significant effect on the combined DV (Pillai’s Trace=.03, F(2,45)=.64, 
p=.534, multivariate η2=.03). The covariate did not significantly influence the combined 
DV (Pillai’s Trace=.02, F(2,45)=.56, p=.578, multivariate η2=.02).  
Univariate ANOVA results are presented in Table 51, and indicated that Trails B 
anosognosia ratios were significantly effected by diagnosis group (F(1,44)=10.70, p=.002, 
partial η2=.19), while WCST anosognosia ratios were not (F(1,44)=3.18, p=.081, partial 
η2=.06). Comparison of Trails B anosognosia ratio means indicated that anosognosia 
ratios for MCI patients were lower than those of dementia patients, indicating that MCI  
 
 
Table 49 
 
Mean scores and standard deviations for the domain of executive function for patient 
prediction anosognosia ratios for MCI and dementia patients 
    Time 
 
Diagnosis Prediction Evaluation Total 
  Group n Mean SD n Mean SD n Mean SD 
WCST                   
 MCI 24 -0.13 0.39 24 -0.27 0.37 48 -0.19 0.06 
 Dementia 25 0.12 0.26 25 -0.17 0.37 50 -0.04 0.06 
  Total 49 -0.01 0.35 49 -0.22 0.37 98 -0.12 0.04 
Trails B                   
 MCI 24 0.19 0.59 24 0.21 0.59 48 0.18 0.11 
 Dementia 25 0.69 0.45 25 0.65 0.47 50 0.70 0.11 
  Total 49 0.45 0.57 49 0.44 0.57 98 0.44 0.07 
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Figure 39. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Wisconsin Card Sorting Test (WCST) 
 
 
 
Figure 40. Prediction and evaluation ratios (±SD) for MCI and dementia patients for the 
Trail Making Test Part B (Trails B) 
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Table 50 
 
Multivariate analysis of covariance analysis for the domain of executive function for 
patient prediction and evaluation anosognosia ratios for MCI and dementia patients 
Effect   Value F 
Hypothesis 
df 
Error 
df Sig. η2 
Between  Intercept 0.07 1.71 2 45 0.193 0.07 
 
Age 0.02 0.56 2 45 0.578 0.02 
 
Diagnosis 0.21 6.04 2 45 0.005 0.21 
Within  Time 0.00 0.09 2 45 0.916 0.00 
 
Time*Age 0.01 0.29 2 45 0.751 0.01 
  Time*Diagnosis 0.03 0.64 2 45 0.534 0.03 
 
 
 
Table 51 
 
Univariate analysis of covariance analysis for the domain of executive function for 
patient prediction and evaluation anosognosia ratios for MCI and dementia patients 
 
Main Effect of         
Time 
Main Effect of 
Diagnosis 
Time x Diagnosis 
Interaction 
 Measure F(1,46) p η2 F(1,46) p η2 F(1,46) p η2 
WCST 0.06 .806 0.00 3.18 .081 0.06 0.82 .370 0.02 
Trails B 0.09 .767 0.00 10.70 .002 0.19 0.70 .406 0.02 
 
 
 
patients had the tendency to provide less favorable predictions of their performance 
relative to their actual performance than the dementia group. 
 
Hypothesis 4 
Logistic Regression – Enter Method 
 A logistic regression was conducted using the enter method to determine if 
predictive anosognosia ratios for all 20 neuropsychological measures across six cognitive 
domains, and age were predictors of diagnostic group membership (MCI vs. dementia, 
see Table 52). A test of the full model with all predictors against a constant-only model 
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was statistically significant, χ2 (21, N=42)=58.129, p=.000, indicating that the predictors, 
as a set, reliably distinguished between patients diagnosed with MCI and those diagnosed 
with dementia. Regression results indicated the overall model fit of the 21 predictors was 
impressive, such that it predicted group membership with 100% accuracy (-2 Log 
Likelihood=.000, Hostmer and Lemeshow χ2 (7, N=42)=.000, p=1.00). Results also 
indicated that anosognosia ratios for the 3MS, Trails A, Animals, CVLT IR, BD, CVLT 
DR, CVLT Rec, LMI, JLO, and WTAR contributed to differential diagnosis between 
MCI and dementia groups (Exp(B)=4.882E+070; Exp(B)=9.501E+039; 3.612E+038; 
Exp(B)=3.906E+11; Exp(B)=2.297E+31; Exp(B)=160739907; Exp(B)=76.999; 20.562; 
Exp(B)=9.843E+27; Exp(B)=5.239E+18, respectively). 
 
Logistic Regression – Forward Method 
 A forward logistic regression was conducted to determine the most predictive set 
of anosognosia ratios for diagnostic group membership, using the same set of predictors 
as the first logistic regression (20 neuropsychological measures across six domains, and 
age). The anosognosia ratios for the 3MS and LMII were the only two predictors to enter 
the model (see Table 53). Regression results indicated the overall model of fit for the two 
predictors was questionable (-2 Log Likelihood=32.545, Hostmer and Lemeshow χ2 (8, 
N=42)=18.421, p=.018) but was statistically reliable in distinguishing between diagnostic 
groups, χ2 (1, N=42)=7.264, p=.007. Regression results also indicated that the model 
impressively predicted group membership, with 85% accuracy for the MCI group and 
81.8% accuracy for the dementia group, for an overall accuracy of 83.3%. These results 
indicate that anosognosia ratios for the 3MS and LMII, in isolation of the rest of the 
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anosognosia ratios, were significant predictors of diagnostic group membership and 
reliably distinguished between MCI and dementia groups. 
 
 
 
Table 52 
 
Summary of simultaneous logistic regression analysis predicting 
diagnostic group membership 
  Measure B SE Exp(B) p 
Age -1.02 4618.03 0.36 1.000 
General Cognitive Ability, Premorbid Function, and Effort 
 
3MS 1.63 1459.22 5.09 .999 
 
WTAR 0.64 885.24 1.89 .999 
 
DC -1.13 1598.60 0.32 .999 
Attention, Concentration, and Processing Speed 
 
Trails A 0.92 865.57 2.51 .999 
 
DSF -0.11 2274.33 0.89 1.000 
 
DSB -0.20 1707.89 0.82 1.000 
 
SDMT -0.21 293.19 0.81 .999 
Language 
    
 
FAS -0.91 981.04 0.40 .999 
 
Animals 0.89 405.97 2.43 .998 
 
BNT -0.01 1182.65 0.99 1.000 
Visuoperceptual and Visuoconstructional 
 
JLO 0.25 487.19 1.29 1.000 
 
BD 0.72 1155.55 2.06 1.000 
Memory 
    
 
CVLT IR 0.27 1086.87 1.31 1.000 
 
CVLT DR 0.19 533.32 1.21 1.000 
 
CVLT Rec 0.04 896.89 1.04 1.000 
 
CVLT FC -0.91 735.45 0.40 .999 
 
LMI 0.03 918.30 1.03 1.000 
 
LMII -0.08 813.39 0.92 1.000 
Executive Function 
   
 
WCST  -0.09 378.08 0.91 1.000 
  Trails B -0.05 1044.84 0.95 1.000 
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Table 53 
 
Summary of forward logistic regression analysis predicting 
diagnostic group membership 
Measure B SE Exp(B) p 
3MS .082 .028 1.085 .003 
LMII .020 .009 1.021 .021 
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CHAPTER SIX 
DISCUSSION 
 
 The current study sought to standardize the assessment of anosognosia using a 
clinically relevant, easily replicable protocol that could readily be incorporated into 
existing routine assessments of patients with cognitive complaints related to mild 
cognitive impairment and dementia diagnoses.  In addition, investigation into the 
relationships between patient predicted performance, informant predicted performance, 
and actual performance were performed in order to assess the validity of current 
anosognosia assessment procedures using informant input as the benchmark for 
assessment of presence and severity of anosognosia (Evans et al., 2005; Flashman & 
McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et al., 1998). The study also 
sought to investigate the relationship between informant and patient performance as they 
relate to actual performance, a methodology seldom used in current anosognosia 
literature (Fleming, Strong, & Ashton, 1996; Barrett et al., 2005).  Emergent awareness, 
which is currently unexamined in anosognosia literature, was assessed by investigating 
the difference between predictions of performance and evaluations of performance before 
and after each neuropsychological measure, respectively, to examine changes in 
awareness after having completed a measure. Lastly, the ability to predict diagnosis based 
on patient predictions of performance relative to actual performance was assessed. 
 
Hypothesis 1 – Patient Versus Informant Ratings 
 It was hypothesized that a significant difference would be present between patient 
and informant predictions of patient performance, such that patients would estimate their 
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performance more favorably than would their respective informants.  Analysis compared 
patient and informant prediction percentages, irrespective of actual performance, for each 
domain of neuropsychological function.  
 
General Cognitive Ability, Premorbid Function, and Effort 
 Patient and informant ratings were significantly different for the domain of 
general cognitive ability, premorbid ability, and effort, with patients providing more 
favorable predictions than informants for a measure of general cognition (3MS). 
Interestingly, patients had the tendency to provide less favorable predictions on a 
measure of effort asking patients to quickly count a series of cards with dots on them 
(DC). It is possible that the difference seen between these two ratings is due to an effect 
of order, because the 3MS is given first in the neuropsychological battery and the DC is 
administered last, thus possibly reflecting a tendency to provide less favorable ratings 
throughout the course of the evaluation. Patients and informants provided similar 
predictions of patient ability to read a list of irregular words (WTAR).  Thus, patients 
provided differentially favorable predictions of their general cognitive ability, but less 
favorable predictions of their ability to perform simple speeded counting tasks. 
 
Attention, Concentration, and Processing Speed 
 Patients and informants provided significantly different ratings for the domain of 
attention, concentration and processing speed. Patients demonstrated the tendency to rate 
themselves more favorably on a measure of speeded visual attention (Trails A) than their 
informant counterparts. Patients and informants provided similar predictions of ability of 
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verbal attention and working memory (DSF and DSB, respectively) and psychomotor 
processing speed (SDMT).   Thus, patients provided differentially favorable predictions 
of their performance on speeded visual attention tasks (Trails A), but not for tasks 
reflective of verbal attention and concentration or psychomotor processing speed. 
 
Language 
 Both groups provided similar ratings for the language domain. There were no 
differences found in patient and informant ratings on phonemic and semantic fluency 
ability (FAS and Animals, respectively) or confrontational naming (BNT). Thus, patients 
did not provide differentially favorable predictions of their language skills. 
 
Visuoperception and Visuoconstruction 
Both groups provided similar ratings for the visuospatial domain.  No differences 
were found in patient and informant predictions of ability for visuoperceptual and 
speeded visuoconstructional ability (JLO and BD, respectively). Thus, patients did not 
provide differentially favorable predictions of their visuospatial skills. 
 
Memory 
 Patient and informant ratings were found to be significantly different for the 
memory domain. Patients more favorably rated their ability to recognize previously 
presented discrete information in forced choice format (CVLT FC). Interestingly, patients 
were found to rate themselves less favorably on delayed contextual memory for stories 
(LMII) than their informant counterparts. No differences were found between patient and 
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informant predictions for immediate or delayed recall of discrete information (CVLT IR, 
CVLT DR, respectively), yes/no recognition ability for previously presented discrete 
information (CVLT Rec), or immediate recall of contextual information (LMI).  Thus, 
patients had the tendency to provide differentially more favorable predictions of their 
forced choice recognition ability, but differentially less favorable predictions of their 
delayed contextual memory. In addition, they did not provide differentially favorable 
predictions of ability on other facets of memory, including discrete immediate, delayed, 
and recognition memory, or immediate contextual memory. 
 
Executive Function 
 Lastly, the groups were found to provide significantly different ratings for the 
domain of executive function. Patients provided differentially more favorable predictions 
of their performance in novel, ambiguous problem solving (WCST) as well as in speeded 
mental set shifting (Trails B).  Thus, on measures of executive function, patients had the 
tendency to provide differentially favorable predictions of their performance than their 
informant counterparts. 
 
Conclusions 
In sum, the hypothesis that patients would provide significantly more favorable 
predictions of their neuropsychological performance ability received mixed support 
across cognitive domains, with support in the areas of general cognitive ability, speeded 
visual attention, forced choice recognition memory, and executive function as a whole.   
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 The reverse pattern of patient and informant ratings between the 3MS and Trails 
A is interesting, given that patients provided more favorable responses than informants 
when asked about their general cognitive ability, while the reverse was seen when asked 
to serially connect 25 numbers on a page, a measure of speeded visual processing. It is 
likely that the manner in which the 3MS measures “general cognitive ability” is 
conceptually different than what is implied when the lay public thinks about general 
cognitive skills, and thus the way in which the question was worded may not have 
translated well to the general public. The reverse pattern of ratings seen in Trails A also 
provides evidence for the idea that patients do not consistently provide more favorable 
predictions of their performance than their informant counterparts. This was also seen on 
a measure of delayed memory for contextual information. The fact that patients failed to 
consistently rate themselves more favorably across all measures, as well as across all 
domains of function, falls in line with research previously conducted, however the 
domains within which anosognosia was apparent differed. Barrett and colleagues (2005) 
found that anosognosia was present primarily for visuospatial function in Alzheimer’s 
dementia patients. It is possible that the heterogeneous diagnostic sample employed in the 
current study diluted the impact of anosognosia seen in dementia, such that the pattern of 
anosognosia seen in their study is specific to Alzheimer’s dementia and not dementia as a 
whole. The current study found that patients and informants provided commensurate 
predictions within the domains of language and visuospatial skills. 
 Previous anosognosia research traditionally measures anosognosia for memory as 
a single construct, but neuropsychological tests assess different aspects of memory, 
which would make it difficult for patients to provide reliable predictions and evaluations 
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of their performance on memory measures (Barrett et al., 2005; Carr, Gray, Baty, & J. C. 
Morris, 2000; Derouesné et al., 1999).  The current study conducted multistep ratings of 
different aspects of memory, parallel with the method of measuring memory skills used 
in traditional neuropsychological assessment. As such, patients were asked for prediction 
and evaluation ratings for immediate and delayed portions memory, as well as yes/no 
recognition memory and forced choice memory for previously presented information. 
Interestingly, differences in patterns of responding were seen across memory measures, 
with patients rating themselves more favorably on forced choice recognition paradigms 
than informants, and less favorably on delayed recall for contextual information. No 
differences were found for immediate, delayed, and yes/no recognition memory for 
discrete information or on immediate memory for contextual information.  In addition, 
patients rated themselves less favorably on delayed recall for contextual information than 
informants. Thus, “memory” is clearly not a unitary construct, and more fine-grained 
analysis of anosognosia within this domain is warranted.  
 Additionally, the fact that patients rated themselves less favorably on measures of 
delayed recall for contextual information relative to their informant counterparts speaks 
to the real world frustration that many family members and caregivers of MCI and 
dementia patients face.  Informants predict, and likely expect, that patients remember 
more contextual information, or presented in story format as opposed to discrete lists, 
than patients predict they will. Thus, it is likely that these family members and caregivers 
are providing information to patients with this idea in mind, which likely leads to a 
disconnect between patient and caregiver expectations of patient ability. In addition, the 
current analysis also revealed that patients tend to overestimate their ability to solve 
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problems, as discussed below, and likely lack the insight to make appropriate 
compensations for their memory ability. 
 Lastly, patients rated themselves consistently more favorably on measures of 
executive function. This may be related to the fact that these types of measures, by 
definition, are novel and require the patient to perform tasks that are not typically asked 
of them. Thus, patients have little experience with these types of tasks to provide a basis 
for prediction of their ability. This is often clinically evident during the 
neuropsychological evaluation process, such that patients are often surprised and/or 
perplexed by the difficulties they encounter when attempting these tasks. 
 
Hypothesis 2 – Accuracy of Ratings 
 Research to date has yet to compare the accuracy of patient predictions of their 
performance or informant predictions of patient performance relative to actual 
performance ability. It was hypothesized that there would be significant differences 
between information sources (patient prediction, informant prediction, and actual 
performance), with informant predictions more accurate than patient predictions. 
Accuracy of patient and informant predictions were assessed relative to patient’s actual 
performance on each measure. In addition, it was hypothesized that there would be 
significant differences between informant predictions based on diagnosis groups, such 
that the accuracy of informant ratings would be better for MCI patients than dementia 
patients. Lastly, domain specific awareness was hypothesized to be accurate for memory 
ability, but poor for visuospatial ability for both patient and informant predictions. 
Analysis employed patient predictions and informant predictions (both irrespective of 
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actual performance), as well as actual performance for MCI and dementia patients for 
each domain of neuropsychological function.  
 
General Cognitive Ability, Premorbid Function, and Effort 
 Significant differences were found between information sources and diagnosis 
group for the domains of general cognitive ability, premorbid function, and effort.  An 
interaction effect was found for a measure of general cognitive ability (3MS), with 
significant overall differences observed for both source of information and diagnosis. For 
both MCI and dementia groups, informants significantly underestimated patient general 
cognitive ability relative to actual performance, and they predicted dementia patient 
performance significantly lower than MCI patient performance. Lastly, MCI patients 
performed significantly better than their dementia counterparts. Thus, patients were 
actually better predictors of their performance than informants for patient general 
cognitive ability, regardless of their diagnosis. It is possible that this finding speaks to the 
limited ecological validity of neuropsychological assessment measures in their sensitivity 
to everyday functional capacity. While patients may, indeed, have areas of preserved 
cognitive function, if their ability to compensate for general areas of weakness is 
impaired, the likelihood of informants to be able to accurately predict their actual ability 
is limited. 
For a measure of premorbid function (WTAR), an interaction effect was seen 
between source of information and diagnosis, with significant overall differences also 
seen between information sources. No significant overall differences were seen for 
diagnosis group. Patients and informants both underestimated patient actual performance, 
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with informants predicting significantly lower performance for dementia patients than 
MCI patients. There was no difference in performance between MCI and dementia 
patients on this measure. Thus, MCI and dementia patients had similar levels of estimated 
premorbid function, but both were inaccurate predictors of their performance. 
On a measure of effort (DC), significant overall differences were seen for source 
of information and diagnosis group. No interaction effect was observed. Patients and 
informants provided significantly different predictions, with patient predictions 
significantly lower than informant predictions. Both patients and informants predictions 
were significantly lower than actual performance. Informants rated MCI patient 
performance more favorably than dementia patient performance, and MCI patients 
performed better than dementia patients. Thus, both patients and informants were 
inaccurate predictors of performance. As discussed previously, it is possible that this 
finding is reflective of emergent awareness across the course of the entire evaluation, 
since the DC is given last in the battery. Thus, patients may be more cautious in their 
ratings on this measure by virtue of having performed several other measures prior.  
 
Attention, Concentration, and Processing Speed 
Significant differences were found between source of information and diagnosis 
group for the domain of attention, concentration, and processing speed. On a measure of 
visual attention, scanning, and processing speed (Trails A), there was a significant 
interaction between source of information and diagnosis, with significant overall 
differences for both source and diagnosis. Patient and informant predictions were 
significantly different, with patients providing more favorable responses. Significant 
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differences were found between informant predictions and actual performance, with 
informants underestimating patient performance. Informants predicted significantly lower 
performance for dementia than MCI patients, with dementia patients actually performing 
worse on this task than MCI patients. Thus, patients were actually better predictors of 
their ability on Trails A than informants, regardless of their diagnosis. 
On a measure of simple verbal attention (DSF), significant differences were seen 
for information source. No significant interaction effect or overall difference for 
diagnosis group was observed. Patient and informant ratings were similar to one another, 
and both were significantly lower than actual performance. Informants rated MCI patient 
performance more favorably than dementia patients, and MCI patients actually performed 
better than dementia patients. Thus, both patients and informants were poor predictors of 
patient performance on this measure of simple attention. 
On a measure of verbal attention and working memory (DSB), no significant 
interaction effects were found between information source and diagnosis, and nor overall 
differences for source of information or group were found. Thus, patients and informants 
were accurate predictors of actual performance, and MCI and dementia patients 
performed similarly on this working memory task. 
On a measure of processing speed (SDMT), a significant interaction effect was 
seen between information source and diagnosis group, and significant overall differences 
were seen between groups. Both patients and informants provided similar predictions, 
and both were accurate predictors of actual performance. MCI patients performed 
significantly better than their dementia counterparts. Thus, both patients and informants 
were accurate predictors of patient performance on this processing speed task. 
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Language 
 Significant differences were found between sources of information as well as 
between diagnosis group. On a measure of phonemic verbal fluency (FAS), informants 
predicted less favorable performance for dementia patients than MCI patients. On a 
measure of semantic verbal fluency (Animals), dementia patients received less favorable 
ratings than their dementia counterparts across all sources of information, including 
actual performance. In addition, informants rated dementia patients significantly less 
favorably than MCI patients. Lastly, on a measure of confrontational naming (BNT), 
informants predicted that patients would perform significantly worse than they actually 
did perform, regardless of diagnosis. Dementia patients, overall, received lower 
predictions than MCI patients regardless of the source of information. Lastly, dementia 
provided predictions that were significantly lower than the MCI patients, and dementia 
patients did, in fact, perform worse than their MCI counterparts. Thus, patients were 
more accurate predictors of their actual semantic fluency ability than informants, while 
the reverse was true for confrontational naming ability. 
 
Visuoperception and Visuoconstruction 
 Significant differences were found between sources of information and diagnosis 
group for the visuoperception and visuoconstruction domain. On a measure of 
visuoperception (JLO), significant interaction was found between information source and 
diagnosis group, with significant overall differences seen between diagnosis groups. Both 
informant and patient predictions were similar to actual performance. Informants 
predicted significantly lower performance for dementia patients than MCI patients, and 
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dementia patients performed significantly worse than their MCI counterparts. Thus, both 
patients and informants were accurate predictors of actual performance for both MCI and 
dementia patients. 
 On a measure of visuoconstruction (BD), a significant interaction was found 
between source of information and diagnosis, and significant overall differences were 
seen between information sources and between diagnosis groups.  Patients and 
informants provided similar predictions, and both informant and patient predictions 
significantly overestimated patient actual performance. Informants provided significantly 
lower performance for dementia patients than MCI patients, and dementia patients 
actually performed significantly worse than their MCI counterparts. Thus, both patients 
and informants were poor predictors of visuoconstructional ability. 
 
Memory 
 Significant differences were found between source of information and diagnosis 
group for the memory domain. On a measure of immediate memory for discrete 
information (CVLT IR), a significant interaction effect was found between source of 
information and diagnosis group, with significant overall differences found between 
sources of information as well as between diagnosis groups. Patient predictions were 
significantly lower than their actual performance, regardless of their diagnosis. MCI 
patients performed significantly better than their dementia group counterparts. Thus, 
patients were poor predictors of their immediate memory ability for discrete information 
regardless of their diagnosis, while informant ratings were accurate for both groups. 
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 On a measure of delayed recall for discrete information (CVLT DR), a significant 
interaction effect was found between source of information and diagnosis group, with 
significant overall differences found between sources of information but not between 
diagnosis groups. Patients and informant predictions were similar and both significantly 
lower than patient actual performance. MCI patients performed significantly better than 
dementia patients. Thus, both patients and informants were poor predictors of patient 
performance, regardless of diagnosis. 
 On a measure of recognition (CVLT Rec), a significant difference was found 
between sources of information. No significant interaction effect or overall differences 
between diagnosis groups were observed. Both patients and informants significantly 
underestimated patient ability relative to their actual performance. Additionally, MCI 
patients performed better than dementia patients. Thus, both patients and informants were 
poor predictors of patient ability, regardless of diagnosis. 
 On a measure of forced choice recognition (CVLT FC), significant differences 
were found for both source of information and diagnosis. No significant interaction effect 
was observed. Patient and informant predictions were significantly different. Though 
both informants and patients significantly underestimated patient performance for both 
MCI and dementia patients, the extent to which informants underestimated performance 
was significantly lower than that of patients’. MCI patients performed significantly better 
than dementia patients. Thus, both patients and informants were poor predictors of 
patient’s forced choice recognition ability. 
 On a measure of immediate memory for contextual information (LMI), a 
significant interaction effect between source of information and diagnosis group was seen, 
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with significant overall differences seen between source of information.  There was no 
significant overall difference observed between diagnosis groups. Patient and informant 
predictions were similar regardless of diagnosis, with both significantly overestimating 
patient actual performance. MCI patients performed significantly better than dementia 
patients. Thus, patients and informants were both poor predictors of patient actual ability 
for immediate memory for contextual information.  
 On a measure of delayed memory for contextual information (LMII), a significant 
interaction was seen between source of information and diagnosis group, and a 
significant overall difference was seen between information sources. No significant 
overall difference was observed in between diagnosis groups. Though patient and 
informant ratings were similar, informants significantly overestimated patient 
performance relative to actual performance, and predicted significantly better 
performance in MCI patients than in dementia patients. MCI patients performed 
significantly better than dementia patients. Thus, patients were more accurate predictors 
of their performance on measures of delayed contextual memory than informants, with 
informants predicting better performance than the patients actually performed. 
 
Executive Function 
 Significant differences were found between source of information and diagnosis 
group for the executive function domain. On a measure of novel, ambiguous problem 
solving (WCST), a significant interaction effect was found between sources of 
information and diagnosis group, with significant overall differences between sources of 
information. No significant overall differences were seen between diagnosis groups. 
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Patient and informant predictions were significantly different, with patient predictions 
similar to actual performance and informant predictions significantly lower than actual 
performance. Dementia patients provided more favorable responses than their MCI 
counterparts, whereas informant predictions were more favorable for MCI patients than 
dementia patients. MCI patients actually performed similarly to dementia patients. Thus, 
patients were better predictors of their actual performance than informants were, with 
informants underestimating patient performance on novel, ambiguous problem solving.  
 On a measure of speeded mental set shifting (Trails B), a significant overall effect 
was found for source of information, and a significant overall effect was also found for 
diagnosis group. No interaction effect was observed. Informants and patients provided 
similar predictions, but patient predictions were significantly higher than actual 
performance. Patient predictions were similar regardless of diagnosis group, but 
informants had the tendency to provide more favorable estimations for MCI patients than 
dementia patients. MCI patients performed better than dementia patients. Thus, patients 
were more accurate predictors of performance than informants for tasks requiring 
speeded mental set shifting. 
 
Conclusions 
In sum, the hypothesis that informants were more accurate predictors of patient 
performance received little support. Out of 20 cognitive measures, informants were only 
more accurate predictors of patient performance on two, immediate memory for discrete 
information and confrontational naming. On five measures, informant and patient 
predictions were both commensurate with actual performance, including measures of 
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auditory working memory, psychomotor processing speed, phonemic verbal fluency, and 
a measure of visuoperception.  
On seven measures, informant and patient predictions were equally poor 
estimations of patient ability, with both sources of information underestimating actual 
patient performance. These measures included a measure of premorbid ability, a measure 
of effort, a measure of simple auditory attention, a measure of visuoconstruction, and 
three measures of memory (delayed recall for discrete information, yes/no recognition 
ability, and forced choice recognition ability). On a measure of immediate memory for 
contextual information, informant and patient predictions were equally poor estimations 
of patient ability, with both sources overestimating actual performance.  
Importantly, on six measures, informants were less accurate predictors of patient 
ability than patients were. These measures included measures of general cognitive ability, 
visual attention, semantic verbal fluency, and delayed recall of contextual information, 
novel problem solving, and speeded mental set shifting. Of note, informants provided 
more favorable predictions than did patients on both immediate and delayed memory for 
contextual information. 
This set of findings provides consistent, potentially alarming evidence for the 
notion that informant reports of patient ability are not universally accurate, and in fact are 
more often inaccurate in relation to actual patient performance. The underlying 
explanation for this discrepancy is likely multifactorial and dependent upon a number of 
factors, including the relationship between the informant and patient (i.e. child vs. spouse 
vs. caregiver), the amount and nature of time spent with the patient (i.e. living together vs. 
visiting regularly vs. visiting on holidays), the cognitive status of the informant, and the 
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context within with the initial referral was placed that may create bias with respect to the 
informant’s perception of the patient’s ability. Thus, the current trend in anosognosia 
literature across neurological diagnoses to use informant ratings as the “benchmark” for 
assessing anosognosia is problematic (Evans, Sherer, Nick, Nakase-Richardson, & 
Yablon, 2005; Flashman & McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et 
al., 1998).  In fact, the current study showed that patients are often better reporters of 
their own ability than informants are, regardless of the severity of their diagnosis (MCI vs 
dementia). Thus, a patient could potentially be evaluated as having anosognosia when, in 
fact, their informant is providing unjustifiably low reports of their function, while their 
own reported functioning is actually commensurate with their actual function. It is 
important to note that the current study is investigating the accuracy of reports of 
neuropsychological function, while informants may be more focused on functional ability. 
This is likely an important factor to consider when formulating anosognosia measures, 
such that informant predictions are relative to real world functionality, not 
neuropsychological performance. Lastly, this analysis provides evidence for the superior 
sensitivity of discrepancy between patient predictions and actual performance than that of 
the discrepancy between informant and patient predictions in determining anosognosia of 
cognitive ability.  
It is certainly possible, and logically conceivable, that informant ratings are 
negatively biased just by the nature of their relationship to the patient. Clinically, 
informants are typically spouses or other family members that are intimately connected to 
the patient, and often also have the responsibility of “filling in the gaps” with regard to 
patients’ everyday functioning, both of which can naturally negatively skew their view of 
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patient ability.  This idea is supported by the fact that informant ratings are consistently 
lower for dementia patients than MCI patients, even on tasks where their actual 
performances are commensurate with one another. 
 
Hypothesis 3 – Emergent Awareness by Cognitive Domain 
 Emergent awareness has not been systematically studied in formal 
neuropsychological assessment paradigms. It was hypothesized that emergent awareness 
would vary across cognitive domains, with more emergent awareness seen for tasks 
allowing for physical manipulation of objects and/or verbal feedback from the examiner 
(i.e. BD and WCST, respectively). It was additionally hypothesized that this emergent 
awareness would be greater in MCI patients than dementia patients. Data was analyzed 
using anosognosia ratios of patient predicted performance to actual performance taken 
prior to administration of each measure, and anosognosia ratios of patient evaluations of 
performance to actual performance taken subsequent to administration of each measure. 
 
General Cognitive Ability, Premorbid Function, and Effort 
 No significant differences were found between time of rating for anosognosia 
ratios for measures of cognitive ability, premorbid function, and effort, though significant 
differences were found between diagnostic groups. On a measure of general cognitive 
ability, MCI patients had the tendency to provide less favorable predictions and 
evaluations of their performance relative to their actual performance in comparison to the 
dementia group. Thus, MCI patients significantly underestimated their ability in 
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comparison to their dementia counterparts, which may be indicative of a general 
increased sensitivity to their general cognitive function than dementia patients.  
 
Attention, Concentration, and Processing Speed 
 No significant differences were found between time of evaluation for anosognosia 
ratings for anosognosia ratios for measures of attention, concentration, and processing 
speed, but significant differences were found between diagnostic groups. On measures of 
speeded visual attention, working memory, and processing speed, MCI patients rated 
themselves less favorably both pre and post testing than dementia patients, which may 
also be indicative of a general increased sensitivity to their functioning in these areas 
relative to dementia patients. 
 
Language 
 No significant differences were found between time of evaluation and diagnosis 
group for anosognosia ratios for measures of language ability. Thus, there were no 
differences between pre and post ratings for MCI and dementia patients relative to actual 
performance on measures of language. 
 
Visuoperception and Visuoconstruction 
 No significant differences were found between time of evaluation for anosognosia 
ratios for measures of visuoperception and visuoconstruction, but there was a significant 
difference between diagnostic groups. On both measures, MCI patients had the tendency 
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to underestimate their performance relative to their actual performance, regardless of the 
time in which the rating was collected.  
 
Memory 
 No significant differences were found between time of evaluation for anosognosia 
ratios for measures of memory, but there was a significant effect between diagnostic 
groups. On a measure of immediate recall of discrete information, as well as immediate 
and delayed memory for contextual information, MCI patients had the tendency to 
provide less favorable ratings of their performance, regardless of the time in which the 
rating was solicited, compared to their dementia counterparts. This may also be indicative 
of an increased sensitivity to their cognitive function in this area. 
 
Executive Function 
 No significant differences were found between time of evaluation for anosognosia 
ratios for measures of executive function, but significant effects were found between 
diagnostic groups. On a measure of speeded mental set shifting, MCI patients had the 
tendency to provide less favorable ratings of their performance, regardless of time, than 
their dementia counterparts. 
 
Conclusions 
In sum, there was no evidence of emergent awareness across time (pre and post 
assessment) in any cognitive domain assessed for either MCI patients or dementia 
patients. This is inconsistent with previous research (Barrett et al., 2005) and the nature 
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of the lack of appreciable differences is unclear.  The fact that previous research typically 
uses Likert scales, requiring patients to provide ordinal responses, and the current study 
employed visual scales, where patients provided their responses along an unmarked line, 
led to difficulty quantifying meaningful change before and after assessment. In other 
words, Likert scales provide a structural context in which to provide responses, with 
clearly delineated markers between ratings that may lend themselves easier to making 
appreciably distinct ratings pre and post assessment. The nature of the currently 
employed scales was to release the patient from that very structure imposed by Likert 
scales, but may have left the determination of “appreciable changes” between prediction 
and evaluation ratings to the discretion of the respondent. Thus, while a one-inch 
difference in ratings for one patient may mean the same decrement in performance that a 
three-inch difference in ratings may mean to a different patient. 
A second influencing factor may be the confrontational nature of the prediction 
and evaluation paradigm used in the current study.  Since patients provided their 
prediction and evaluation responses on the same sheet of paper, they are confronted with 
their predicted performance ratings at the time that they are asked to provide their 
evaluation of performance ratings. Previous studies lack the confrontational nature in 
their pre and post assessment, which may also contribute to the disparity in results seen 
across studies (Evans, Sherer, Nick, Nakase-Richardson, & Yablon, 2005; Flashman & 
McAllister, 2002; Hart, Seignourel, & Sherer, 2009; Sherer et al., 1998). 
There was, however, significant effects of diagnostic group across all domains 
except for language, with MCI patients consistently providing less favorable ratings of 
their performance relative to their actual performance, regardless of the time in which the 
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ratings were collected. This provides evidence for the fact that MCI patients are 
anosognostic with regard to their cognitive function in the negative direction, such that 
they consistently underpredict and underevaluate their actual performance. However, the 
hypothesis that emergent awareness would differ across cognitive domains received no 
support. 
 
Hypothesis 4 – Diagnostic Utility of Anosognosia Assessment 
 It was hypothesized that measures of anosognosia across the entire evaluation 
would be reliably predictive of group membership, and thus diagnostically informative. It 
was also hypothesized that anosognosia measures of memory would be the best 
predicting measures of diagnostic group membership.  
 
Logistic Regression – Enter Method 
 In order to investigate the possibility of predicting diagnosis group based on 
emergent awareness over the course of the evaluation, a logistic regression was 
performed using the enter method and force entering all 21 anosognosia prediction ratios 
for neurocognitive measures and age for both MCI and dementia patients. Statistical 
analyses revealed that MCI and dementia diagnoses could be reliably predicted based on 
anosognosia ratios with 100% accuracy for both groups. 
 
Logistic Regression – Forward Method 
 In order to investigate the possibility of predicting diagnosis group based on 
predictive anosognosia ratios for specific measures, a second logistic regression was 
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performed using for forward method, such that only predictors that significantly 
accounted for variance in anosognosia ratios entered the model. The 21 anosognosia 
prediction ratios for neurocognitive measures and age were entered into the analysis. Two 
iterations were completed, with the anosognosia prediction ratios for general cognitive 
function (3MS) and delayed contextual memory (LM II) remaining in the model. MCI 
group membership was predicted with 85% accuracy, and dementia group membership 
was predicted with 81.8% accuracy based on the model. Thus, group membership can be 
reliably predicted using only predictive anosognosia ratios for general cognitive function 
measures and delayed contextual memory. With respect to predictive anosognosia ratios 
for general cognitive ability, MCI patients had the tendency to provide less favorable 
estimations of their performance relative to their actual performance, while dementia 
patients provided more accurate predictions relative to their actual performance ability. 
For delayed contextual memory, MCI patients had the tendency to provide slightly less 
favorable predictions relative to their actual ability, while dementia patients had the 
tendency to provide largely more favorable predictions of their performance relative to 
their actual performance.  
 
Conclusions 
 No prior published study to date has utilized regression models to predict group 
membership based on measures of anosognosia. The current regression analyses provide 
both strong and convincing evidence for the clinical relevance of anosognosia assessment 
in diagnosis of MCI and dementia. The fact that, by using the 21 prediction anosognosia 
ratios, it was possible to predict group membership in the current sample with 100% 
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accuracy speaks to the clinical sensitivity of discrepancies between patient predicted and 
actual performance and the importance of including awareness assessment in the clinical 
standard of care for neuropsychological work-ups secondary to complaints of dementia-
related symptomatology. 
 In addition, the predictive power of two single measures of anosognosia, such that 
MCI and dementia diagnosis was predicted with such high rates of accuracy in the 
current sample is equally compelling. It is conceptually fitting that awareness of ability 
on a measure of general cognitive ability, in conjunction with that of a measure of long 
term contextual memory, would accurately predict diagnostic group membership. Since 
general cognitive status is highly related to patient functional ability, and functional 
ability is the single differential diagnostic criterion between MCI and dementia diagnosis, 
it is parsimonious that this predictive anosognosia rating would explain a large amount of 
the variance between diagnostic groups. Similarly, since contextual memory measures are 
often viewed as increasingly complex in relation to discrete memory measures, and that 
memory complaints also constitute a diagnostic criterion in both MCI and dementia 
evaluations, it is also logical that this measure of predictive anosognosia would also 
explain a large amount of variance between diagnostic groups. 
 
General 
 The current study provides evidence for the notion that anosognosia is 
multifaceted construct, and not an “all or none” phenomenon, such that patients display 
anosognosia for specific areas of cognitive function while maintaining preserved 
awareness in other domains of cognitive function. It also provides novel evidence to 
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show that informant predictions of patient ability are not uniformly accurate, and that 
patient predictions of their own ability may be more accurate measures of their actual 
ability. Importantly, the current study provides evidence for the fact that, while there is 
much debate in the literature regarding the presence of anosognosia in MCI populations, 
that there were numerous areas measures of awareness across multiple cognitive domains 
that failed to show differences between patient and informant ratings, meaning to say that 
MCI and dementia patients showed similar levels of awareness and similar levels of 
anosognosia across different areas of cognitive function. Lastly, the current study speaks 
to the clinical utility and unique value of anosognosia assessment in MCI and dementia 
evaluation, as well as the predictive power of anosognosia ratings in isolation. 
 While the current study provides novel and informative results, there are a 
number of limiting factors that could potentially confound its results. First, the relatively 
small sample size used in the study (n=49) could potentially inadvertently accentuate any 
significant differences between groups. Also, diagnostic categories were collapsed across 
different types of MCI and dementia, which lead to heterogeneous populations within 
each group. By increasing the overall study sample, thus bolstering the number of 
contributing diagnoses, would be helpful in providing finer distinctions within each 
overarching diagnostic group, and allow for more detailed analysis investigating 
differences between various types of MCI and dementia with well-documented 
differences in neuropathology. Second, the current study did not employ 
counterbalancing techniques to prevent the impact of order of test administration on the 
results. While unlikely, it is conceivably possible that the nature of the results are related 
to the order in which neuropsychological tests were administered, independent of the 
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nature of the tests themselves. Third, given the nature of the populations studied, the age 
range of the sample was relatively restricted in comparison to the lifespan. As such, it is 
possible that the current results are reflective of simple cohort effects between elderly 
adults, who are also more likely to be diagnosed with dementia, and their younger 
counterparts, who are more likely to be diagnosed with MCI. Thus, it is possible that the 
nature of the upbringing of these different generations of patients may lend themselves to 
simple cohort differences related to awareness, introspection, education, and employment. 
 The horizon for future research is plentiful, with novel evidence providing new 
pathways to pursue. First, future research could conduct a similar study and employ a 
healthy control group, which would provide for additional comparisons. It would also be 
helpful to include clinician predictions of patient performance using the current paradigm, 
which is also used in current literature as a benchmark for evaluating patient awareness.  
It would be interesting to investigate the cognitive status of the informant as well, as they 
relate to more similar or more discordant ratings of patient ability. Second, given that the 
current study found informants to be poor predictors of patient performance, future 
research could also investigate differences in accuracy across different types of 
informants, such as spouses, children, and caregivers. Given the various relationships 
informants may have with the patient, it is possible that the bias associated with patient-
informant interactions is qualitatively different depending on who the informant is. Lastly, 
it would be interesting to systematically investigate the relationship between levels of 
anosognosia in MCI patients and their associated diagnostic trajectory to see if 
anosognosia evident early on is predictive of conversion to dementia. 
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APPENDIX A 
LLUMC FREQUENTLY ASKED QUESTIONS SHEET 
 
Loma Linda University Medical Center 
Department of Neuropsychology 
 
FAQ Sheet 
Welcome, I am Dr. Travis Fogel, Director of the Department of Neuropsychology. You 
have been referred by your physician for neuropsychological assessment. If you are like 
most individuals, you have many questions about our services. I have prepared the 
following Frequently Asked Questions (FAQ) and am hopeful that this will answer many 
of your questions.  
 
What is your address?  
Department of Neuropsychology  
Outpatient Rehabilitation Center  
11406 Loma Linda Drive, South Entrance  
Loma Linda, CA 92354  
 
How can I reach you?  
For appointments, please contact our scheduler, Melissa Abraham at (909) 558-4000, ext. 
66142. If you need to reach me directly, you can also call my direct office line at (909) 
558-4000, ext. 66105. You may also reach me by email at: tfogel@llu.edu.  
 
Where are your offices located?  
Our offices are located in the Outpatient Rehabilitation Center (ORC) or Ambulatory 
Care Services. This is a single-story peach-colored building about one mile east of the 
main hospital. Below are directions from the 10 Freeway. Our reception area is at the 
South Entrance of the building (middle of the building facing away from Barton Road).  
 
DIRECTIONS FROM LOS ANGELES:  
10 Freeway East  
Take Mountain View Ave. exit  
Turn RIGHT onto Mountain View Ave. (stay on this for about 2 miles)  
Turn RIGHT onto Barton Rd. at light (as you turn, a gas station will be on your right)  
Turn LEFT onto Loma Linda Dr. (this will be the first traffic light after taking a right on 
Barton)  
Turn RIGHT into the Outpatient Rehabilitation Center (a peach-colored single-story 
Spanish style building immediately before some condo-type homes -- about 400 yards 
after turning onto the road)  
Enter SOUTH ENTRANCE (it will be facing away from Barton Road toward a small 
wall with condos on the other side)  
Check in with the receptionist and I will be paged.  
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DIRECTIONS FROM PALM SPRINGS:  
10 Freeway West  
Take Mountain View Ave. exit  
Turn LEFT onto Mountain View Ave. (stay on this for about 2 miles)  
Turn RIGHT onto Barton Rd. at light (as you turn, a gas station will be on your right)  
Turn LEFT onto Loma Linda Dr. (this will be the first traffic light after taking a right on 
Barton)  
Turn RIGHT into the Outpatient Rehabilitation Center (a peach-colored single-story 
Spanish style building immediately before some condo-type homes -- about 400 yards 
after turning onto the road)  
Enter SOUTH ENTRANCE (it will be facing away from Barton Road toward a small 
wall with condos on the other side)  
Check in with the receptionist and I will be paged.  
 
Why was I referred to see a neuropsychologist?  
Your physician has referred you for a neuropsychological evaluation. This evaluation 
may be of help in:  
 
 
 
 
ealth care provider(s), and/or,  
 
 
What is a neuropsychologist?  
A neuropsychologist is a licensed psychologist specializing in the area of brain-behavior 
relationships. Although a neuropsychologist has a doctoral degree in psychology, he or 
she does not just focus on emotional or psychological problems. The neuropsychologist 
has additional training in the specialty field of clinical neuropsychology. That means a 
neuropsychologist is educated in brain anatomy, brain function, and brain injury or 
disease. The neuropsychologist also has specialized training in administering and 
interpreting the specific kinds of tests included in your neuropsychological evaluation. As 
a part of the required education, a neuropsychologist also has years of practical 
experience working with people who have had problems involving the brain.  
 
What will happen during my first appointment and what should I bring?  
The first appointment will consist of a 60-90 minute clinical interview. Some very brief 
preliminary testing also may be conducted at the very end of the interview in order to 
help develop the subsequent test battery. You are more than welcome to bring someone 
with you to this appointment. Such a person can provide valuable supplementary 
information about you (for example, their observations regarding your condition or 
clarification of dates).  
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It is also very helpful to prepare a list of your medications, current medical providers, and 
chronology of events. This chronology might include the date of onset of your condition, 
dates of any hospitalizations, and dates of any significant changes in your symptoms. It is 
also helpful to obtain copies of any medical records you might possess. I can make a 
copy of these records at the office. You do not need to bring any MRI films with you. 
Please be on time to your appointment. Unlike physicians who may have many 
overlapping appointments during their clinic hours, we block off the scheduled time for 
you alone. That is, the time slot is reserved for you and you alone. As such, we are unable 
to extend the appointment beyond the allotted time if you arrive late.  
  
What will happen after the first appointment?  
After the first appointment, if it is deemed appropriate, you will be scheduled for 
neuropsychological testing, to occur at a later date.  
  
How long does the testing last?  
The length of this testing can vary greatly and depends on the nature of the referral 
question and many other factors. Sometimes the evaluation will last only a couple of 
hours. More frequently, the evaluation will last all day (6-8 hours). As examples, the test 
battery for persons referred to see me as part of their pre-surgical epilepsy evaluation 
requires about 6-8 hours. Persons referred for dementia evaluations may only require 1-3 
hours. For longer test batteries, we may divide testing into a couple of different days.  
 
What will happen during testing?  
Testing involves taking paper-and-pencil measures or answering questions of a wide 
range of mental abilities including your memory, attention and concentration, processing 
speed, language skills, visuospatial skills, cognitive flexibility, planning, and 
organization. Questionnaires may also be given to assess your coping skills. I also may 
give you questionnaires to provide persons who know you well in order to obtain their 
impressions about certain aspects of your neuropsychological functioning.  
 
Is there anything I need to do to prepare for the day of testing?  
Get plenty of rest. Otherwise the testing may simply reflect how tired you were rather 
than your optimal performance. Bring your glasses and hearing aids if you typically use 
them. Take your medications as you normally would. Dress comfortably. Bring a jacket 
or sweater as temperatures can vary. Feel free to also bring drinks or snacks. We will take 
rest breaks periodically. This is not an endurance contest; I want you to be at your best so 
that I can obtain accurate and meaningful results. If testing will last all day, we will break 
for about one hour for lunch. There are restaurants within walking distance. Lastly, if 
someone drives you to your appointment, there is no need for them  
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to stay. Third party observers are not allowed to be present in the room during testing, 
and they will be asked to wait outside. It is perfectly fine for persons to drop you off and 
leave. However, I would recommend that you have some way to reach them in case we 
end early.  
 
Who will administer the battery?  
Typically I administer the test battery. I also have three doctoral neuropsychology interns 
whom may perform portions of the battery. These are individuals whom I have selected 
to train with me for one year as part of their doctoral training through Loma Linda 
University’s Department of Psychology.  
 
What happens after the testing is completed?  
After you complete testing, in some ways, my work just begins. The test data will be 
scored and interpreted. A formal neuropsychological evaluation report will then be 
prepared. Included in this report will be a summary of your history of illness, pertinent 
background, test performance, interpretation of findings, and recommendations. This 
report will then be sent to the physician who referred you. Typically you and I will then 
meet for a formal feedback session to review the results and my recommendations. This 
feedback session lasts about an hour. You are welcome to bring whomever you would 
like to this feedback session.  
I look forward to working with you and believe you will find the evaluation experience 
rewarding.  
 
 
 
Travis G. Fogel, Ph.D., ABPP-CN  
Neuropsychologist, PSY 17746  
Director, Department of Neuropsychology and Rehabilitation Psychology  
Assistant Professor, Physical Medicine and Rehabilitation  
Loma Linda University Medical Center  
OFFICE: (909) 558-4000, ext. 66105  
FAX: (909) 558-6418  
EMAIL: tfogel@llu.edu  
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Loma Linda University Medical Center 
Department of Neuropsychology 
 
Here is a checklist of things to bring with you to your first appointment.  
 
 
 
al records (I can make copies of your copies during the 
interview).  
 
purpose for seeing them)  
 
 
 
 
 
change in symptoms, etc.).  
 
Date of Appointment: _________________________  
 
Time of Appointment: _________________________  
 
Appointment with: Dr. Travis Fogel____________  
 
Referred By: _________________________ 
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APPENDIX B 
 
DEMOGRAPHIC AND PATIENT HISTORY VARIABLES COLLECTED 
 
 
Marital Status:  Ethnicity:  Language:  
Years Married:  Education:  D.Hand:  
Informant Present: ☐ No  ☐ Yes – If yes, Relationship to Patient?                                             Years Known? 
Subjective 
complaints 
☐ Yes   
☐ No 
If yes, describe. 
 
 
 
Onset: 
Collateral 
complaints 
☐ Yes  
☐ No 
If yes, description of complaints and 
from whom? 
 
 
 
Onset: 
Current Living Arrangement ☐ Alone  ☐ Alone w/Nursing  ☐ w/Spouse  ☐ w/Children  ☐ w/Roommate  ☐ 
Assisted Living   
☐ Skilled Nursing Facility  ☐ Other (Please List) 
Premorbid Occupation  
 
PERSONAL MEDICAL HISTORY 
TBI/LOC 
☐ Yes  ☐ No 
If yes, how many? Severity? 
 
Stroke 
☐ Yes  ☐ No 
If yes, how many? Residual effects? 
Medical Diagnoses 
☐ Yes  ☐ No 
If yes, please list: 
 
Surgery 
☐ Yes  ☐ No 
If yes, please list type and date: 
 
Neurologic Diagnosis 
☐ Yes  ☐ No 
If yes, please list type and date: 
 
ADD /LD Diagnosis 
☐ Yes  ☐ No 
If yes, please list type and date: 
 
Psychiatric Treatment 
☐ Yes  ☐ No 
If yes, please list type, date, and duration: 
 
Cigarette Use 
☐ Yes  ☐ No 
Currently Smoking?  ☐ Yes  ☐ No 
If yes, please list quantity and duration: 
 
Alcohol Use 
☐ Yes  ☐ No 
Currently Drinking?  ☐ Yes  ☐ No 
If yes, please list quantity and duration: 
 
Illicit Drug Use 
☐ Yes  ☐ No 
Currently Using?  ☐ Yes  ☐ No 
If yes, please list quantity and duration: 
 
FAMILY MEDICAL HISTORY 
Medical Disorders 
☐ Yes  ☐ No 
If yes, please list type: 
 
Neurologic Disorders 
☐ Yes  ☐ No 
If yes, please list type: 
 
Notes  
 
 
160 
APPENDIX C 
 
 
INFORMANT PACKET – PATIENT HISTORY FORM 
 
For how long have you known the patient? _____ Relationship: ____________________ 
Patient Occupation/Former Occupation: ____________ Patient Education (Years) _____ 
 
Please answer the following questions to the best of your ability. If you don’t know the 
answer, just check “Don’t know”. The questionnaire is long, but it serves several 
important purposes; it stimulates you to think about your own observations in greater 
depth and detail and helps you to include information you might not have thought 
important. And it will be read. 
 
1. Was onset of problem with memory, language, or daily function sudden __ or gradual 
__? 
2. Has there been a steady progression _______, abrupt decline _______, or no 
progression _______? 
Is there a problem with:   Don’t  
 No Yes Know   
MEMORY 
3. Remembering people’s names _____ _____ _____  
4. Recognizing familiar faces _____ _____ _____ 
5. Finding way indoors  _____ _____ _____ 
6. Finding way on familiar streets _____ _____ _____  
7. Remembering a short list of items _____ _____ _____ 
8. More confusion late in the day  _____ _____ _____ 
EXPRESSION 
9. Finding the right word _____ _____ _____ 
10. Understanding words _____ _____ _____ 
DAILY FUNCTIONING 
11. Trouble with household tasks _____ _____ _____ 
12. Trouble handling money _____ _____ _____ 
13. Doesn't grasp situations or explanations _____ _____ _____ 
14. Difficulty at work (check if NA _____) _____ _____ _____ 
    Don’t  
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  No Yes Know  
15. Trouble dressing or caring for self _____ _____ _____ 
16. Trouble feeding self _____ _____ _____  
17. Trouble controlling bladder and bowels _____ _____ _____ 
PERSONALITY 
18. More irritable _____ _____ _____ 
19. Less interested _____ _____ _____  
20. Less sensitive to others  _____ _____ _____ 
21. Loss of social graces or manners _____ _____ _____ 
22. Loss of initiative _____ _____ _____ 
23. Physical violence _____ _____ _____ 
24. Developed odd habits or interests  _____ _____ _____ 
SLEEPING AND EATING 
25. Excessive daytime sleepiness _____ _____ _____ 
26. Vivid dreams; dreams seem real _____ _____ _____ 
27. Violent movement/talking in sleep _____ _____ _____ 
28. Overeating/Consuming sweets _____ _____ _____ 
29. Appetite loss _____ _____ _____ 
30. Eating nonfood substances _____ _____ _____ 
THINKING 
31. More suspicious _____ _____ _____ 
32. Delusions or false beliefs _____ _____ _____ 
33. Hallucinations (sight, sound, odor) _____ _____ _____ 
34. Illusions; mistakes one thing for another  _____ _____ _____ 
35. Thinks others are doubles or imposters _____ _____ _____  
36. Talks of suicide or attempts suicide _____ _____ _____ 
37. Aware of having a problem  _____ _____ _____ 
    Don’t  
 No Yes Know  
OTHER PROBLEMS 
38. Poor hearing _____ _____ _____ 
39. Poor eyesight _____ _____ _____ 
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40. High cholesterol _____ _____ _____ 
41. Stroke(s) _____ _____ _____ 
42. High blood pressure _____ _____ _____  
43. Heart attack _____ _____ _____  
44. Abnormal heart beat _____ _____ _____  
45. Unexplained falls _____ _____ _____  
46. Parkinson disease (shaking, shuffling gait) _____ _____ _____  
47. Fainting spells _____ _____ _____  
48. Head injury with loss of consciousness _____ _____ _____  
49. Seizure or epilepsy _____ _____ _____  
50. Brain tumor  _____ _____ _____ 
51. Diabetes  _____ _____ _____  
52. High or low thyroid function _____ _____ _____  
53. Treated for mental/emotional problems _____ _____ _____  
a. Diagnosis _____________________________________________ 
b. Hospitalized?     No _____ Yes _____ 
54. Down Syndrome     No _____ Self _____ Family Member ______ 
55. Other medical problems 
_____________________________________________________________________ 
56. Drugs: medication for memory?  _____ _____ _____  
a. _____________________________________________ 
b. _____________________________________________ 
c. _____________________________________________ 
d. _____________________________________________ 
  
    Don’t  
  No Yes Know  
57. Drugs: medication for calming? _____ _____ _____  
a. _____________________________________________ 
b. _____________________________________________ 
c. _____________________________________________ 
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d. _____________________________________________ 
e. Side Effects (specify) _______________________________________ 
58. Illegal street drugs? _____ _____ _____  
a. Other drug abuse/dependence (prescription, etc)? 
___________________________________ 
59. Alcohol Use  _____ _____ _____  
a. Current number of ounces per week? __________ 
60. Alcohol Abuse _____ _____ _____  
61. Toxic chemical exposure _____ _____ _____  
a. Type _______________________________________ 
62. Syphilis _____ _____ _____
 _______________ 
63. Other infection (HIV, hepatitis, etc) _____ _____ _____  
a. Specify _______________________________________ 
64. Cancer (other than skin) _____ _____ _____  
a. Type _______________________________________ 
b. Treatment:      None _____     Radiation ______     Chemotherapy _____     
Surgery _____     Other _____ 
65. Cataract surgery or other eye surgery _____ _____ _____  
66. Surgery with general anesthesia _____ _____ _____  
a. _____________________________________________ 
b. _____________________________________________ 
c. _____________________________________________ 
d. _____________________________________________ 
67. CAT scan or MRI (Head) _____ _____ _____  
      Don’t  
  No Yes Know  
a. Allergies _____ _____ _____ 
b. Type _______________________________________ 
68. Anyone in family with similar problem _____ _____ _____ 
a. Relationship to patient _______________________________________ 
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69. Ever had psychiatric neurological exam _____ _____ _____  
a. Diagnosis _______________________________________ 
70. Name and address of doctors seen for same or similar purpose 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
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INFORMANT PREDICTION OF PATIENT PERFORMANCE 
 
In general, how concerned are you about the patient’s overall cognitive skills/thinking 
ability? Please circle your answer on the following scale. 
1 2 3 4 5 6 7 8 9 10 
 Not Concerned About Average Very Concerned 
 
Based on your knowledge of the patient, please answer the following questions. Please 
compare the patient to his/her same aged peers using the following scale: 
 
1 2 3 4 5 6 7 8 9 10 
       Relatively Poorly              About Average   Relatively Well  
  
1. Overall, how do you think the patient’s general cognitive (thinking) ability compares 
with his/her same aged peers? _____ 
2. How well do you think the patient could initially memorize a list of 9 words if we 
read the list out loud to him/her several times? _____ 
3. How well do you think the patient would remember those words after about 10 
minutes? _____ 
4. If we were to read a list of more words to the patient, some of which were on the 
original list and some of which were new words, how well do you think the patient 
would be able to recognize the words from the original list? _____ 
5. If we were then to give the patient two words at a time, one of which was on the 
original list and one of which wasn’t, how accurately do you think the patient would 
be able to pick out the word from the list? _____ 
6. If we were to ask the patient to initially memorize two short stories, how well do you 
think he/she would do compared to his/her same aged peers? _____ 
7. How well do you think the patient would remember those stories after 25 minutes? 
_____ 
8. If we were to give the patient a set of blocks and ask him/her to arrange them so that 
they matched a picture, how well do you think he/she would do compared to his/her 
same aged peers? _____ 
9. How well do you think the patient could visually judge the angle of two lines if given 
a reference like a protractor (assume he/she cannot place the protractor directly over 
the lines given)? _____ 
10. If we were to show the patient a series of pictures of objects and asked him/her to 
name them, how well do you think he/she would do? _____ 
11. If we were to give the patient a letter of the alphabet and ask him/her to come up with 
as many words as he/she could within one minute, how well do you think he/she 
would do? _____ 
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12. If we were to ask the patient to name as many animals as he/she could in one minute, 
how well do you think he/she would do? _____ 
13. If we were to read the patient a string of numbers and asked him/her to repeat them 
back to us in the same order that they were read, how well do you think he/she would 
do? _____ 
14. If we were to read the patient a string of numbers and asked him/her to repeat them 
back to us in the reverse order that they were read (backwards), how well do you 
think he/she would do? _____ 
15. If we were to give the patient a key that showed a list of shapes that corresponded to 
numbers and asked him/her to substitute the appropriate numbers for a row of shapes 
as quickly as he/she could, how well do you think he/she would do? _____ 
16. If we were to give the patient a sheet with 25 randomly placed numbers and asked 
him/her to connect them in order as fast as he/she could, how well do you think 
he/she would do? _____ 
17. If we were to give the patient a sheet with 25 randomly placed numbers AND letters 
and asked him/her to connect them by alternating between connecting numbers and 
letters in order (i.e. 1-A-2-B-3-C, etc) as fast as he/she could, how well do you think 
he/she would do? _____ 
18. If we were to give the patient a test that assessed his/her ability to problem solve in 
new ways without really knowing where to start, how well do you think he/she would 
do? _____ 
19. If we were to give the patient a list of uncommon words to pronounce out loud, how 
well do you think he/she would do? _____ 
20. In general, how depressed do you think the patient is? _____ 
21. If we were to show the patient a series of cards, each with dots on them, how quickly 
do you think he/she would be able to count the dots on the card and tell us his/her 
answer? _____ 
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LEVEL OF FUNCTION SCALE 
 
Please circle the patient’s current level of function at these tasks of everyday life. 
 
 
Independent, 
as good as 
ever 
Independent, 
not as good 
as past 
Needs 
prompting 
or 
reminding 
to perform 
task 
Needs 
hands-on 
help or 
step-by-
step 
directions 
Can’t do, 
depends 
on others 
to do 
Work 
responsibilities 
 
0 1 2 3 4 
Hobbies 
 
0 1 2 3 4 
Household 
chores 
 
0 1 2 3 4 
Shopping for 
needs 
 
0 1 2 3 4 
Driving 
 
0 1 2 3 4 
Appointments 
 
0 1 2 3 4 
Finding one’s 
things 
 
0 1 2 3 4 
Dressing 
 
0 1 2 3 4 
Washing and 
Grooming 
 
0 1 2 3 4 
Eating 
 
0 1 2 3 4 
Toileting 
 
0 1 2 3 4 
Other: 
 
0 1 2 3 4 
Other: 
 
0 1 2 3 4 
Is there anything else you’d like to mention? 
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APPENDIX D 
 
INFORMANT PACKET – PATIENT PSYCHIATRIC HISTORY 
 
 
For how long have you known the patient? __________ Relationship: 
_________________________ 
 
How would you rate your knowledge of the patient? 
 Very familiar/provides daily care 
 Somewhat familiar/often cares for 
 Not very familiar, has minimal interaction with 
If you do not live with the patient, how many hours per week do you see him/her? 
_______________ 
 
Please indicate whether the patient has displayed any of the behaviors listed below within 
the past four weeks. If you answer yes to any of the following questions, please continue 
to the page noted to answer follow up questions related to that item. 
 
A. Delusions: Does the patient have beliefs that you know are not true? For example, 
insisting that people are trying to harm him/her. Has he/she said that family members are 
not who they say they are, or that the house is not their home? (Please do not include 
suspicious activity, please only indicate true beliefs on the part of the patient.) 
 No (If no, please proceed to B) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
B. Hallucinations: Does the patient have hallucinations such as false visions or voices? 
Does he/she see, hear, or experience things that are not present? By this, we do not mean 
just mistaken beliefs such as stating that someone who has died is still alive; rather we are 
asking if the patient actually has abnormal experiences of sounds or visions. 
 No (If no, please proceed to C) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
C. Agitation/Aggression: Does the patient have periods when he/she refuses to cooperate 
or won’t let people help him/her? Is he/she hard to handle? 
 No (If no, please proceed to D) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
D. Depression/Dysphoria: Does the patient seem sad or depressed? Does he/she say that 
he/she feels sad or depressed? 
 No (If no, please proceed to E) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
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E. Anxiety: Is the patient very nervous, worried, or frightened for no reason? Does he/she 
seem very tense or fidgety? Is he/she afraid to be apart from you? 
 No (If no, please proceed to F) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
F.  Elation/Euphoria: Does the patient seem too cheerful or too happy for no reason? We 
don’t mean the normal happiness that comes from seeing friends, receiving presents, or 
spending time with family members. We are asking if he/she has a persistent and 
abnormally good mood or finds humor where others do not. 
 No (If no, please proceed to G) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
G. Apathy/Indifference: Does the patient sit quietly without paying attention to things 
going on around him/her? Has he/she lost interest in the world around him/her? Has 
he/she lost interest in doing things or lack motivation for participating in activities? Is it 
difficult to involve him/her in conversation or in doing chores? 
 No (If no, please proceed to H) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
H. Disinhibition: Does the patient seem to act impulsively without thinking? Does he/she 
do or say things that are not usually done or said in public? Does he/she say things that 
are embarrassing to you or others? 
 No (If no, please proceed to I) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
I. Irritability/Lability: Does that patient get irritated and easily disturbed? Are his/her 
moods very changeable? Is he/she abnormally impatient? We do not mean frustration 
over memory loss or inability to perform usual tasks; we are interested to know if the 
patient has abnormal irritability, impatience, or rapid emotional changes different from 
his/her usual self. 
 No (If no, please proceed to J) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
J. Aberrant Motor Behavior: Does the patient pace, do things over and over such as 
opening closets or drawers, or repeatedly pick at things, or wind string or threads? 
 No (If no, please proceed to K) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
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K. Sleep: Does the patient have difficulty sleeping (aside from getting up once or twice to 
go to the restroom and falling back asleep immediately)? Is he/she up at night? Does 
he/she wander at night, get dressed, or disturb your sleep? 
 No (If no, please proceed to L) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
L. Appetite and Eating Disorders: Has the patient had any changes in appetite, weight, or 
eating habits? Has there been any change in type of food he/she prefers? (Please mark 
Not Applicable if the patient is incapacitated and has to be fed.) 
 No (If no, please stop here) 
 Yes (If yes, please see additional related questions) 
 Not applicable 
 
CONTINUED FROM QUESTION A: DELUSIONS 
 
1. Does the patient believe that he/she is in danger – that others are planning to hurt 
him/her? 
 ☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient believe that others are stealing from him/her? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient believe that his/her spouse is having an affair? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient believe that unwelcome guests are living in his/her house? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient believe that his/her spouse or others are not who they claim to 
be? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient believe that his/her home is not his/her home? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient believe that family members plan to abandon him/her? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Does the patient believe that television or magazine figures are actually present in 
the home/room?  
☐ No     ☐ Yes     ☐ Not Applicable 
               If yes, does he/she try to talk or interact with them? ☐ No     ☐ Yes      
 
9. Does the patient believe any other unusual things that have not been covered 
here?  
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☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
10. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
11. How severe do you consider the patient’s symptoms? 
 Mild – delusions are present but seem harmless, and do not upset the patient 
that much 
 Moderate – delusions are stressful and upsetting to the patient and cause 
unusual or strange behavior 
 Marked – delusions are very stressful and upsetting to the patient and cause a 
major amount of unusual or strange behavior  
 
12. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION B: HALLUCINATIONS 
 
1. Does the patient describe hearing voices or act as if he/she hears voices? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient talk to people who are not there? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient describe seeing things not seen by others, or behave as he/she is 
seeing things not seen by others (i.e. people, animals, lights, etc.)? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient report smelling odors not smelled by others? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient describe feeling things on his/her skin, or otherwise appear to be 
feeling things crawling or touching him/her? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient describe tastes that are without known cause? 
☐ No     ☐ Yes     ☐ Not Applicable 
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7. Does the patient describe any other unusual sensory experiences? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
9. How severe do you consider the patient’s symptoms? 
 Mild – hallucinations are present but seem harmless, and do not upset the 
patient that much 
 Moderate – hallucinations are distressing and disruptive 
 Marked – hallucinations are very disruptive and are a major source of 
behavioral disturbance (medications may be required to control them)  
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
 
CONTINUED FROM QUESTION C: AGITATION/AGGRESSION 
 
1. Does the patient get upset when people are trying to care for him/her to resist 
activities such as bathing or changing clothes? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Is the patient stubborn, having to have things his/her way? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Is the patient uncooperative, resistive to help from others? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient have any other behaviors that make him/her hard to handle? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient shout or curse angrily? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient slam doors, kick furniture, or throw things? 
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☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient attempt to hurt or hit others? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Does the patient have any other aggressive or agitated behavior?  
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
9. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
10. How severe do you consider the patient’s symptoms? 
 Mild – behavior is disruptive but can be managed with redirection or 
assurance 
 Moderate – behaviors are disruptive and difficult to redirect or control 
 Marked – agitation is very disruptive and a major source of difficulty; there 
may be a threat of personal harm. Medications are often required.  
 
11. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION D: DEPRESSION/DYSPHORIA 
 
1. Does the patient have periods of tearfulness or sobbing that seem to indicate 
sadness? 
 ☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient say or act as if he/she is sad or in low spirits? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient put him/herself down or say that he/she feels like a failure? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient say that he/she is a bad person or deserves to be punished? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient seem very discouraged or say that he/she has no future? 
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☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient say he/she is a burden to the family or that the family would be 
better off without him/her? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient express a wish for death or talk about killing him/herself? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Does the patient show any other signs of depression or sadness?  
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
9. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
10. How severe do you consider the patient’s symptoms? 
 Mild – depression is distressing, but usually responds to redirection or 
reassurance 
 Moderate – depression is distressing, depressive symptoms are spontaneously 
voiced by the patient and difficult to alleviate 
 Marked – depression is very distressing and a major source of suffering for 
the patient  
 
11. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION E: ANXIETY 
 
1. Does the patient say that he/she is worried about planned events? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient have periods of feeling shaky, unable to relax, or feeling 
excessively tense? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient have periods of or complain of shortness of breath, gaping, or 
sighing for no reason other than nervousness? 
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☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient complain of butterflies in his/her stomach, or of racing or 
pounding of the heart in association with nervousness? 
☐ No     ☐ Yes     ☐ Not Applicable 
If yes, is this associated with a medical condition? 
☐ No     ☐ Yes      
 
5. Does the patient avoid certain places or situations that make him/her more 
nervous such as riding in the car, meeting with friends, or being in crowds? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient become nervous or upset when separated from you or his/her 
caregiver?  
☐ No     ☐ Yes     ☐ Not Applicable 
If yes, does he/she cling to you to keep from being separated? 
☐ No     ☐ Yes      
 
7. Does the patient show any other signs of anxiety?  
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
9. How severe do you consider the patient’s symptoms? 
 Mild – anxiety is stressful, but usually responds to redirection or reassurance 
 Moderate – anxiety is stressful, anxiety symptoms are spontaneously voiced 
by the patient and difficult to alleviate 
 Marked – anxiety is very distressing and a major source of suffering  
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
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CONTINUED FROM QUESTION F: ELATION/EUPHORIA 
 
1. Does the patient appear to feel good or to be too happy, different from his/her 
usual self? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient find humor and laugh at things that others do not find funny? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient seem to have a childish sense of humor with a tendency to giggle 
or laugh inappropriately (such as when something unfortunate happens to others)? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient tell jokes or make remarks that have little humor? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient play childish pranks such as pinching or playing “keep away” for 
the fun of it? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient “talk big” or claim to have more abilities or wealth than is true? 
☐ No     ☐ Yes     ☐ Not Applicable 
If yes, does he/she cling to you to keep from being separated? 
☐ No     ☐ Yes      
 
7. Does the patient show any other signs of feeling to good or being too happy? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
9. How severe do you consider the patient’s symptoms? 
 Mild – the patient is too happy at times 
 Moderate – the patient is too happy at times, and this sometimes causes 
strange behavior 
 Marked – the patient is almost always too happy and finds nearly everything 
to be funny  
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
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 Moderately 
 Severely 
 Very severely or extremely 
 
 
CONTINUED FROM QUESTION G: Apathy/Indifference 
 
1. Does the patient seem less spontaneous and less active than usual? 
 ☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Is the patient less likely to initiate a conversation? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Is the patient less affectionate or lacking in emotions when compared to his/her 
usual self? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient contribute less to household chores? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient seem less interested in the activities and plans of others? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Has the patient lost interest in friends and family members? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Is the patient less enthusiastic about his/her usual interests? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Does the patient show any other signs that he/she doesn’t care about doing new 
things? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
9. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
10. How severe do you consider the patient’s symptoms? 
 Mild – apathy is notable but produces little interference with daily routines; 
only mildly different from the patient’s usual behavior; the patient responds to 
suggestion to engage in activities 
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 Moderate – apathy is very evident; may be overcome with coaxing and 
encouragement; responds spontaneously only to powerful events such as visits 
from close relatives or family members 
 Marked – apathy is very evident and usually fails to respond to any 
encouragement or external events 
 
11. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION H: DISINHIBITION 
 
1. Does the patient act impulsively without appearing to consider the consequences? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient talk to total strangers as if he/she knew them? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient say things to people that are insensitive or hurt their feelings? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient say crude things or make sexual remarks that they would not 
usually have said? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient talk openly about very personal or private matters not usually 
discussed in public? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient take liberties or touch or hug others in a way that is out of 
character for him/her? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient show any other signs of loss of control of his/her impulse? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
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9. How severe do you consider the patient’s symptoms? 
 Mild – disinhibitiion is notable, but usually responds to redirection and 
guidance 
 Moderate – disinhibition is very evident and difficult to overcome by the 
caregiver 
 Marked – disinhibition usually fails to respond to any intervention by the 
caregiver and is a source of embarrassment or social distress 
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION I: IRRITABILITY/LABILITY 
 
1. Does the patient have a bad temper, “flying off the handle” easily over little 
things? 
 ☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient rapidly change moods from one to another, being fine one minute 
and angry the next? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient have sudden flashes of anger? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Is the patient impatient, having trouble coping with delays or waiting for planned 
activities? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Is the patient cranky and irritable? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Is the patient argumentative and difficult to get along with? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient show any other signs of irritability? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
180 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
9. How severe do you consider the patient’s symptoms? 
 Mild – irritability or lability is notable but usually responds to redirection and 
reassurance 
 Moderate – irritability and lability are very evident and difficult to overcome 
by the caregiver 
 Marked – irritability and lability are very evident, they usually fail to respond 
to any intervention by the caregiver, and they are a major source of distress  
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION J: ABBERANT MOTOR BEHAVIOIR 
 
1. Does the patient pace around the house without purpose? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient rummage around opening and unpacking drawers or closets? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient repeatedly put on and take off clothing? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient have repetitive activities or “habits” that he/she performs over 
and over? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient engage in repetitive activities such as handling buttons, picking, 
wrapping string, etc? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet 
or tap his/her fingers a lot? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Does the patient do any other activities over and over? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
181 
 
8. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
9. How severe do you consider the patient’s symptoms? 
 Mild – abnormal motor activity is notable but produces little interference with 
daily routines 
 Moderate – abnormal motor activity is very evident; can be overcome by the 
caregiver 
 Marked – abnormal motor activity is very evident, it usually fails to respond 
to any intervention by the caregiver and is a major source of distress 
 
10. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION K: SLEEP 
 
1. Does the patient have difficulty falling asleep? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient get up during the night (do not count if the patient gets up once 
or twice per night only to go to the bathroom and falls back asleep immediately)? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Does the patient wander, pace, or get involved in inappropriate activities at night? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Does the patient awaken you during the night? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient wake up at night, dress, and plan to go out, thinking that it is 
morning and time to start the day? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
6. Does the patient wake up too early in the morning (earlier than was his/her habit)? 
☐ Yes     ☐ No     ☐ Not Applicable 
 
7. Does the patient sleep excessively during the day? 
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☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Does the patient have any other night-time behaviors that bother you that haven’t 
been asked about here? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
9. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
10. How severe do you consider the patient’s symptoms? 
 Mild – night-time behaviors occur but they are not particularly disruptive 
 Moderate – night-time behaviors occur and disturb the patient and the sleep of 
the caregiver; more than one type of night-time behavior may be present 
 Marked – night-time behaviors occur; several types of behavior may be 
present; the patient is very distressed during the night and the caregiver’s 
sleep is markedly disturbed  
 
11. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
 
CONTINUED FROM QUESTION L: APPETITE AND EATING DISORDERS 
 
1. Does the patient have poor appetite (loss of appetite)? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
2. Does the patient have an abnormally good appetite (increase in appetite)? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
3. Has the patient lost weight? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
4. Has the patient gained weight? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
5. Does the patient have unusual eating behavior, such as putting too much food in 
his/her mouth at once? 
☐ No     ☐ Yes     ☐ Not Applicable 
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6. Has the patient had a change in the kind of food he/she likes, such as wanting too 
many sweets or other specific types of food? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
7. Has the patient developed eating behaviors, such as eating exactly the same types 
of food each day, or eating the food in exactly the same order? 
☐ No     ☐ Yes     ☐ Not Applicable 
 
8. Have there been any other changes in appetite or eating that haven’t been asked 
about here? 
☐ No     ☐ Yes     ☐ Not Applicable 
If so, please describe (use the back of this page if necessary): 
 
9. How frequently does the patient experience these symptoms? 
 Occasionally – less than once per week 
 Often – about once per week 
 Frequently – several times per week, but less than every day 
 Very Frequently – once or more per day 
 
10. How severe do you consider the patient’s symptoms? 
 Mild – appetite changes are present but usually responds well to redirection 
and reassurance 
 Moderate – appetite changes are very evident and difficult to overcome by the 
caregiver 
 Marked – appetite changes are very evident, they usually fail to respond to 
any intervention by the caregiver, and they are a major source of distress  
 
11. How emotionally distressing do you find this behavior? 
 Not at all 
 Minimally 
 Mildly 
 Moderately 
 Severely 
 Very severely or extremely 
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APPENDIX E 
 
NEUROPSYCHOLOGICAL BATTERY ORDER OF 
ADMINISTRATION 
 
NOTE: Use BLUE pen for predictions, and GREEN pen for evaluations 
 
"Throughout the testing process today, I am going to ask you some questions that require 
you to estimate how well you would do on a certain task compared to people your same 
age and education level that haven’t had complaints about their thinking ability. Please 
draw a line on this scale indicating where you think your performance would fall, with 
the very top of the line being extremely well (point) and the very bottom of the line being 
extremely poorly (point). Remember that you are rating yourself in comparison to the 
average person your same age and education." 
 
1. Concern (PRE) (1) 
2. Read SCRIPT Above 
3. WCST Prediction (2) 
4. 3MS Prediction (3) 
5. 3MS 
6. 3MS Evaluation (3) 
7. Trails A Prediction (4) 
8. Trails A 
9. Trails A Evaluation (4) 
10. Trails B Prediction (5) 
11. Trails B 
12. Trails B Evaluation (5) 
13. FAS Prediction (6) 
14. FAS  
15. FAS Evaluation (6) 
16. Animals Prediction (7) 
17. Animals 
18. Animals Evaluation (7) 
19. CVLT Immediate Recall (IR) Prediction (8) 
20. CVLT Immediate Free Recall 
21. CVLT Short Delay Free Recall 
22. CVLT Immediate Recall (IR) Evaluation (8) 
23. Block Design (BD) Prediction (9) 
24. Block Design  
25. Block Design (BD) Evaluation (9) 
26. CVLT Delayed Recall (DR) Prediction (10) 
27. CVLT Long Delay Free Recall 
28. CVLT Long Delay Cued Recall 
29. CVLT Delayed Recall (DR) Evaluation (10) 
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30. CVLT Recognition Prediction (11) 
31. CVLT Long Delay Recognition 
32. CVLT Recognition Evaluation (11) 
33. SDMT Prediction (12) 
34. SDMT – Written  
35. SDMT Evaluation (12) 
36. GDS Prediction (13) 
37. GDS 
38. GDS Evaluation (13) 
39. CVLT Forced Choice Prediction (14) 
40. CVLT Forced Choice 
41. CVLT Forced Choice Evaluation (14) 
42. Logical Memory I (LMI) Prediction (15) 
43. Logical Memory I 
44. Logical Memory I (LMI) Evaluation (15) 
45. Logical Memory II (LMII) Pre-Prediction (16) 
46. Digit Span Forward (DS-F) Prediction (17) 
47. Digit Span Forward 
48. Digit Span Forward (DS-F) Evaluation (17) 
49. Digit Span Backward (DS-B) Prediction (18) 
50. Digit Span Backward 
51. Digit Span Backward (DS-B) Evaluation (18) 
52. Judgment of Line Orientation (JoLO) Prediction (19) 
53. Judgment of Line Orientation (JoLO) 
54. Judgment of Line Orientation (JoLO) Evaluation (19) 
55. Boston Naming (BNT) Prediction (20) 
56. Boston Naming Test 
57. Boston Naming (BNT) Evaluation (20) 
58. WTAR Prediction (21) 
59. WTAR 
60. WTAR Evaluation (21) 
61. WCST 
62. WCST Evaluation (2) 
63. Logical Memory II (LMII) Prediction (22) 
64. Logical Memory II 
65. Logical Memory II (LMII) Evaluation (22) 
66. Dot Counting (DC) Prediction (23) 
67. Dot Counting  
68. Dot Counting (DC) Evaluation (23) 
69. General Evaluation (24) 
70. Concern (POST) (25) 
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APPENDIX E 
 
PREDICITON AND EVALUATIONS RATING SCRIPT 
 
 
 Prediction Evaluation 
1 
C
O
N
C
E
R
N
 
Evaluation 1 (B): In general, how 
concerned is your family about your 
current thinking skills or cognitive 
ability? 
Evaluation 2 (G): In general, how 
concerned are you about your current 
thinking skills or cognitive ability? 
 
Evaluation 1 (B): Now that we’ve completed 
all these different tasks, how concerned is 
your family about your current thinking 
skills or cognitive ability? 
Evaluation 2 (G): In general, how concerned 
are you about your current thinking skills or 
cognitive ability? 
 
2 
W
C
S
T
 
If I were to give you a test that 
assessed your ability to solve 
problems in new ways without really 
knowing where to start, how well do 
you think you’d do? 
 
Earlier you said you’d do this well if I tested 
your ability to solve problems in new ways. 
Now that we’ve done the task, how well do 
you think you actually did? 
3 
3
M
S
 
Overall, how do you think your 
general cognitive ability compares 
with your same age and educated 
peers? 
Now that we’ve done a short set of tasks that 
look at your overall cognitive ability, how 
well do you think you actually did in 
comparison to your same age and educated 
peers? 
 
4 
T
ra
il
s 
A
 
If I were to give you a sheet with 25 
randomly distributed, numbered 
circles and ask you to connect them in 
order as fast as you could, how well 
do you think you’d do? 
 
Earlier you said you’d do this well if I asked 
you to connect 25 randomly distributed, 
numbered circles. Now that we’ve done the 
task, how well do you think you actually 
did? 
5 
T
ra
il
s 
B
 
If I were to give you a sheet with 25 
randomly distributed circles, half of 
them numbered and half of them 
lettered, and asked you to connect 
them alternating between numbers and 
letters in order as fast as you could, 
how well do you think you’d do? 
 
Earlier you said you’d do this well if I asked 
you to connect 25 randomly distributed 
circles alternating between numbers and 
letters in order. Now that we’ve done the 
task, how well do you think you actually 
did? 
6 
F
A
S
 
If I were to give you a letter of the 
alphabet and you were given one 
minute to come up with as many 
words as you could that start with that 
letter, how well do you think you’d 
do? 
 
Earlier you said you would do this well if 
given one minute to say as many words as 
you could that started with a given letter. 
Now that we’ve actually done the task, how 
well do you think you did? 
7 
A
n
im
al
s 
If I were to give you a category (like 
things you could find in a kitchen) and 
ask you to name as many items that 
fall within that category as you could 
in one minute, how well do you think 
Earlier you said you would do this well if 
given a category and asked to name as many 
items as you could in one minute. Now that 
we’ve actually done the task, how well do 
you think you actually did? 
187 
you’d do?  
8 
C
V
L
T
  
IR
 
If I were to read you a list of words to 
memorize and asked you to repeat as 
many words as you could, how well 
do you think you’d do? 
Earlier you said you’d do this well (point to 
estimate) if asked to memorize a list of 
words I read to you. Now that we’ve done 
the task, how well do you think you actually 
did? 
 
9 
B
D
 
If I were to give you a set of blocks 
and ask you to arrange the blocks so 
that they look like a given picture I 
show you, how well do you think 
you’d do? 
 
Earlier you said you’d do this well if asked 
to recreate  
a picture out of blocks. Now that we’ve done 
the task, how well do you think you actually 
did? 
 
10 
C
V
L
T
  
D
R
 
Earlier I read you a list of words and 
asked you to repeat back as many 
words as you could. If I were to ask 
you to repeat back as many of those 
words as you can now, how well do 
you think you’d do? 
Earlier you said you’d do this well (point to 
estimate) if asked to repeat as many words as 
you could remember from a list I read to you 
some time ago. Now that we’ve done the 
task, how well do you think you actually 
did? 
 
11 
C
V
L
T
 
R
ec
o
g
n
it
io
n
 
Earlier I read a list of words to you 
several times and asked you to repeat 
back as many of them as you could 
remember. How well do you think 
you’d be able to recognize those 
words from a list including words that 
were and were not from that original 
list? 
Earlier you said you’d do this well (point to 
estimate) if asked to recognize the words 
from the list that I read to you earlier from a 
list including words that were and were not 
from that original list. Now that we’ve 
actually done the task, how well do you think 
you actually did? 
 
12 
S
D
M
T
 
If I were to give you a key that 
showed a list of shapes that 
corresponded to numbers, how 
quickly do you think you could 
substitute the appropriate numbers for 
a row of shapes? 
 
You said you’d do this well if asked to 
substitute the appropriate numbers for a row 
of shapes if given a key. Now that we’ve 
done the task, how well do you think you 
actually did? 
13 
G
D
S
 In general, how often do you think 
you’ve experienced depression over 
the past two weeks in comparison to 
other people your same age? 
You just completed a questionnaire that 
assesses your level of depression. How do 
you think your answers compare to other 
people your same age?  
14 
C
V
L
T
 
F
C
 
Earlier I read a list of words to you 
several times and asked you to repeat 
back as many of them as you could 
remember. If I were to give you words 
two at a time, one of which was on the 
list and one of which was not, how 
accurately do you think you’d be able 
to pick out the word from the list? 
Earlier you said you’d do this well (point to 
estimate) if asked to pick out the correct 
word if given two choices. Now that we’ve 
actually done the task, how well do you think 
you actually did? 
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15 
L
M
I 
If I were to read you a story to 
memorize and asked you to repeat it 
back to me, how well do you think 
you’d do? 
Earlier you said you’d do this well (point to 
estimate) if asked to memorize a story I read 
to you. Now that we’ve done the task, how 
well do you think you actually did? 
 
16 
D
S
-F
 
If I were to read you a string of 
numbers and asked you to repeat them 
back to me in the same order, how 
well do you think you’d do? 
Earlier you said you’d do this well if asked 
to repeat a string of numbers in the same 
order that I read them to you in. Now that 
we’ve done the task, how well do you think 
you actually did? 
 
17 
D
S
-B
 
If I were to read you a string of 
numbers and asked you to repeat them 
back to me in reverse order, how well 
do you think you’d do? 
Earlier you said you’d do this well if asked 
to repeat a string of numbers in reverse 
order. Now that we’ve done the task, how 
well do you think you actually did? 
 
18 
Jo
L
O
 
How well do you think you could pick 
out the line in the group above (point 
to sample) that matches the line 
shown below (point to sample)? 
Earlier you said you’d do this well if asked 
to pick out the lines in the group that 
corresponded to the lines shown below. Now 
that we’ve actually completed the task, how 
well do you think you did? 
 
19 
B
N
T
 
If I were to assess your word finding 
ability by showing you a series of 
pictures of objects and asking you to 
name them, how well do you think 
you’d do? 
Earlier you said that you’d do this well if 
asked to name items when shown a picture 
of them. Now that we’ve done the task, how 
well do you think you actually did? 
 
20 
W
T
A
R
 If I were to give you a list of 
uncommon words to pronounce out 
loud, how well do you think you’d 
do? 
Earlier you said you’d do this well if I asked 
you to pronounce a list of uncommon words 
out loud. Now that we’ve done the task, how 
well do you think you actually did? 
 
21 
L
M
II
 
I read you two stories earlier, do you 
remember? If I were to ask you to tell 
me as much about those stories as you 
can remember now, how well do you 
think you’d do? 
 
Earlier you said you’d do this well (point to 
estimate) if asked to repeat back as much of 
those stories as you could. Now that we’ve 
done the task, how well do you think you 
actually did? 
22 
G
E
N
E
R
A
L
 
 In general, how well do you think you did on 
the tasks you engaged in today?  
 
If you were to have engaged in these same 
tasks before you (or your family) began 
noticing changes in your cognitive ability, 
how well do you think you would have 
done? 
 
 
189 
APPENDIX G 
 
SAMPLE RATING SCALES 
 
 
 
 
 
Not Concerned 
Very Concerned 
190 
 
 
 
Extremely Well 
Extremely Poorly 
